TW201443026A - Pyridazinone compound and herbicide containing the same - Google Patents

Pyridazinone compound and herbicide containing the same Download PDF

Info

Publication number
TW201443026A
TW201443026A TW103103102A TW103103102A TW201443026A TW 201443026 A TW201443026 A TW 201443026A TW 103103102 A TW103103102 A TW 103103102A TW 103103102 A TW103103102 A TW 103103102A TW 201443026 A TW201443026 A TW 201443026A
Authority
TW
Taiwan
Prior art keywords
group
alkyl
alkoxy
compound
mode
Prior art date
Application number
TW103103102A
Other languages
Chinese (zh)
Inventor
Tomohiro Araki
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of TW201443026A publication Critical patent/TW201443026A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/581,2-Diazines; Hydrogenated 1,2-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/761,3-Oxazoles; Hydrogenated 1,3-oxazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/781,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • C07D237/16Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A compound represented by the formula (I) is provided: wherein R1, R2, and R3 is a C1-6alkyl group; R4 and R5 is a hydrogen atom or A is a mono or dicyclic condensed ring aryl group; G is a hydrogen atom... etc.

Description

嗒 酮化合物及含該化合物之除草劑Anthrone compound and herbicide containing the same

本發明是關於嗒酮化合物及含有該化合物的除草劑。 The present invention relates to 嗒 a ketone compound and a herbicide containing the same.

以往由於對於用於防治雜草的除草劑的有效成分的化合物的開發進展,而發現了有雜草防治效力的化合物。 Conventionally, compounds having potency of weed control have been found due to advances in the development of compounds for the active ingredients of herbicides for controlling weeds.

已知具有除草活性的嗒酮化合物(WO 2007/119434、WO 2009/035150、WO 2009/086041、WO 2010/069525、WO 2010/069526、WO 2010/078912、WO 2010/104217、WO 2012/091156、WO 2013/160126、J.Heterocycl.Chem.,vol.42,p.427-435,2005等)。 Herbicide known to have herbicidal activity Ketone compounds (WO 2007/119434, WO 2009/035150, WO 2009/086041, WO 2010/069525, WO 2010/069526, WO 2010/078912, WO 2010/104217, WO 2012/091156, WO 2013/160126, J. Heterocycl. Chem., vol. 42, p. 427-435, 2005, etc.).

本發明是以提供有優異的雜草防治效力的化合物作為課題。 The present invention is directed to a compound which provides excellent weed control efficacy.

本發明者等精心檢討的結果,發現下述式(I)表示的嗒酮化合物有優異的雜草防治效力,而達到本發明。 As a result of careful examination by the inventors, the enthalpy represented by the following formula (I) was found. The ketone compound has excellent weed control efficacy and achieves the present invention.

即、本發明如下。 That is, the present invention is as follows.

(項1)式(I)表示的嗒酮化合物(以下、簡稱為本發明化合物。) (Item 1) Formula (I) A ketone compound (hereinafter, simply referred to as a compound of the present invention.)

[式中,R1表示氫、C1-6烷基、C3-8環烷基、(C3-8環烷基)C1-6烷基、C3-4烯基或C3-4炔基,R2表示氫、鹵素、氰基、硝基、C1-6烷基、C1-6鹵烷基、C1-6烷氧基、C1-6鹵烷氧基、C1-6烷硫基、C1-6烷基亞磺醯基、C1-6烷基磺醯基、C1-6鹵烷硫基、C1-6鹵烷基亞磺醯基、C1-6鹵烷基磺醯基、C3-8環烷基、(C3-8環烷基)C1-6烷基、C3-8環烷氧基、(C3-8環烷基)C1-6烷氧基、(C1-6烷硫基)C1-6烷氧基、(C1-6烷氧基)C1-6烷氧基、C3-6烯氧基、C3-6炔氧基、氰基C1-6烷氧基、(C1-6烷氧基)羰基C1-6烷氧基、胺甲醯基C1-6烷氧基、{(C1-6烷基)胺基羰基}C1-6烷氧基、{二(C1-6烷基)胺基羰基}C1-6烷氧基、胺基、C1-6烷胺基、二(C1-6烷基)胺基、甲醯基胺基、(C1-6烷基)羰基胺基、羥基C1-6烷基、(C1-6烷氧基)C1-6烷基、(C1-6鹵烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、{(C3-8環烷基)C1-6烷氧基}C1-6烷基、(C1-6烷硫基)C1-6烷基、(C1-6鹵烷硫基)C1-6烷基、氰基C1-6烷基、羥基亞胺基C1-6烷基、(C1-6烷氧基)亞胺基C1-6烷基、甲醯基或(C1-6烷基)羰基,R3表示鹵素、C1-3烷基、C1-3鹵烷基、C2-4烯基、C2-4炔基、C1-3烷氧基、C1-3鹵烷氧基或C3-8環烷基,R4及R5可以相同或不相同,表示氫、鹵素、C1-3烷基、C1-3鹵烷基、C2-4烯基、C2-4炔基、C1-3烷氧基、C1-3鹵烷氧基或C3-8環烷 基,A表示單環式或二環式縮合環的芳基或者含由氮、氧及硫所成的群選出的1個以上的原子作為雜原子的單環式或二環式縮合環的雜芳基,該等基可以具有由B群選出的1個以上的原子或基,G表示氫或下述式表示的任一種基: [式中,L表示氧或硫,R6表示C1-12烷基、C3-8環烷基、C2-12烯基、C2-12炔基、可以具有由D群選出的1個以上的原子或基的C6-10芳基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-12烷基、C1-12烷氧基、C3-8環烷氧基、C3-12烯氧基、C3-12炔氧基、可以具有由D群選出的1個以上的原子或基的C6-10芳氧基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-12烷氧基、(C3-8環烷基)C1-6烷基、(C1-6烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、(C1-6烷硫基)C1-6烷基、(C1-6烷基亞磺醯基)C1-6烷基、(C1-6烷基磺醯基)C1-6烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳氧基)C1-12烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基硫基)C1-12烷基、{(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-6烷氧基}C1-6烷基、(C3-8環烷基)C1-6烷氧基、二(C1-6烷基)胺基、二(C3-6烯基)胺基、(C1-6烷基)(C6-10芳基)胺基或5至6員的雜芳基,R7表示C1-6烷基、C1-3鹵烷基、可以具有由D群選出的1個以上的原子或基的C6-10芳基或二(C1-6烷基)胺基, R8及R9可以相同或不相同,表示C1-6烷基、C3-8環烷基、C6-10芳基、C1-6烷氧基、C3-8環烷氧基、C6-10芳氧基、(C6-10芳基)C1-6烷氧基、C1-6烷硫基或二(C1-6烷基)胺基,R10表示氫或C1-6烷基,W表示可以具有由D群選出的1個以上的原子或基的苯基、C1-6烷氧基、C1-6烷硫基、C1-6烷基亞磺醯基或C1-6烷基磺醯基。在這裏,R6、R7、R8、R9及W個別所表示的任意的基都可以具有鹵素,R6的C3-8環烷基、R6、R8及R9的C3-8環烷氧基、R8及R9的(C1-6烷基)(C6-10芳基)胺基的芳基部分及5至6員的雜芳基之任何一個都可以具有C1-6烷基]。 Wherein R 1 represents hydrogen, C 1-6 alkyl, C 3-8 cycloalkyl, (C 3-8 cycloalkyl) C 1-6 alkyl, C 3-4 alkenyl or C 3- 4 alkynyl, R 2 represents hydrogen, halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 1-6 alkylthio, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, C 1-6 haloalkylthio, C 1-6 haloalkylsulfinyl, C 1-6 haloalkylsulfonyl, C 3-8 cycloalkyl, (C 3-8 cycloalkyl) C 1-6 alkyl, C 3-8 cycloalkoxy, (C 3-8 naphthenic) yl) C 1-6 alkoxy, (C 1-6 alkylthio) C 1-6 alkoxy, (C 1-6 alkoxy) C 1-6 alkoxy, C 3-6 alkenyloxy a group, a C 3-6 alkynyloxy group, a cyano C 1-6 alkoxy group, a (C 1-6 alkoxy)carbonyl C 1-6 alkoxy group, an amine carbaryl C 1-6 alkoxy group, {(C 1-6 alkyl)aminocarbonyl}C 1-6 alkoxy, {di(C 1-6 alkyl)aminocarbonyl}C 1-6 alkoxy, amine, C 1-6 An alkylamino group, a di(C 1-6 alkyl)amino group, a decylamino group, a (C 1-6 alkyl)carbonylamino group, a hydroxy C 1-6 alkyl group, a (C 1-6 alkoxy group) C 1-6 alkyl, (C 1-6 haloalkoxy) C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, {(C 3-8 naphthenic) Base) C 1-6 alkoxy} C 1-6 alkane , (C 1-6 alkylthio) C 1-6 alkyl, (C 1-6 haloalkylthio) C 1-6 alkyl, cyano C 1-6 alkyl, hydroxyimino C 1 a -6 alkyl group, a (C 1-6 alkoxy) imido C 1-6 alkyl group, a decyl group or a (C 1-6 alkyl) carbonyl group, and R 3 represents a halogen, a C 1-3 alkyl group, C 1-3 haloalkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-3 alkoxy, C 1-3 haloalkoxy or C 3-8 cycloalkyl, R 4 and R 5 may be the same or different and represents hydrogen, halogen, C 1-3 alkyl, C 1-3 haloalkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-3 alkoxy, C 1-3 haloalkoxy or C 3-8 cycloalkyl, and A represents an aryl group of a monocyclic or bicyclic condensed ring or one or more atoms selected from a group consisting of nitrogen, oxygen and sulfur. As the heteroaryl group of the monocyclic or bicyclic condensed ring of a hetero atom, the group may have one or more atoms or groups selected from the group B, and G represents hydrogen or any one represented by the following formula: Wherein L represents oxygen or sulfur, and R 6 represents C 1-12 alkyl, C 3-8 cycloalkyl, C 2-12 alkenyl, C 2-12 alkynyl, and may have 1 selected from group D. one or more atoms or C 6-10 aryl group, (D may have selected a group of one or more atoms or groups C 6-10 aryl) C 1-12 alkyl, C 1-12 alkoxy a C 3-8 cycloalkoxy group, a C 3-12 alkenyloxy group, a C 3-12 alkynyloxy group, a C 6-10 aryloxy group which may have one or more atoms or groups selected from the D group, (C 6-10 aryl group having 1 or more atoms or groups selected from the D group) C 1-12 alkoxy group, (C 3-8 cycloalkyl) C 1-6 alkyl group, (C 1 -6 alkoxy) C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, (C 1-6 alkylthio) C 1-6 alkyl, (C 1- 6 alkylsulfinyl acyl) C 1-6 alkyl, (C C1-6 alkylsulfonyl group) C 1-6 alkyl, (C may have a group selected from D or more atoms or groups 6-10 aryloxy) C 1-12 alkyl, (D may have selected a group of one or more atom or group of C 6-10 arylthio) C 1-12 alkyl, {(may have One or more atoms selected from group D or a C 6-10 aryl)C 1-6 alkoxy}C 1-6 alkyl group, (C 3-8 cycloalkyl) C 1-6 alkoxy group base Di (C 1-6 alkyl) amino, di (C 3-6 alkenyl) amino, (C 1-6 alkyl) (C 6-10 aryl) amino group or 5-6 heteroaryl And R 7 represents a C 1-6 alkyl group, a C 1-3 haloalkyl group, a C 6-10 aryl group or a di(C 1-6 alkyl group) which may have one or more atoms or groups selected from the D group. Amino, R 8 and R 9 may be the same or different and represent C 1-6 alkyl, C 3-8 cycloalkyl, C 6-10 aryl, C 1-6 alkoxy, C 3-8 Cycloalkoxy, C 6-10 aryloxy, (C 6-10 aryl) C 1-6 alkoxy, C 1-6 alkylthio or di(C 1-6 alkyl)amine, R 10 represents hydrogen or C 1-6 alkyl, W represents a one or more atom or group selected from the group D is phenyl, C 1-6 alkoxy, C 1-6 alkylthio, C 1- 6 alkylsulfinyl or C 1-6 alkylsulfonyl. Here, R 6, R 7, R 8, R 9 and W is any group represented by the individual may have halogen, R C 6 cycloalkyl of 3-8, R 6, R C 3 8 and R 9 is Any one of an aryl group of a -8 cycloalkoxy group, a (C 1-6 alkyl)(C 6-10 aryl)amino group of R 8 and R 9 and a heteroaryl group of 5 to 6 members may have C 1-6 alkyl].

B群:由鹵素、C1-3烷基、C1-3鹵烷基、C1-3烷氧基、C1-3鹵烷氧基、C3-8環烷基、C2-4烯基、C2-4鹵烯基、C2-4炔基、C1-3烷硫基、C1-3鹵烷硫基、C1-3烷基亞磺醯基、C1-3鹵烷基亞磺醯基、C1-3烷基磺醯基、C1-3鹵烷基磺醯基、硝基、氰基、(C1-6烷基)羰基、(C1-6烷氧基)羰基、胺甲醯基、(C1-3烷基)胺基羰基、二(C1-3烷基)胺基羰基、(C1-6烷基)羰基胺基、(C3-8環烷基)羰基胺基、(C1-6烷氧基)羰基胺基、及(C1-3烷氧基)C1-3烷基所成的群。 Group B: from halogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-3 alkoxy, C 1-3 haloalkoxy, C 3-8 cycloalkyl, C 2-4 Alkenyl, C 2-4 haloalkenyl, C 2-4 alkynyl, C 1-3 alkylthio, C 1-3 haloalkylthio, C 1-3 alkylsulfinyl, C 1-3 Haloalkylsulfinyl, C 1-3 alkylsulfonyl, C 1-3 haloalkylsulfonyl, nitro, cyano, (C 1-6 alkyl)carbonyl, (C 1-6 Alkoxy)carbonyl, aminemethanyl, (C 1-3 alkyl)aminocarbonyl, di(C 1-3 alkyl)aminocarbonyl, (C 1-6 alkyl)carbonylamino, (C A group of a 3-8 cycloalkyl)carbonylamino group, a (C 1-6 alkoxy)carbonylamino group, and a (C 1-3 alkoxy) C 1-3 alkyl group.

D群:由鹵素、C1-6烷基、C1-3鹵烷基、C1-3烷氧基、C1-3鹵烷氧基、C1-3烷硫基、氰基及硝基所成的群]。 Group D: from halogen, C 1-6 alkyl, C 1-3 haloalkyl, C 1-3 alkoxy, C 1-3 haloalkoxy, C 1-3 alkylthio, cyano and nitrate The group formed by the base].

(項2)前述(項1)所述的嗒酮化合物,其中,A表示苯基、萘基、吡啶基、嗒基、嘧啶基、吡基、苯并噻唑基、苯并唑基、喹啉基、噌啉基(cinnolinyl)、喹唑啉基、喹啉基或苯并三基,該等的基可以具有由B群選出的1個以上的原子或基, G表示氫或下述式表示的任一種基: [式中,R6a表示C1-12烷基、C1-12鹵烷基、C3-8環烷基、可以具有由D群選出的1個以上的原子或基的C6-10芳基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-12烷基、C1-12烷氧基、C3-12烯氧基、C3-12炔氧基、可以具有由D群選出的1個以上的原子或基的C6-10芳氧基、(C3-8環烷基)C1-6烷基、(C1-6烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、(C1-6烷硫基)C1-6烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳氧基)C1-12烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基硫基)C1-12烷基、{(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-6烷氧基}C1-6烷基或(C3-8環烷基)C1-6烷氧基,R7a表示C1-6烷基或可以具有由D群選出的1個以上的原子或基的C6-10芳基,Wa表示C1-3烷氧基或可以具有由D群選出的1個以上的原子或基的苯基] (Item 2) The 嗒 described in the above (Item 1) a ketone compound, wherein A represents a phenyl group, a naphthyl group, a pyridyl group, an anthracene Base, pyrimidinyl, pyridyl Benzothiazolyl, benzo Azolyl, quinolyl, cinnolinyl, quinazolinyl, quin Porphyrin or benzotrien Further, these groups may have one or more atoms or groups selected from Group B, and G represents hydrogen or any of the groups represented by the following formula: Wherein R 6a represents a C 1-12 alkyl group, a C 1-12 haloalkyl group, a C 3-8 cycloalkyl group, or a C 6-10 aryl group which may have one or more atoms or groups selected from the D group. a group, a C 6-10 aryl group (which may have one or more atoms or groups selected from the D group), a C 1-12 alkyl group, a C 1-12 alkoxy group, a C 3-12 alkenyloxy group, a C 3 group a -12 alkynyloxy group, a C 6-10 aryloxy group having 1 or more atoms or groups selected from the D group, (C 3-8 cycloalkyl) C 1-6 alkyl group, (C 1-6 Alkoxy)C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, (C 1-6 alkylthio) C 1-6 alkyl, (may have a group D C 6-10 aryl group selected from one or more atom or group) C 1-12 alkyl, (which may have one or more atom or group selected from the group D C 6-10 arylthio) C 1-12 alkyl, {(C 6-10 aryl which may have 1 or more atoms selected from the D group) C 1-6 alkoxy} C 1-6 alkyl or (C 3- 8 -cycloalkyl)C 1-6 alkoxy, R 7a represents a C 1-6 alkyl group or a C 6-10 aryl group which may have one or more atoms or groups selected from the D group, and W a represents C 1 a -3 alkoxy group or a phenyl group which may have one or more atoms or groups selected from the D group]

B群是鹵素、C1-3烷基、C1-3鹵烷基、C1-3烷氧基、C1-3鹵烷氧基、硝基或氰基。 Group B is halogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-3 alkoxy, C 1-3 haloalkoxy, nitro or cyano.

(項3)前述(項2)所述的嗒酮化合物,其中,R2表示氫、C1-3烷基、C1-3鹵烷基、C1-6烷氧基、C1-6鹵烷氧基、C3-8環烷基、C3-8環烷氧基或(C3-8環烷基)C1-6烷氧基。 (Item 3) The 嗒 described in the above (Item 2) a ketone compound, wherein R 2 represents hydrogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 3-8 cycloalkyl, C 3-8 cycloalkoxy or (C 3-8 cycloalkyl) C 1-6 alkoxy.

(項4)前述(項3)所述的嗒酮化合物,其中,R1是甲基。 (Item 4) The 嗒 described in the above (Item 3) A ketone compound wherein R 1 is a methyl group.

(項5)前述(項3)所述的嗒酮化合物,其中,R2是氫、甲基或甲氧基。 (Item 5) The 嗒 described in the above (Item 3) A ketone compound wherein R 2 is hydrogen, methyl or methoxy.

(項6)前述(項2)所述的嗒酮化合物,其中,R1是甲基,R2是氫、甲基或甲氧基,R3是甲基、乙基、丙基、環丙基、鹵素或鹵甲基,R4是氫或甲基,R5是氫、甲基、乙基、丙基、環丙基、鹵素或鹵甲基。 (Item 6) The 嗒 described in the above (Item 2) a ketone compound wherein R 1 is methyl, R 2 is hydrogen, methyl or methoxy, R 3 is methyl, ethyl, propyl, cyclopropyl, halogen or halomethyl, and R 4 is hydrogen or Methyl, R 5 is hydrogen, methyl, ethyl, propyl, cyclopropyl, halogen or halomethyl.

(項7)前述(項1)所述的嗒酮化合物,其中,A是吡啶基、苯并噻唑基、苯并唑基或喹啉基,該等的基可以具有由B群選出的1個以上的原子或基。 (Item 7) The 嗒 described in the above (Item 1) a ketone compound wherein A is pyridyl, benzothiazolyl, benzo The azole group or the quinolyl group may have one or more atoms or groups selected from the group B.

(項8)前述(項6)所述的嗒酮化合物,其中,R3是甲基、乙基、丙基、環丙基,R4及R5是氫,A是吡啶基、苯并噻唑基、苯并唑基或喹啉基,該等的基可以具有由B群選出的1個以上的原子或基。 (Item 8) The 嗒 described in the above (Item 6) a ketone compound wherein R 3 is methyl, ethyl, propyl or cyclopropyl, R 4 and R 5 are hydrogen, and A is pyridyl, benzothiazolyl, benzo The azole group or the quinolyl group may have one or more atoms or groups selected from the group B.

(項9)一種除草劑,係含有前述(項1)至(項8)任一項所述的嗒酮化合物作為有效成分。 (Item 9) A herbicide comprising the hydrazine according to any one of (1) to (8) A ketone compound is used as an active ingredient.

(項10)一種雜草的防治方法,是將前述(項1)至(項8)任一項所述的嗒酮化合物的有效量,對雜草或雜草生長的土壤施用。 (Item 10) A method for controlling weeds according to any one of (1) to (8) An effective amount of a ketone compound applied to the soil in which weeds or weeds grow.

(項11)將前述(項1)至(項8)任一項所述的嗒酮化合物的使用,係用於雜草的防治。 (Item 11) The enthalpy according to any one of (1) to (8) The use of ketone compounds is used for the control of weeds.

本發明化合物有雜草防治效力,可作為有效的除草 劑的有效成分。 The compound of the invention has weed control efficacy and can be used as effective weeding The active ingredient of the agent.

下面說明本發明中的取代基。 The substituents in the present invention are explained below.

就鹵素而言,例如可列舉氟、氯、溴及碘。 Examples of the halogen include fluorine, chlorine, bromine, and iodine.

C1-3烷基就是意指碳數1至3的烷基,可列舉甲基、乙基、丙基及異丙基。 The C 1-3 alkyl group means an alkyl group having 1 to 3 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group and an isopropyl group.

C1-6烷基就是意指碳數1至6的烷基,例如可列舉甲基、乙基、丙基、異丙基、2,2-二甲基丙基、丁基、異丁基、二級丁基、三級丁基、1-甲基丁基、2-甲基丁基、3-甲基丁基、戊基、己基及異己基。 The C 1-6 alkyl group means an alkyl group having 1 to 6 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 2,2-dimethylpropyl group, a butyl group, and an isobutyl group. , secondary butyl, tert-butyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, pentyl, hexyl and isohexyl.

C1-12烷基就是意指碳數1至12的烷基,例如可列舉甲基、乙基、丙基、異丙基、1-甲基丙基、2-甲基丙基、1-乙基丙基、2,2-二甲基丙基、丁基、異丁基、二級丁基、三級丁基、1-甲基丁基、2-甲基丁基、3-甲基丁基、1-乙基丁基、1-丙基丁基、戊基、1-甲基戊基、1-乙基戊基、2,4,4-三甲基戊基、己基、庚基、辛基、壬基、癸基、十一基及十二基。 The C 1-12 alkyl group means an alkyl group having 1 to 12 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1-methylpropyl group, a 2-methylpropyl group, and a 1- Ethylpropyl, 2,2-dimethylpropyl, butyl, isobutyl, secondary butyl, tert-butyl, 1-methylbutyl, 2-methylbutyl, 3-methyl Butyl, 1-ethylbutyl, 1-propylbutyl, pentyl, 1-methylpentyl, 1-ethylpentyl, 2,4,4-trimethylpentyl, hexyl, heptyl , octyl, sulfhydryl, sulfhydryl, eleven and twelve bases.

鹵甲基就是意指具有氟、氯、溴、碘等鹵素的甲基,例如可列舉三氟甲基、二氟甲基、溴甲基及氯甲基。 The halomethyl group means a methyl group having a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trifluoromethyl group, a difluoromethyl group, a bromomethyl group and a chloromethyl group.

C1-3鹵烷基就是意指具有氟、氯、溴、碘等鹵素的碳數1至3的烷基,例如可列舉三氟甲基、氯甲基、2,2-二氟乙基、2,2,2-三氯乙基、2,2,2-三氟乙基及2,2,2-三氟-1,1-二氯乙基。 The C 1-3 haloalkyl group means an alkyl group having 1 to 3 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trifluoromethyl group, a chloromethyl group and a 2,2-difluoroethyl group. 2,2,2-trichloroethyl, 2,2,2-trifluoroethyl and 2,2,2-trifluoro-1,1-dichloroethyl.

C1-6鹵烷基就是意指具有氟、氯、溴、碘等鹵素的碳數1至6 的烷基,例如可列舉三氟甲基、氯甲基、2,2-二氟乙基、2,2,2-三氯乙基、2,2,2-三氟乙基、2,2,2-三氟-1,1-二氯乙基及2,2-二氟己基。 The C 1-6 haloalkyl group means an alkyl group having 1 to 6 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trifluoromethyl group, a chloromethyl group and a 2,2-difluoroethyl group. 2,2,2-trichloroethyl, 2,2,2-trifluoroethyl, 2,2,2-trifluoro-1,1-dichloroethyl and 2,2-difluorohexyl.

C1-12鹵烷基就是意指具有氟、氯、溴、碘等鹵素的碳數1至6的烷基,例如可列舉三氟甲基、氯甲基、2,2-二氟乙基、2,2,2-三氯乙基、2,2,2-三氟乙基、2,2,2-三氟-I,1-二氯乙基、2,2-二氟己基及1,1-二氟十二基。 The C 1-12 haloalkyl group means an alkyl group having 1 to 6 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trifluoromethyl group, a chloromethyl group and a 2,2-difluoroethyl group. , 2,2,2-trichloroethyl, 2,2,2-trifluoroethyl, 2,2,2-trifluoro-I,1-dichloroethyl, 2,2-difluorohexyl and 1 , 1-difluorododecyl.

C3-8環烷基就是意指碳數3至8的環烷基,例如可列舉環丙基、環丁基、環戊基及環己基。 The C 3-8 cycloalkyl group means a cycloalkyl group having 3 to 8 carbon atoms, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group.

(C3-8環烷基)C1-6烷基就是意指具有碳數3至8的環烷基的碳數1至6的烷基,例如可列舉環丙基甲基及環戊基甲基。 (C 3-8 cycloalkyl)C 1-6 alkyl means an alkyl group having 1 to 6 carbon atoms having a cycloalkyl group having 3 to 8 carbon atoms, and examples thereof include a cyclopropylmethyl group and a cyclopentyl group. methyl.

C2-4烯基就是意指碳數2至4的烯基,例如可列舉乙烯基、烯丙基、1-丁烯基、2-丁烯基及3-丁烯基。 The C 2-4 alkenyl group means an alkenyl group having 2 to 4 carbon atoms, and examples thereof include a vinyl group, an allyl group, a 1-butenyl group, a 2-butenyl group, and a 3-butenyl group.

C3-4烯基就是意指碳數3至4的烯基,例如可列舉烯丙基、1-丁烯基、2-丁烯基及3-丁烯基。 The C 3-4 alkenyl group means an alkenyl group having 3 to 4 carbon atoms, and examples thereof include an allyl group, a 1-butenyl group, a 2-butenyl group and a 3-butenyl group.

C2-12烯基就是意指碳數2至12的烯基,例如可列舉乙烯基、烯丙基、1-丁烯基、2-丁烯基、3-丁烯基、5-己烯基及11-十二烯基。 The C 2-12 alkenyl group means an alkenyl group having 2 to 12 carbon atoms, and examples thereof include a vinyl group, an allyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, and a 5-hexene group. And 11-dodecenyl.

C2-4炔基就是意指碳數2至4的炔基,例如可列舉乙炔基、炔丙基及2-丁炔基。 The C 2-4 alkynyl group means an alkynyl group having 2 to 4 carbon atoms, and examples thereof include an ethynyl group, a propargyl group, and a 2-butynyl group.

C3-4炔基就是意指碳數3至4的炔基,例如可列舉炔丙基及2-丁炔基。 The C 3-4 alkynyl group means an alkynyl group having 3 to 4 carbon atoms, and examples thereof include a propargyl group and a 2-butynyl group.

C2-12炔基就是意指碳數2至12的炔基,例如可列舉乙烯基、炔丙基、2-丁炔基、5-己炔基及11-十二炔基。 The C 2-12 alkynyl group means an alkynyl group having 2 to 12 carbon atoms, and examples thereof include a vinyl group, a propargyl group, a 2-butynyl group, a 5-hexynyl group, and an 11-dodecynyl group.

C1-3烷氧基就是意指碳數1至3的烷氧基,可列舉 甲氧基、乙氧基、正丙氧基、異丙氧基。 The C 1-3 alkoxy group means an alkoxy group having 1 to 3 carbon atoms, and examples thereof include a methoxy group, an ethoxy group, a n-propoxy group, and an isopropoxy group.

C1-6烷氧基就是意指碳數1至6的烷氧基,例如可列舉甲氧基、乙氧基、丙氧基、異丙氧基、丁氧基、2-甲基丙氧基、3-甲基丙氧基、三級丁氧基、戊氧基、二級戊氧基、異戊氧基、新戊氧基、己氧基及異己氧基。 The C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms, and examples thereof include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, and a 2-methylpropoxy group. Base, 3-methylpropoxy, tert-butoxy, pentyloxy, secondary pentyloxy, isopentyloxy, neopentyloxy, hexyloxy and isohexyloxy.

C1-12烷氧基就是意指碳數1至12的烷氧基,例如可列舉甲氧基、乙氧基、丙氧基、異丙氧基、丁氧基、2-甲基丙氧基、3-甲基丙氧基、三級丁氧基、戊氧基、二級戊氧基、異戊氧基、新戊氧基、己氧基、異己氧基及十二氧基。 The C 1-12 alkoxy group means an alkoxy group having 1 to 12 carbon atoms, and examples thereof include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, and a 2-methylpropoxy group. Base, 3-methylpropoxy, tert-butoxy, pentyloxy, secondary pentyloxy, isopentyloxy, neopentyloxy, hexyloxy, isohexyloxy and dodecyloxy.

C1-3鹵烷氧基就是意指具有氟、氯、溴、碘等鹵素的碳數1至3的烷氧基,例如可列舉三氟甲氧基、2,2-二氟乙氧基、2,2,2-三氟乙氧基、2,2,2-三氯乙氧基及3,3-二氟丙氧基。 The C 1-3 haloalkoxy group means an alkoxy group having 1 to 3 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trifluoromethoxy group and a 2,2-difluoroethoxy group. 2,2,2-trifluoroethoxy, 2,2,2-trichloroethoxy and 3,3-difluoropropoxy.

C1-6鹵烷氧基就是意指具有氟、氯、溴、碘等鹵素的碳數1至3的烷氧基,例如可列舉三氟甲氧基、2,2-二氟乙氧基、2,2,2-三氟乙氧基、2,2,2-三氯乙氧基、3,3-二氟丙氧基及6-氟己氧基。 The C 1-6 haloalkoxy group means an alkoxy group having 1 to 3 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trifluoromethoxy group and a 2,2-difluoroethoxy group. 2,2,2-Trifluoroethoxy, 2,2,2-trichloroethoxy, 3,3-difluoropropoxy and 6-fluorohexyloxy.

C1-6烷硫基就是意指碳數1至6的烷硫基,例如可列舉甲硫基、乙硫基及異丙硫基。 The C 1-6 alkylthio group means an alkylthio group having 1 to 6 carbon atoms, and examples thereof include a methylthio group, an ethylthio group and an isopropylthio group.

C1-6烷基亞磺醯基就是意指碳數1至6的烷基亞磺醯基,例如可列舉甲基亞磺醯基、乙基亞磺醯基及異丙基亞磺醯基。 The C 1-6 alkylsulfinyl group means an alkylsulfinyl group having 1 to 6 carbon atoms, and examples thereof include a methylsulfinyl group, an ethylsulfinyl group, and an isopropylsulfinyl group. .

C1-6烷基磺醯基就是意指碳數1至6的烷基磺醯基,例如可列舉甲基磺醯基、乙基磺醯基及異丙基磺醯基。 The C 1-6 alkylsulfonyl group means an alkylsulfonyl group having 1 to 6 carbon atoms, and examples thereof include a methylsulfonyl group, an ethylsulfonyl group, and an isopropylsulfonyl group.

C1-6鹵烷硫基就是意指具有氟、氯、溴、碘等鹵素的碳數1至6的烷硫基,例如可列舉三氯甲硫基、三氟甲硫基、2,2-二氟乙硫基、2,2,2-三氟乙硫基、2,2,2-三氯乙硫基及3-氯丙硫 基。 The C 1-6 haloalkylthio group means an alkylthio group having 1 to 6 carbon atoms having a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trichloromethylthio group, a trifluoromethylthio group, and 2,2. -difluoroethylthio, 2,2,2-trifluoroethylthio, 2,2,2-trichloroethylthio and 3-chloropropylthio.

C1-6鹵烷基亞磺醯基就是意指具有氟、氯、溴、碘等鹵素的碳數1至6的烷基亞磺醯基。例如可列舉三氯甲基亞磺醯基、三氟甲基亞磺醯基、2,2-二氟乙基亞磺醯基、2,2,2-三氟乙基亞磺醯基、2,2,2-三氯乙基亞磺醯基及3-氯丙基亞磺醯基。 The C 1-6 haloalkylsulfinyl group means an alkylsulfinyl group having 1 to 6 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine. For example, trichloromethylsulfinyl, trifluoromethylsulfinyl, 2,2-difluoroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2 , 2,2-trichloroethylsulfinyl and 3-chloropropylsulfinyl.

C1-6鹵烷基磺醯基就是意指具有氟、氯、溴、碘等鹵素的碳數1至6的烷基磺醯基,例如可列舉三氯甲基磺醯基、三氟甲基磺醯基、2,2-二氟乙基磺醯基、2,2,2-三氟乙基磺醯基、2,2,2-三氯乙基磺醯基及3-氯丙基磺醯基。 The C 1-6 haloalkylsulfonyl group means an alkylsulfonyl group having 1 to 6 carbon atoms having a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include trichloromethylsulfonyl group and trifluoromethyl group. Sulfosyl, 2,2-difluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2,2,2-trichloroethylsulfonyl and 3-chloropropyl Sulfonyl.

C3-8環烷氧基就是意指碳數3至8的環烷氧基,例如可列舉環丙氧基、環戊氧基及環己氧基。 The C 3-8 cycloalkoxy group means a cycloalkyloxy group having 3 to 8 carbon atoms, and examples thereof include a cyclopropoxy group, a cyclopentyloxy group, and a cyclohexyloxy group.

(C3-8環烷基)C1-6烷氧基就是意指具有碳數3至8的環烷基的碳數1至6的烷氧基,例如可列舉環丙基甲氧基、1-環丙基乙氧基及環戊基甲氧基。 The (C 3-8 cycloalkyl) C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms having a cycloalkyl group having 3 to 8 carbon atoms, and examples thereof include a cyclopropylmethoxy group. 1-cyclopropylethoxy and cyclopentylmethoxy.

(C1-6烷硫基)C1-6烷氧基就是意指與碳數1至6的烷硫基結合的碳數1至6的烷氧基,例如可列舉甲硫基甲氧基、甲硫基乙氧基、甲硫基丙氧基、乙硫基甲氧基及乙硫基乙氧基。 The (C 1-6 alkylthio) C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms bonded to an alkylthio group having 1 to 6 carbon atoms, and examples thereof include a methylthiomethoxy group. Methylthioethoxy, methylthiopropoxy, ethylthiomethoxy and ethylthioethoxy.

(C1-6烷氧基)C1-6烷氧基就是意指與碳數1至6的烷氧基結合的碳數1至6的烷氧基,例如可列舉甲氧基甲氧基、乙氧基甲氧基、正丙氧基甲氧基、異丙氧基甲氧基、2-甲氧基乙氧基、2-乙氧基乙氧基及3-甲氧基丙氧基。 (C 1-6 alkoxy) C 1-6 alkoxy carbon atoms is intended to mean an alkoxy group having 1 to 6 bonded alkoxy having 1 to 6, and examples thereof include methoxymethoxy , ethoxymethoxy, n-propoxymethoxy, isopropoxymethoxy, 2-methoxyethoxy, 2-ethoxyethoxy and 3-methoxypropoxy .

C3-6烯氧基就是意指碳原子數3至6的烯氧基,例如可列舉烯丙氧基及2-丁烯氧基。 The C 3-6 alkenyloxy group means an alkenyloxy group having 3 to 6 carbon atoms, and examples thereof include an allyloxy group and a 2-butenyloxy group.

C3-12烯氧基就是意指碳原子數3至12的烯氧基,例如可列舉 烯丙氧基、2-丁烯氧基、5-己烯氧基及11-十二烯氧基。 It means a C 3-12 alkenyloxy group is an alkenyloxy group having 3 to 12 carbon atoms, for example, allyloxy, 2-butenyloxy, 5-hexenyloxy group and dodecene 11- .

C3-6炔氧基就是意指碳原子數3至6的炔氧基,例如可列舉炔丙氧基及2-丁炔氧基。 The C 3-6 alkynyloxy group means an alkynyloxy group having 3 to 6 carbon atoms, and examples thereof include a propargyloxy group and a 2-butynyloxy group.

C3-12炔氧基就是意指碳原子數3至12的炔氧基,例如可列舉炔丙氧基、2-丁炔氧基、5-己炔氧基及11-十二炔氧基。 The C 3-12 alkynyloxy group means an alkynyloxy group having 3 to 12 carbon atoms, and examples thereof include a propargyloxy group, a 2-butynyloxy group, a 5-hexynyloxy group, and an 11-dodecynyloxy group. .

氰基C1-6烷氧基就是意指具有氰基的碳數1至6的烷氧基,例如可列舉氰基甲氧基、1-氰基甲氧基、2-氰基乙氧基及3-氰基丙氧基。 The cyano C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms having a cyano group, and examples thereof include a cyanomethoxy group, a 1-cyanomethoxy group, and a 2-cyanoethoxy group. And 3-cyanopropoxy.

(C1-6烷氧基)羰基C1-6烷氧基就是意指與具有(碳數1至6的烷氧基)的羰基結合的碳數1至6的烷氧基,例如可列舉甲氧基羰基甲氧基及乙氧基羰基甲氧基。 The (C 1-6 alkoxy)carbonyl C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms bonded to a carbonyl group having an alkoxy group (having 1 to 6 carbon atoms), for example, Methoxycarbonylmethoxy and ethoxycarbonylmethoxy.

胺甲醯基C1-6烷氧基就是意指具有胺甲醯基的碳數1至6的烷氧基,例如可列舉胺甲醯基甲氧基。 The amidamidyl C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms which has an amine carbenyl group, and examples thereof include an amine methyl methoxy group.

{(C1-6烷基)胺基羰基}C1-6烷氧基就是意指與(具有碳數1至6的烷基的胺基羰基)結合的碳數1至6的烷氧基,例如可列舉甲胺基羰基甲氧基。 The {(C 1-6 alkyl)aminocarbonyl}C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms bonded to an aminocarbonyl group having an alkyl group having 1 to 6 carbon atoms. For example, a methylaminocarbonylmethoxy group can be mentioned.

(二(C1-6烷基)胺基羰基)C1-6烷氧基就是意指與{與(具有2個相同或不相同的碳數1至6的烷基的胺基)結合的羰基}結合的碳數1至6的烷氧基,例如可列舉二甲基胺基羰基甲氧基。 (Bis(C 1-6 alkyl)aminocarbonyl)C 1-6 alkoxy is meant to be bonded to {with (an amine group having 2 identical or different alkyl groups having 1 to 6 carbon atoms) The alkoxy group having 1 to 6 carbon atoms bonded to the carbonyl group may, for example, be dimethylaminocarbonylcarbonyl.

C1-6烷胺基就是意指碳數1至6的烷胺基,例如可列舉甲胺基、乙胺基及異丙胺基。 The C 1-6 alkylamino group means an alkylamino group having 1 to 6 carbon atoms, and examples thereof include a methylamino group, an ethylamino group and an isopropylamine group.

二(C1-6烷基)胺基就是意指具有2個相同或不相同的碳數1至6的烷基的胺基,例如可列舉二甲基胺基、二乙基胺基及乙基甲基胺基。 The bis(C 1-6 alkyl)amino group means an amine group having two identical or different alkyl groups having 1 to 6 carbon atoms, and examples thereof include a dimethylamino group, a diethylamino group and a Methylamino group.

(C1-6烷基)羰基胺基就是意指與具有碳數1至6的烷基的羰基結合的胺基,例如可列舉乙醯胺基及丙醯胺基。 The (C 1-6 alkyl)carbonylamino group means an amine group bonded to a carbonyl group having an alkyl group having 1 to 6 carbon atoms, and examples thereof include an ethylamine group and a acrylamide group.

羥基C1-6烷基就是意指具有羥基的碳數1至6的烷基,例如可列舉羥甲基、1-羥乙基、2-羥乙基及3-羥丙基。 The hydroxy C 1-6 alkyl group means an alkyl group having 1 to 6 carbon atoms having a hydroxyl group, and examples thereof include a methylol group, a 1-hydroxyethyl group, a 2-hydroxyethyl group, and a 3-hydroxypropyl group.

(C1-6烷氧基)C1-6烷基就是意指與碳數1至6的烷氧基結合的碳數1至6的烷基,例如可列舉甲氧基甲基、1-甲氧基乙基、乙氧基甲基、丙氧基甲基、丁氧基甲基、1-甲基2-甲氧基乙基及2-乙氧基乙基。 The (C 1-6 alkoxy) C 1-6 alkyl group means an alkyl group having 1 to 6 carbon atoms bonded to an alkoxy group having 1 to 6 carbon atoms, and examples thereof include a methoxymethyl group and 1 Methoxyethyl, ethoxymethyl, propoxymethyl, butoxymethyl, 1-methyl 2-methoxyethyl and 2-ethoxyethyl.

(C1-6鹵烷氧基)C1-6烷基就是意指與(具有氟、氯、溴、碘等鹵素的碳數1至6的烷氧基)結合的碳數1至6的烷基,例如可列舉2,2-二氟乙氧基甲基、2,2,2-三氟乙氧基甲基、2,2-二氟乙氧基乙基及2,2,2-三氟乙氧基乙基。 (C 1-6 haloalkoxy) C 1-6 alkyl means a carbon number of 1 to 6 bonded to (alkoxy having 1 to 6 carbon atoms having a halogen such as fluorine, chlorine, bromine or iodine) The alkyl group may, for example, be 2,2-difluoroethoxymethyl, 2,2,2-trifluoroethoxymethyl, 2,2-difluoroethoxyethyl and 2,2,2- Trifluoroethoxyethyl.

(C3-8環烷氧基)C1-6烷基就是意指與碳數3至8的環烷氧基結合的碳數1至6的烷基,例如可列舉環丙氧基甲基及環戊氧基甲基。 (C 3-8 cycloalkoxy) C 1-6 alkyl means an alkyl group having 1 to 6 carbon atoms bonded to a cycloalkyloxy group having 3 to 8 carbon atoms, and examples thereof include a cyclopropoxymethyl group. And cyclopentyloxymethyl.

{(C3-8環烷基)C1-6烷氧基}C1-6烷基就是意指與{與(碳數3至8的環烷基)結合的碳數1至6的烷氧基}結合的碳數1至6的烷基,例如可列舉環丙基甲氧基甲基。 {(C 3-8 cycloalkyl)C 1-6 alkoxy}C 1-6 alkyl means an alkane having 1 to 6 carbon atoms bonded to {with a cycloalkyl group of 3 to 8 carbon atoms) The alkyl group having 1 to 6 carbon atoms bonded to the oxy} group may, for example, be a cyclopropylmethoxymethyl group.

(C1-6烷硫基)C1-6烷基就是意指與碳數1至6的烷硫基結合的碳數1至6的烷基,例如可列舉甲硫基甲基、1-(甲硫基)乙基、乙硫基甲基、丙硫基甲基、丁硫基甲基、1-甲基-2-(甲硫基)乙基及2-(乙硫基)乙基。 (C 1-6 alkylthio) C 1-6 alkyl means an alkyl group having 1 to 6 carbon atoms bonded to an alkylthio group having 1 to 6 carbon atoms, and examples thereof include methylthiomethyl group and 1- (Methylthio)ethyl, ethylthiomethyl, propylthiomethyl, butylthiomethyl, 1-methyl-2-(methylthio)ethyl and 2-(ethylthio)ethyl .

(C1-6烷基亞磺醯基)C1-6烷基就是意指與碳數1至6的烷基亞磺醯基結合的碳數1至6的烷基,例如可列舉甲基亞磺醯基甲基 及乙基亞磺醯基甲基。 (C 1-6 alkylsulfinyl) C 1-6 alkyl means an alkyl group having 1 to 6 carbon atoms bonded to an alkylsulfinyl group having 1 to 6 carbon atoms, and examples thereof include a methyl group. Sulfosylmethyl and ethylsulfinylmethyl.

(C1-6烷基磺醯基)C1-6烷基就是意指與碳數1至6的烷基磺醯基結合的碳數1至6的烷基,例如可列舉甲基磺醯基甲基、乙基磺醯基甲基及2-(甲基磺醯基)乙基。 (C 1-6 alkylsulfonyl) C 1-6 alkyl means an alkyl group having 1 to 6 carbon atoms bonded to an alkylsulfonyl group having 1 to 6 carbon atoms, and examples thereof include methylsulfonium sulfonate. Methyl, ethylsulfonylmethyl and 2-(methylsulfonyl)ethyl.

(C1-6鹵烷硫基)C1-6烷基就是意指與(具有氟、氯、溴、碘等鹵素的碳數1至6的烷硫基)結合的碳數1至6的烷基,例如可列舉三氟甲硫基甲基、2,2-二氟乙硫基甲基及2,2,2-三氟乙硫基甲基。 (C 1-6 haloalkylthio) C 1-6 alkyl means a carbon number of 1 to 6 in combination with an alkylthio group having 1 to 6 carbon atoms having a halogen such as fluorine, chlorine, bromine or iodine. Examples of the alkyl group include a trifluoromethylthiomethyl group, a 2,2-difluoroethylthiomethyl group, and a 2,2,2-trifluoroethylthiomethyl group.

氰基C1-6烷基就是意指具有氰基的碳數1至6的烷基,例如可列舉氰甲基、1-氰乙基、2-氰乙基及3-氰乙基。 The cyano C 1-6 alkyl group means an alkyl group having 1 to 6 carbon atoms having a cyano group, and examples thereof include a cyanomethyl group, a 1-cyanoethyl group, a 2-cyanoethyl group, and a 3-cyanoethyl group.

羥基亞胺基C1-6烷基就是意指具有羥基亞胺基的碳數1至6的烷基,例如可列舉羥基亞胺基甲基。 The hydroxyimino group C 1-6 alkyl group means an alkyl group having 1 to 6 carbon atoms having a hydroxyimino group, and examples thereof include a hydroxyiminomethyl group.

(C1-6烷氧基)亞胺基C1-6烷基就是意指與(與碳數1至6的烷氧基結合的亞胺基)結合的碳數1至6的烷基,例如可列舉甲氧基亞胺基甲基及乙氧基亞胺基甲基。 (C 1-6 alkoxy)imino C 1-6 alkyl means an alkyl group having 1 to 6 carbon atoms bonded to (an imine group bonded to an alkoxy group having 1 to 6 carbon atoms), For example, a methoxyiminomethyl group and an ethoxyiminomethyl group are mentioned.

(C1-6烷基)羰基就是意指與碳數1至6的烷基結合的羰基,例如可列舉乙醯基、丙醯基及丁醯基。 The (C 1-6 alkyl)carbonyl group means a carbonyl group bonded to an alkyl group having 1 to 6 carbon atoms, and examples thereof include an ethyl group, a propyl group and a butyl group.

單環式或二環式縮合環的芳基就是可列舉5或6員的單環式的芳基、或者6-6員或6-5員的二環式縮合環的芳基,例如可列舉苯基、萘基、二氫茚基(indanyl)或1,2,3,4-四氫萘基。 The aryl group of the monocyclic or bicyclic condensed ring is exemplified by a 5- or 6-membered monocyclic aryl group or a 6-membered or 6-membered bicyclic condensed ring aryl group, for example, Phenyl, naphthyl, indanyl or 1,2,3,4-tetrahydronaphthyl.

含有由氮、氧及硫所成的群選出的1個以上的原子作為雜原子的單環式或二環式縮合環的雜芳基就是意指在單環式中最多含有3個,在二環式縮合環中最多含有4個由氮、氧及硫所成的群選出的雜原子的雜環基,可列舉5或6員的單環式的雜芳基、或者6-6員或6-5員的二環式縮合環的雜芳基,例如可列舉呋喃基、 噻吩基、吡咯基、吡唑基、咪唑基、1,2,3-三唑基、1,2,4-三唑基、唑基、異唑基、噻唑基、異噻唑基、1,2,4-二唑基、1,3,4-二唑基、1,2,5-二唑基、1,2,3-噻二唑基、1,2,4-噻二唑基、1,3,4-噻二唑基、1,2,5-噻二唑基、吡啶基、嗒基、嘧啶基、吡基、1,2,3-三基、1,2,4-三基、吲哚啉基、異吲哚啉基、香豆素基、1,3,5-三基、苯并呋喃基、苯并異呋喃基、苯并噻吩基、苯并異噻吩基、吲哚基、異吲哚基、吲唑基、苯并噻唑基、苯并異噻唑基、苯并唑基、苯并咪唑基、2,1,3-苯并二唑基、喹啉基、異喹啉基、噌啉基、呔基(phthalazinyl)、喹唑啉基、喹啉基、啶基(naphthyridinyl)、苯并三基、嘌呤基、喋啶基(pteridinyl)及吲哚啶基(indolizinyl)。 A heteroaryl group containing a monocyclic or bicyclic condensed ring in which one or more atoms selected from the group consisting of nitrogen, oxygen and sulfur are used as a hetero atom means that there are at most three in the monocyclic ring, in the second The heterocyclic group of the hetero atom selected from the group consisting of nitrogen, oxygen and sulfur in the cyclic condensed ring may be a 5- or 6-membered monocyclic heteroaryl group, or 6-6 members or 6 The heteroaryl group of the 5-membered bicyclic condensed ring may, for example, be furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-triazolyl, 1,2,4-tri Azolyl, Azolyl, different Azyl, thiazolyl, isothiazolyl, 1,2,4- Diazolyl, 1,3,4- Diazolyl, 1, 2, 5- Diazolyl, 1,2,3-thiadiazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl, pyridyl ,despair Base, pyrimidinyl, pyridyl Base, 1, 2, 3-three Base, 1, 2, 4-three Base, porphyrin group, isoindolyl group, coumarin group, 1,3,5-three Benzofuranyl, benzoisofuranyl, benzothienyl, benzisothienyl, fluorenyl, isodecyl, oxazolyl, benzothiazolyl, benzisothiazolyl, benzo Azolyl, benzimidazolyl, 2,1,3-benzo Diazolyl, quinolyl, isoquinolinyl, porphyrinyl, anthracene Phthaazinyl, quinazolinyl, quin Olinyl group, Naphthyridinyl, benzotrien Base, sulfhydryl, pteridinyl and ruthenium Indolizinyl.

C2-6烯基就是意指碳數2至6的烯基,例如可列舉乙烯基、烯丙基、1-丁烯-3-基及3-丁烯-1-基。 The C 2-6 alkenyl group means an alkenyl group having 2 to 6 carbon atoms, and examples thereof include a vinyl group, an allyl group, a 1-buten-3-yl group, and a 3-buten-1-yl group.

C2-6炔基就是意指碳數2至6的炔基,例如可列舉乙炔基、炔丙基及2-丁炔基。 The C 2-6 alkynyl group means an alkynyl group having 2 to 6 carbon atoms, and examples thereof include an ethynyl group, a propargyl group, and a 2-butynyl group.

C6-10芳基就是意指碳原子數6至10的芳基,例如可列舉苯基及萘基。 The C 6-10 aryl group means an aryl group having 6 to 10 carbon atoms, and examples thereof include a phenyl group and a naphthyl group.

(C6-10芳基)C1-6烷基就是意指與碳原子數6至10的芳基結合的碳數1至6的烷基,例如可列舉苄基及苯乙基。 The (C 6-10 aryl) C 1-6 alkyl group means an alkyl group having 1 to 6 carbon atoms bonded to an aryl group having 6 to 10 carbon atoms, and examples thereof include a benzyl group and a phenethyl group.

(C6-10芳基)C1-12烷基就是意指與碳原子數6至10的芳基結合的碳數1至12的烷基,例如可列舉苄基、1-苯乙基、苯乙基、3-苯丙基、6-苯己基及12-苯十二基。 (C 6-10 aryl) C 1-12 alkyl means an alkyl group having 1 to 12 carbon atoms bonded to an aryl group having 6 to 10 carbon atoms, and examples thereof include a benzyl group and a 1-phenylethyl group. Phenylethyl, 3-phenylpropyl, 6-phenylhexyl and 12-phenyldodecyl.

C6-10芳氧基就是意指碳原子數6至10的芳氧基,例如可列舉苯氧基及萘氧基。 The C 6-10 aryloxy group means an aryloxy group having 6 to 10 carbon atoms, and examples thereof include a phenoxy group and a naphthyloxy group.

(C6-10芳基)C1-6烷氧基就是意指與碳原子數6至10的芳基結合的碳數1至6的烷氧基,例如可列舉苄氧基及苯乙氧基。 The (C 6-10 aryl) C 1-6 alkoxy group means an alkoxy group having 1 to 6 carbon atoms bonded to an aryl group having 6 to 10 carbon atoms, and examples thereof include a benzyloxy group and a phenethyloxy group. base.

(C6-10芳氧基)C1-12烷基就是意指與碳原子數6至10的芳氧基結合的碳數1至12的烷基,例如可列舉苯氧基甲基、2-苯氧基乙基、1-甲基-2-苯氧基乙基及3-苯氧基丙基。 (C 6-10 aryloxy) C 1-12 alkyl means an alkyl group having 1 to 12 carbon atoms bonded to an aryloxy group having 6 to 10 carbon atoms, and examples thereof include a phenoxymethyl group, 2 - phenoxyethyl, 1-methyl-2-phenoxyethyl and 3-phenoxypropyl.

(C6-10芳基硫基)C1-12烷基就是意指與碳原子數6至10的芳基硫基結合的碳數1至12的烷基,例如可列舉苯硫基甲基、2-苯硫基乙基、1-甲基-2-苯硫基乙基及3-苯硫基丙基。 (C 6-10 arylthio) C 1-12 alkyl means an alkyl group having 1 to 12 carbon atoms bonded to an arylthio group having 6 to 10 carbon atoms, and, for example, a phenylthiomethyl group , 2-phenylthioethyl, 1-methyl-2-phenylthioethyl and 3-phenylthiopropyl.

(C6-10芳基)C1-12烷氧基就是意指與碳原子數6至10的芳基結合的碳數1至12的烷氧基,例如可列舉苄氧基、苯乙氧基、3-苯丙氧基、6-苯己氧基及12-苯十二基氧基。 The (C 6-10 aryl) C 1-12 alkoxy group means an alkoxy group having 1 to 12 carbon atoms bonded to an aryl group having 6 to 10 carbon atoms, and examples thereof include a benzyloxy group and a phenethyloxy group. Base, 3-phenylpropoxy, 6-phenylhexyloxy and 12-phenyldodecyloxy.

{(C6-10芳基)C1-6烷氧基}C1-6烷基就是意指與{與(碳原子數6至10的芳基)結合的碳數1至12的烷氧基)結合的碳數1至12的烷基,例如可列舉苄氧基甲基。 {(C 6-10 aryl) C 1-6 alkoxy} C 1-6 alkyl means an alkoxy group having a carbon number of 1 to 12 bonded to {with (aryl group having 6 to 10 carbon atoms) The alkyl group having 1 to 12 carbon atoms bonded thereto may, for example, be a benzyloxymethyl group.

二(C3-6烯基)胺基就是意指具有2個相同或不相同的碳數3至6的烯基的胺基,例如可列舉二烯丙基胺基及二(3-丁烯基)胺基。 The bis(C 3-6 alkenyl)amino group means an amine group having two identical or different carbon atoms of 3 to 6 carbon atoms, and examples thereof include diallylamino groups and di(3-butene). Amino group.

(C1-6烷基)(C6-10芳基)胺基就是意指具有碳數1至6的烷基及C6-10芳基的胺基,例如可列舉甲基苯基胺基及乙基苯基胺基。 The (C 1-6 alkyl)(C 6-10 aryl)amino group means an amine group having an alkyl group having 1 to 6 carbon atoms and a C 6-10 aryl group, and examples thereof include a methylphenylamino group. And ethylphenylamino group.

5至6員的雜芳基就是意指含1至3個由氮、氧及硫所成的群選出的雜原子的芳香族的5或6員的雜環基,例如可列舉3-吡啶基、3-噻吩基及1-吡唑基。 The heteroaryl group of 5 to 6 members means an aromatic 5- or 6-membered heterocyclic group having 1 to 3 hetero atoms selected from a group consisting of nitrogen, oxygen and sulfur, and examples thereof include 3-pyridyl group. , 3-thienyl and 1-pyrazolyl.

C2-4鹵烯基就是意指具有氟、氯、溴、碘等鹵素的碳數2至4 的烯基,例如可列舉2,2-二氟乙烯基及2,2-二氯乙烯基。 The C 2-4 haloalkenyl group means an alkenyl group having 2 to 4 carbon atoms having a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include 2,2-difluorovinyl and 2,2-dichlorovinyl. .

C1-3烷硫基就是意指碳數1至3的烷硫基,例如可列舉甲硫基、乙硫基及丙硫基。 The C 1-3 alkylthio group means an alkylthio group having 1 to 3 carbon atoms, and examples thereof include a methylthio group, an ethylthio group and a propylthio group.

C1-3鹵烷硫基就是意指具有氟、氯、溴、碘等鹵素的碳數1至6的烷硫基,例如可列舉三氯甲硫基、三氟甲硫基、2,2-二氟乙硫基、2,2,2-三氟乙硫基、2,2,2-三氯乙硫基及3-氯丙硫基。 The C 1-3 haloalkylthio group means an alkylthio group having 1 to 6 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trichloromethylthio group, a trifluoromethylthio group, and 2,2. -difluoroethylthio, 2,2,2-trifluoroethylthio, 2,2,2-trichloroethylthio and 3-chloropropylthio.

C1-3烷基亞磺醯就是意指碳數1至3的烷基亞磺醯基,例如可列舉甲基亞磺醯基、乙基亞磺醯基及丙基亞磺醯基。 The C 1-3 alkylsulfinium sulfonate means an alkylsulfinyl group having 1 to 3 carbon atoms, and examples thereof include a methylsulfinyl group, an ethylsulfinyl group, and a propylsulfinylene group.

C1-3鹵烷基亞磺醯基就是意指具有氟、氯、溴、碘等鹵素的碳數1至3的烷基亞磺醯基,例如可列舉三氟甲基亞磺醯基。 The C 1-3 haloalkylsulfinyl group means an alkylsulfinyl group having 1 to 3 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trifluoromethylsulfinyl group.

C1-3烷基磺醯基就是意指碳數1至3的烷基磺醯基,例如可列舉甲基磺醯基、乙基磺醯基及異丙基磺醯基。 The C 1-3 alkylsulfonyl group means an alkylsulfonyl group having 1 to 3 carbon atoms, and examples thereof include a methylsulfonyl group, an ethylsulfonyl group, and an isopropylsulfonyl group.

C1-3鹵烷基磺醯基就是意指具有氟、氯、溴、碘等鹵素的碳數1至6的烷基磺醯基,例如可列舉三氯甲基磺醯基、三氟甲基磺醯基、2,2-二氟乙基磺醯基、2,2,2-三氟乙基磺醯基、2,2,2-三氯乙基磺醯基及3-氯丙基磺醯基。 The C 1-3 haloalkylsulfonyl group means an alkylsulfonyl group having 1 to 6 carbon atoms which has a halogen such as fluorine, chlorine, bromine or iodine, and examples thereof include a trichloromethylsulfonyl group and a trifluoromethyl group. Sulfosyl, 2,2-difluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2,2,2-trichloroethylsulfonyl and 3-chloropropyl Sulfonyl.

(C1-6烷氧基)羰基就是意指與(碳數1至6的烷氧基)結合的羰基,例如可列舉甲氧基羰基、乙氧基羰基及正己氧基羰基。 The (C 1-6 alkoxy)carbonyl group means a carbonyl group bonded to (alkoxy group having 1 to 6 carbon atoms), and examples thereof include a methoxycarbonyl group, an ethoxycarbonyl group, and a n-hexyloxycarbonyl group.

(C1-3烷基)胺基羰基就是意指與具有(碳數1至3的烷基)的胺基結合的羰基,例如可列舉甲胺基羰基。 The (C 1-3 alkyl)aminocarbonyl group means a carbonyl group bonded to an amine group having (alkyl group having 1 to 3 carbon atoms), and for example, a methylaminocarbonyl group can be cited.

二(C1-3烷基)胺基羰基就是意指與具有2個相同或不相同的碳數1至3的烷基的胺基結合的羰基,例如可列舉二甲基胺基羰基。 The bis(C 1-3 alkyl)aminocarbonyl group means a carbonyl group bonded to an amine group having two identical or different alkyl groups having 1 to 3 carbon atoms, and examples thereof include a dimethylaminocarbonyl group.

(C3-8環烷基)羰基胺基就是意指與(碳數3至8的環烷基)結合的羰基胺基,例如可列舉環丙基羰基胺基及環己基羰基胺基。 The (C 3-8 cycloalkyl)carbonylamino group means a carbonylamino group bonded to a (cycloalkyl group having 3 to 8 carbon atoms), and examples thereof include a cyclopropylcarbonylamino group and a cyclohexylcarbonylamino group.

(C1-6烷氧基)羰基胺基就是意指與(碳數1至6的烷氧基)結合的羰基胺基,例如可列舉甲氧基羰基胺基。 The (C 1-6 alkoxy)carbonylamino group means a carbonylamino group bonded to (alkoxy group having 1 to 6 carbon atoms), and examples thereof include a methoxycarbonylamino group.

(C1-3烷氧基)C1-3烷基就是意指與(碳數1至3的烷氧基)結合的碳數1至3的烷基,例如可列舉甲氧基甲基、1-甲氧基乙基、乙氧基甲基及2-乙氧基乙基。 (C 1-3 alkoxy) C 1-3 alkyl means an alkyl group having 1 to 3 carbon atoms bonded to (alkoxy group having 1 to 3 carbon atoms), and examples thereof include a methoxymethyl group. 1-methoxyethyl, ethoxymethyl and 2-ethoxyethyl.

在本發明化合物中,式(I)表示的嗒酮化合物會有與無機鹼或有機鹼等形成在農學上可容許的鹽的形態的情況,本發明也包括該鹽形態的嗒酮化合物。這種鹽例如可列舉與無機鹼(例如可列舉鹼金屬(鋰、鈉、鉀等)的氫氧化物、碳酸鹽、碳酸氫鹽、乙酸鹽、氫化物等,鹼土類金屬(鎂、鈣、鋇等)的氫氧化物、氫化物等,氨)、有機鹼(例如可列舉二甲胺、三乙胺、哌、吡咯啶、哌啶、2-苯乙胺、苄胺、乙醇胺、二乙醇胺、吡啶、柯林鹼等)、金屬烷氧化物(例如可列舉甲氧鈉、三級丁氧鉀、甲氧鎂等)等混合所生成的鹽。 In the compound of the present invention, the oxime represented by the formula (I) The ketone compound may be in the form of an agronomically acceptable salt with an inorganic base or an organic base, and the present invention also includes the form of the salt. Ketone compound. Examples of such a salt include an inorganic base (for example, a hydroxide, a carbonate, a hydrogencarbonate, an acetate, a hydride, or the like of an alkali metal (lithium, sodium, potassium, etc.), an alkaline earth metal (magnesium, calcium, or the like). Hydroxide, hydride, etc., ammonia, and an organic base (for example, dimethylamine, triethylamine, and piperidin) , pyrrolidine, piperidine, 2-phenylethylamine, benzylamine, ethanolamine, diethanolamine, pyridine, Colin base, etc.), metal alkoxides (for example, sodium methoxide, potassium tert-butoxide, magnesium methoxide) Etc.) Mix the resulting salt.

本發明化合物具有1個以上的不對稱中心時,該化合物有2個以上的立體異構物(例如可列舉鏡像異構物,非鏡像異構物等)的存在。本發明化合物包含該等的全部的立體異構物及該等的任意2個以上所成的混合物。 When the compound of the present invention has one or more asymmetric centers, the compound may have two or more stereoisomers (for example, a mirror image isomer, a non-image isomer, etc.). The compound of the present invention contains all such stereoisomers and mixtures of any two or more of these.

又本發明化合物具有基於雙鍵等的幾何異構時,該化合物有2個以上的幾何異構物(例如可列舉E/Z或反/順的各異構物,S-反/S-順的各異構物等)的存在。本發明化合物包含該等的全部的幾何 異構物及該等的任意2個以上所成的混合物。 Further, when the compound of the present invention has geometrical isomerism based on a double bond or the like, the compound has two or more geometric isomers (for example, E/Z or reverse/cis isomers, S-anti/S-cis The presence of each isomer, etc.). The compounds of the invention comprise all of the geometries An isomer and a mixture of any two or more of these.

就本發明化合物而言,例如可列舉以下所示的化合物。 Examples of the compound of the present invention include the compounds shown below.

[方式1]式(Ia)表示的嗒酮化合物: [式中,R1、R3、R4、R5及A表示與前述相同的意義,R2表示氫、鹵素、氰基、硝基、C1-6烷基、C1-6鹵烷基、C1-6烷氧基、C1-6鹵烷氧基、C1-6烷硫基、C1-6烷基亞磺醯基、C1-6烷基磺醯基、C1-6鹵烷硫基、C1-6鹵烷基亞磺醯基、C1-6鹵烷基磺醯基、C3-8環烷基、C3-8環烷氧基、(C3-8環烷基)C1-6烷氧基、(C1-6烷硫基)C1-6烷氧基、(C1-6烷氧基)C1-6烷氧基、C3-6烯氧基、C3-6炔氧基、氰基C1-6烷氧基、(C1-6烷氧基)羰基C1-6烷氧基、胺甲醯基C1-6烷氧基、{(C1-6烷基)胺基羰基}C1-6烷氧基、(二(C1-6烷基)胺基羰基)C1-6烷氧基、胺基、C1-6烷胺基、二(C1-6烷基)胺基、甲醯胺基、(C1-6烷基)羰基胺基、羥基C1-6烷基、(C1-6烷氧基)C1-6烷基、(C1-6鹵烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、{(C3-8環烷基)C1-6烷氧基}C1-6烷基、(C1-6烷硫基)C1-6烷基、(C1-6鹵烷硫基)C1-6烷基、氰基C1-6烷基、羥基亞胺基C1-6烷基、(C1-6烷氧基)亞胺基C1-6烷基、甲醯基或(C1-6烷基)羰基,R3表示鹵素、C1-3烷基、C1-3鹵烷基、C2-4烯基、C2-4炔基、C1-3烷氧基、C1-3鹵烷氧基或C3-8環烷基,G21表示氫或下述式表示的任一種基: [Mode 1] 嗒 expressed by the formula (Ia) Ketone compounds: Wherein R 1 , R 3 , R 4 , R 5 and A represent the same meaning as defined above, and R 2 represents hydrogen, halogen, cyano, nitro, C 1-6 alkyl, C 1-6 halo , C 1-6 alkoxy, C 1-6 haloalkoxy, C 1-6 alkylthio, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, C 1 -6 haloalkylthio, C 1-6 haloalkylsulfinyl, C 1-6 haloalkylsulfonyl, C 3-8 cycloalkyl, C 3-8 cycloalkoxy, (C 3 -8 cycloalkyl)C 1-6 alkoxy, (C 1-6 alkylthio) C 1-6 alkoxy, (C 1-6 alkoxy) C 1-6 alkoxy, C 3 -6 -alkenyloxy, C 3-6 alkynyloxy, cyano C 1-6 alkoxy, (C 1-6 alkoxy)carbonyl C 1-6 alkoxy, amine carbaryl C 1-6 Alkoxy, {(C 1-6 alkyl)aminocarbonyl}C 1-6 alkoxy, (di(C 1-6 alkyl)aminocarbonyl)C 1-6 alkoxy, amine group, C 1-6 alkylamino group, di(C 1-6 alkyl)amino group, formamidine, (C 1-6 alkyl)carbonylamino group, hydroxy C 1-6 alkyl group, (C 1-6 Alkoxy)C 1-6 alkyl, (C 1-6 haloalkoxy) C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, {(C 3- 8 -cycloalkyl)C 1-6 alkoxy}C 1-6 alkyl, (C 1-6 alkylthio) C 1-6 alkyl, (C 1-6 haloalkylthio) C 1-6 Alkyl, cyano C 1-6 alkyl, hydroxyimino C 1-6 alkyl, (C 1-6 alkoxy) imido C 1-6 alkyl, methionyl or (C 1-6 alkyl)carbonyl, R 3 represents halogen, C 1-3 alkyl, C 1-3 haloalkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-3 alkoxy, C 1-3 haloalkoxy Or C 3-8 cycloalkyl, G 21 represents hydrogen or any of the groups represented by the formula:

{式中,L表示氧或硫,R61表示C1-6烷基、C1-3鹵烷基、C3-6環烷基、C2-6烯基、C2-6炔基、可以具有由C群選出的1個以上的原子或基的C6-10芳基、(可以具有由C群選出的1個以上的原子或基的C6-10芳基)C1-6烷基、C1-6烷氧基、C3-8環烷氧基、C3-6烯氧基、C3-6炔氧基、可以具有由C群選出的1個以上的原子或基的C6-10芳氧基、(可以具有由C群選出的1個以上的原子或基的C6-10芳基)C1-6烷氧基、二(C1-6烷基)胺基、二(C3-6烯基)胺基、(C1-6烷基)(C6-10芳基)胺基或5至6員的雜芳基,R71表示C1-6烷基、C1-3鹵烷基、可以具有由C群選出的1個以上的原子或基的C6-10芳基或二(C1-6烷基)胺基,R81及R91可以相同或不相同,表示C1-6烷基、C3-8環烷基、C6-10芳基、C1-6烷氧基、C3-8環烷氧基、C6-10芳氧基、(C6-10芳基)C1-6烷氧基、C1-6烷硫基或二(C1-6烷基)胺基,R101表示氫或C1-6烷基,W21表示:可以具有由C群選出的1個以上的原子或基的苯基、C1-6烷氧基、C1-6烷硫基、C1-6烷基亞磺醯基或C1-6烷基磺醯基(但,R61、R71、R81、R91及W21各個表示的任一種基都可以具有鹵素,C3-8環烷基、C6-10芳基、(C6-10芳基)C1-6烷基的芳基部分、C3-8環烷氧基、C6-10芳氧基、(C6-10芳基)C1-6烷氧基的芳基部分、(C1-6烷基)(C6-10芳基)胺基的芳基部分及5至6員的雜芳基中的任一種都可以具有C1-6烷基)} Wherein L represents oxygen or sulfur, and R 61 represents a C 1-6 alkyl group, a C 1-3 haloalkyl group, a C 3-6 cycloalkyl group, a C 2-6 alkenyl group, a C 2-6 alkynyl group, It may have one or more atom or group selected from the group C, C 6-10 aryl group, (which may have one or more atom or group selected from the group C C 6-10 aryl) C 1-6 alkyl a group, a C 1-6 alkoxy group, a C 3-8 cycloalkoxy group, a C 3-6 alkenyloxy group, a C 3-6 alkynyloxy group, or a group having one or more atoms or groups selected from the group C; C 6-10 aryl group (the group may have selected one or more C atoms or a group of C 6-10 aryl) C 1-6 alkoxy, di (C 1-6 alkyl) amino , a di(C 3-6 alkenyl)amino group, a (C 1-6 alkyl)(C 6-10 aryl)amino group or a heteroaryl group of 5 to 6 members, and R 71 represents a C 1-6 alkyl group , C 1-3 haloalkyl, C 6-10 aryl or di(C 1-6 alkyl)amino group which may have one or more atoms or groups selected from Group C, and R 81 and R 91 may be the same Or different, meaning C 1-6 alkyl, C 3-8 cycloalkyl, C 6-10 aryl, C 1-6 alkoxy, C 3-8 cycloalkoxy, C 6-10 aryloxy a (C 6-10 aryl) C 1-6 alkoxy group, a C 1-6 alkylthio group or a di(C 1-6 alkyl)amino group, and R 101 represents hydrogen or a C 1-6 alkyl group. W 2 1 represents a phenyl group, a C 1-6 alkoxy group, a C 1-6 alkylthio group, a C 1-6 alkylsulfinyl group or a C 1 group which may have one or more atoms or groups selected from the group C. a -6 alkylsulfonyl group (however, any of R 61 , R 71 , R 81 , R 91 and W 21 each may have a halogen, a C 3-8 cycloalkyl group, a C 6-10 aryl group, (C 6-10 aryl) aryl moiety of C 1-6 alkyl, C 3-8 cycloalkoxy, C 6-10 aryloxy, (C 6-10 aryl) C 1-6 alkoxy Any of the aryl moiety of the group, the aryl moiety of the (C 1-6 alkyl)(C 6-10 aryl)amine group, and the heteroaryl group of 5 to 6 members may have a C 1-6 alkyl group. )}

C群表示鹵素、C1-3烷基、C1-3鹵烷基、C1-6烷氧基或硝基] Group C represents halogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-6 alkoxy or nitro]

[方式2]一種化合物,其中,在[方式1]中,R1是C1-3烷基,[方式3]一種化合物,其中,在[方式2]中,R1是甲基,[方式4]一種化合物,其中,在[方式1]至[方式3]的任一方式中,R21是氫、C1-3烷基、C1-3鹵烷基、C1-6烷氧基、C1-6鹵烷氧基、C3-8環烷基、C3-8環烷氧基或(C3-8環烷基)C1-6烷氧基,[方式5]一種化合物,其中,在[方式4]中,R21是C1-3烷基,[方式6]一種化合物,其中,在[方式5]中,R21是甲基,[方式7]一種化合物,其中,在[方式6]中,R21是C1-6烷氧基,[方式8]一種化合物,其中,在[方式7]中,R21是甲氧基,[方式10]一種化合物,其中,在[方式1]至[方式9]之任一種方式中,R3是C1-3烷基,[方式11]一種化合物,其中,在[方式10]中,R3是甲基,[方式12]一種化合物,其中,在[方式10]中,R3是乙基,[方式13]一種化合物,其中,在[方式1]至[方式12]之任一種方式中,R4是氫,[方式14]一種化合物,其中,在[方式1]至[方式13]之任一種方式中,R5是氫,[方式15]一種化合物,其中,在[方式1]至[方式14]之任一方式中,A表示單環式或二環式縮合環的芳基,或者表示含有由氮、氧及硫所成的群選出的1或2個原子作為雜原子的單環式或二環式縮合環的雜芳基,該等基可以具有由B群選出的1個以上的原子或基, [方式16]一種化合物,其中,在[方式1]至[方式15]之任一方式中,A係苯基、萘基、吡啶基、嗒基、嘧啶基、吡基、苯并喹唑基、苯并唑基、喹啉基、噌啉基、喹唑啉基、喹啉基或苯并三基,該等基可以具有由B群選出的1個以上的原子或基,[方式17]一種化合物,其中,在[方式16]中,A是可以具有由B群選出的1個以上的原子或基的苯基,[方式18]一種化合物,其中,在[方式17]中,A是2-氟-4-氰基苯基,[方式19]一種化合物,其中,在[方式17]中,A是4-三氟甲基苯基,[方式20]一種化合物,其中,在[方式17]中,A是2-氯-4-三氟甲基苯基,[方式21]一種化合物,其中,在[方式16]中,A是可以具有由B群選出的1個以上的原子或基的吡啶基,[方式22]一種化合物,其中,在[方式21]中,A是5-三氟甲基吡啶-2-基,[方式23]一種化合物,其中,在[方式21]中,A是2-氯-5-三氟甲基吡啶-2-基,[方式24]一種化合物,其中,在[方式21]中,A是2-氟-5-三氟甲基吡啶-2-基,[方式25]一種化合物,其中,在[方式21]中,A是2-氟-5-氯甲基吡啶-2-基,[方式26]一種化合物,其中,在[方式16]中,A是可以有由B群選出的1個以上的原子或基的苯并噻唑基, [方式27]一種化合物,其中,在[方式26]中,A是苯并噻唑基,[方式28]一種化合物,其中,在[方式26]中,A是6-氯苯并噻唑基,[方式29]一種化合物,其中,在[方式16]中,A是可以具有由B群選出的1個以上的原子或基的苯并唑基,[方式30]一種化合物,其中,在[方式29]中,A是6-氯苯并唑基,[方式31]一種化合物,其中,在[方式16]中,A是可以有由B群選出的1個以上的原子或基的喹啉基,[方式32]一種化合物,其中,在[方式31]中,A是6-氯喹啉基,[方式33]一種化合物,其中,在[方式1]至[方式32]之任一方式中,G21是氫或下述式表示者: [Mode 2] A compound wherein, in [Mode 1], R 1 is a C 1-3 alkyl group, [Mode 3] a compound wherein, in [Mode 2], R 1 is a methyl group, [method] 4] A compound wherein, in any one of [Mode 1] to [Mode 3], R 21 is hydrogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-6 alkoxy , C 1-6 haloalkoxy, C 3-8 cycloalkyl, C 3-8 cycloalkoxy or (C 3-8 cycloalkyl) C 1-6 alkoxy, [Mode 5] a compound Wherein, in [Mode 4], R 21 is a C 1-3 alkyl group, [Mode 6] a compound wherein, in [Mode 5], R 21 is a methyl group, [Mode 7] a compound wherein In [Mode 6], R 21 is a C 1-6 alkoxy group, [Mode 8] a compound wherein, in [Mode 7], R 21 is a methoxy group, [Mode 10] a compound wherein In any one of [Mode 1] to [Mode 9], R 3 is a C 1-3 alkyl group, [Mode 11] a compound wherein, in [Mode 10], R 3 is a methyl group, [ 12 according to any embodiment] a compound wherein, in the 10], [embodiment, R 3 is ethyl, [embodiment 13] a compound wherein [embodiment 1] to [embodiment 12] one way of , R 4 is hydrogen, [14 embodiment] A compound wherein [Embodiment 1] to [Embodiment 13] of any one embodiment, R 5 is hydrogen, [Embodiment 15] A compound wherein [Embodiment 1] In any one of [Mode 14], A represents an aryl group of a monocyclic or bicyclic condensed ring, or represents 1 or 2 atoms selected from a group consisting of nitrogen, oxygen and sulfur as a hetero atom. a heteroaryl group of a monocyclic or bicyclic condensed ring, which may have one or more atoms or groups selected from the group B, [Mode 16] a compound in which [Mode 1] to [Mode 15] In any of the methods, A is a phenyl group, a naphthyl group, a pyridyl group, a fluorene group. Base, pyrimidinyl, pyridyl Benzoquinazolyl, benzo Azyl, quinolyl, porphyrin, quinazolinyl, quin Porphyrin or benzotrien Further, the group may have one or more atoms or groups selected from the group B, and [method 17] wherein, in [method 16], A may have one or more atoms selected from the group B. Or a phenyl group, [Mode 18] a compound wherein, in [Mode 17], A is 2-fluoro-4-cyanophenyl, [Mode 19] a compound wherein [Mode 17] , A is 4-trifluoromethylphenyl, [Mode 20] a compound wherein, in [Mode 17], A is 2-chloro-4-trifluoromethylphenyl, [Mode 21] a compound, In the [Mode 16], A is a pyridyl group which may have one or more atoms or groups selected from the B group, and [Mode 22] a compound in which, in [Mode 21], A is 5-three. Fluoromethylpyridin-2-yl, [Mode 23] a compound wherein, in [Mode 21], A is 2-chloro-5-trifluoromethylpyridin-2-yl, [Mode 24] a compound, Wherein, in [Mode 21], A is 2-fluoro-5-trifluoromethylpyridin-2-yl, [Mode 25] a compound wherein, in [Mode 21], A is 2-fluoro-5 -Chloromethylpyridin-2-yl, [Mode 26] a compound in which [Mode 16] In the above, A is a benzothiazolyl group which may have one or more atoms or groups selected from the group B, [Mode 27] A compound in which, in [Mode 26], A is a benzothiazolyl group, [Mode 28] A compound wherein, in [Mode 26], A is 6-chlorobenzothiazolyl, [Mode 29] a compound wherein, in [Mode 16], A is one which may be selected from Group B. Above atom or base benzo Azolyl, [Mode 30] a compound wherein, in [Mode 29], A is 6-chlorobenzo Azolyl, [Mode 31] A compound wherein, in [Mode 16], A is a quinine which may have one or more atoms or groups selected from Group B. A phenyl group, [Mode 32] a compound wherein, in [Mode 31], A is 6-chloroquine [Formula 33] A compound wherein, in any of [Mode 1] to [Mode 32], G 21 is hydrogen or a formula represented by the following formula:

式中,R61表示C1-6烷基、C3-8環烷基、C1-6烷氧基、C3-6烯氧基、C3-6炔氧基、可以具有由C群選出的1個以上的原子或基的C8-10芳基或可以具有由C群選出的1個以上的原子或基的C8-10芳氧基,W21是C1-3烷氧基或可以具有由C群選出的1個以上的原子或基的苯基,[方式34]一種化合物,其中,在[方式33]中,G21是氫,[方式35]一種化合物,其中,在[方式33]中,G21是(C1-6烷基)羰基,[方式36]一種化合物,其中,在[方式33]中,G21是乙醯基,[方式37]一種化合物,其中,在[方式33]中,G21是丙醯基, [方式38]一種化合物,其中,在[方式33]中,G21是異丁醯基,[方式39]一種化合物,其中,在[方式33]中,G21是三甲基乙醯基,[方式40]一種化合物,其中,在[方式33]中,G21是(C1-6烷氧基)羰基,[方式41]一種化合物,其中,在[方式33]中,G21是甲氧基羰基,[方式42]一種化合物,其中,在[方式33]中,G21是C1-3烷氧基甲基,[方式43]一種化合物,其中,在[方式33]中,G21是甲氧基甲基,[方式44]一種化合物,其中,在[方式33]中,G21是可以具有由C群選出的1個以上的原子或基的苄基,[方式45]一種化合物,其中,在[方式33]中,G21是苄基,[方式46]一種化合物,其中,在[方式33]中,G21是2-硝基苄基,[方式47]一種化合物,其中,在[方式33]中,G21是環丙基羰基,[方式48]一種化合物,其中,在[方式33]中,G21是環丁基羰基,[方式49]一種化合物,其中,在[方式33]中,G21是環戊基羰基, [方式50]一種化合物,其中,在[方式33]中,G21是環己基羰基,[方式51]一種化合物,其中,在[方式33]中,G21是苄醯基,[方式52]一種化合物,其中,在[方式33]中,G21是2-甲基苄醯基,[方式53]一種化合物,其中,在[方式33]中,G21是3-甲基苄醯基,[方式54]一種化合物,其中,在[方式33]中,G21是4-甲基苄醯基, [方式55]式(Ib)表示的嗒酮化合物: 式中,[R11表示C1-3烷基,R21a表示C1-6烷基或C1-6烷氧基,R31表示C1-3烷基,R41及R51表示氫,A21表示單環式或二環式縮合環的芳基,或含有由氮、氧及硫所成的群選出的1或2個原子作為雜原子的單環式或二環式縮合環的雜芳基,該等的基可以具有由鹵原子及C1-3鹵烷基所成的群選出的1個以上的原子或基, G22是氫或下述式表示的任一種基: [式中,R61b表示C1-6烷基、C3-6環烷基、可以具有由C群選出的1個以上的原子或基的C6-10芳基或C1-6烷氧基,W21b表示可以具有C1-6烷氧基或硝基的苯基] Wherein R 61 represents a C 1-6 alkyl group, a C 3-8 cycloalkyl group, a C 1-6 alkoxy group, a C 3-6 alkenyloxy group, a C 3-6 alkynyloxy group, and may have a C group the selected one or more atom or group or a C 8-10 aryl group may have one or more C atoms or a group selected from the group of C 8-10 aryloxy group, W 21 is a C 1-3 alkoxy group Or a phenyl group having one or more atoms or groups selected from the group C, [Mode 34] a compound wherein, in [Mode 33], G 21 is hydrogen, [Mode 35] a compound in which [Mode 33] wherein G 21 is (C 1-6 alkyl)carbonyl, [Mode 36] a compound wherein, in [Mode 33], G 21 is an ethyl group, [Mode 37] a compound wherein In [Mode 33], G 21 is a propyl group, [Mode 38] a compound wherein, in [Mode 33], G 21 is an isobutyl group, [Mode 39] a compound in which [Mode 33 Wherein G 21 is a trimethylethenyl group, [Mode 40] a compound wherein, in [Mode 33], G 21 is a (C 1-6 alkoxy)carbonyl group, [Mode 41] a compound, wherein, in the [embodiment 33], G 21 is a methoxycarbonyl group, [embodiment 42] a compound, , The [embodiment 33] in, G 21 is a C 1-3 alkoxy-methyl group, [embodiment 43] A compound wherein, in the [embodiment 33], G 21 is methoxy methyl, [embodiment 44 ] a compound wherein, in the [embodiment 33], G 21 is benzyl group which has one or more atom or group selected from the group C, 45] of a compound [manner, wherein, in the [embodiment 33], G 21 is a benzyl group, [Mode 46] a compound wherein, in [Mode 33], G 21 is 2-nitrobenzyl, [Mode 47] a compound wherein [21], G 21 Is a cyclopropylcarbonyl group, [Mode 48] a compound wherein, in [Mode 33], G 21 is a cyclobutylcarbonyl group, [Mode 49] a compound wherein, in [Mode 33], G 21 is a ring A pentylcarbonyl group, [Mode 50] A compound wherein, in [Mode 33], G 21 is a cyclohexylcarbonyl group, [Mode 51] a compound wherein, in [Mode 33], G 21 is a benzyl fluorenyl group, [Mode 52] A compound wherein, in [Mode 33], G 21 is 2-methylbenzylidene, [Mode 53] a compound wherein, in [Mode 33], G 21 is 3-methyl Benzylidene group, [Mode 54] a kind A compound wherein, in [Mode 33], G 21 is a 4-methylbenzylidene group, [Formula 55] a hydrazine represented by the formula (Ib) Ketone compounds: Wherein [R 11 represents C 1-3 alkyl, R 21a represents C 1-6 alkyl or C 1-6 alkoxy, R 31 represents C 1-3 alkyl, and R 41 and R 51 represent hydrogen, A 21 represents an aryl group of a monocyclic or bicyclic condensed ring, or a monocyclic or bicyclic condensed ring containing 1 or 2 atoms selected from a group consisting of nitrogen, oxygen and sulfur as a hetero atom. The aryl group may have one or more atoms or groups selected from the group consisting of a halogen atom and a C 1-3 haloalkyl group, and G 22 is hydrogen or any one of the following formulas: Wherein R 61b represents a C 1-6 alkyl group, a C 3-6 cycloalkyl group, a C 6-10 aryl group or a C 1-6 alkoxy group which may have one or more atoms or groups selected from the C group. a group, W 21b represents a phenyl group which may have a C 1-6 alkoxy group or a nitro group]

[方式56]一種嗒酮化合物,其中,在[方式55]中,R11表示甲基,R21表示氫、甲基或甲氧基,A21表示吡啶基、苯并噻唑基、苯并唑基或喹啉基, [方式57]一種化合物,其中,在式(I)中,R1是C1-3烷基,[方式58]一種化合物,其中,在[方式57]中,R1是甲基,[方式59]一種化合物,其中,在[方式57]或[方式58]中,R2是氫、C1-3烷基、C1-3鹵烷基、C1-6烷氧基、C1-6鹵烷氧基、C3-8環烷基、C3-8環烷氧基或(C3-6環烷基)C1-6烷氧基,[方式60]一種化合物,其中,在[方式59]中,R2是C1-3烷基,[方式61]一種化合物,其中,在[方式60]中,R2是甲基,[方式62]一種化合物,其中,在[方式59]中,R2是C1-6烷氧基,[方式63]一種化合物,其中,在[方式62]中,R2是甲氧基,[方式64]一種化合物,其中,在式(I)中,R3是C1-3烷基,[方式65]一種化合物,其中,在[方式57]至[方式63]之任一方式中,R3是C1-3烷基,[方式66]一種化合物,其中,在[方式65]中,R3是甲基,[方式67]一種化合物,其中,在[方式65]中,R3是乙基,[方式68]一種化合物,其中,在式(I)中,R4是氫,[方式69]一種化合物,其中,在[方式57]至[方式67]之任一方式中,R4是氫,[方式70]一種化合物,其中,在式(I)中,R5是氫,[方式71]一種化合物,其中,在[方式57]至[方式69]之任一方式中,R5是氫,[方式72]一種化合物,其中,在式(I)中,A是苯基、萘基、吡啶基、嗒基、嘧啶基、吡基、苯并噻唑基、苯并唑基、喹啉基、噌啉基、喹唑啉基、喹啉基或苯并三基,該等的基可以具有由B群選出的1個以上的原子或基, [方式73]一種化合物,其中,在[方式57]至[方式71]之任一方式中,A是苯基、萘基、吡啶基、嗒基、嘧啶基、吡基、苯并噻唑基、苯并唑基、喹啉基、噌啉基、喹唑啉基、喹啉基或苯并三基,該等的基可以具有由B群選出的1個以上的原子或基,[方式74]一種化合物,其中,在[方式73]中,A是可以具有由B群選出的1個以上的原子或基的苯基,[方式75]一種化合物,其中,在[方式74]中,A是2-氟-4-氰基苯基,[方式76]一種化合物,其中,在[方式74]中,A是4-三氟甲基苯基,[方式77]一種化合物,其中,在[方式74]中,A是2-氯-4-三氟甲基苯基,[方式78]一種化合物,其中,在[方式73]中,A是可以具有由B群選出的1個以上的原子或基的吡啶基,[方式79]一種化合物,其中,在[方式78]中,A是5-三氟甲基吡啶-2-基,[方式80]一種化合物,其中,在[方式78]中,A是2-氯-5-三氟甲基吡啶-2-基,[方式81]一種化合物,其中,在[方式78]中,A是2-氟-5-三氟甲基吡啶-2-基,[方式82]一種化合物,其中,在[方式78]中,A是2-氟-5-氯甲基吡啶-2-基,[方式83]一種化合物,其中,在[方式73]中,A是可以具有由B 群選出的1個以上的原子或基的苯并噻唑基,[方式84]一種化合物,其中,在[方式83]中,A是苯并噻唑基,[方式85]一種化合物,其中,在[方式83]中,A是6-氯苯并噻唑基,[方式86]一種化合物,其中,在[方式73]中,A是可以具有由B群選出的1個以上的原子或基的苯并唑基,[方式87]一種化合物,其中,在[方式86]中,A是6-氯苯并唑基,[方式88]一種化合物,其中,在[方式73]中,A是可以具有由B群選出的1個以上的原子或基的喹啉基,[方式89]一種化合物,其中,在[方式88]中,A是6-氯喹啉基,[方式90]一種化合物,其中,在式(I)中,G是氫或下述式表示的基 [Mode 56] A kind of 嗒 A ketone compound, wherein, in [Mode 55], R 11 represents a methyl group, R 21 represents hydrogen, a methyl group or a methoxy group, and A 21 represents a pyridyl group, a benzothiazolyl group, a benzo group. Azolyl or quinolyl, [Mode 57] A compound wherein, in the formula (I), R 1 is a C 1-3 alkyl group, [Mode 58] a compound wherein, in [Mode 57], R 1 is a methyl group, [Mode 59] a compound wherein, in [Mode 57] or [Mode 58], R 2 is hydrogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-6 Alkoxy, C 1-6 haloalkoxy, C 3-8 cycloalkyl, C 3-8 cycloalkoxy or (C 3-6 cycloalkyl) C 1-6 alkoxy, [method 60 A compound wherein, in [Mode 59], R 2 is a C 1-3 alkyl group, [Mode 61] a compound wherein, in [Mode 60], R 2 is a methyl group, [Mode 62] A compound wherein, in [Mode 59], R 2 is a C 1-6 alkoxy group, [Mode 63] a compound wherein, in [Mode 62], R 2 is a methoxy group, [Mode 64] A compound, wherein, in the formula (I), R 3 is a C 1-3 alkyl group, [method 65] a compound wherein, in any one of [Mode 57] to [Mode 63], R 3 is C C1-3 alkyl, [embodiment 66] a compound wherein, in the [embodiment 65], R 3 is methyl, [embodiment 67] a compound wherein, in the [embodiment 65], R 3 is ethyl [Embodiment 68] A compound wherein, in formula (the I), R 4 is hydrogen, [embodiment 69] A compound wherein, in any of [embodiment 57] to [embodiment 67] The one embodiment, R 4 is hydrogen [Mode 70] A compound wherein, in the formula (I), R 5 is hydrogen, [Mode 71] a compound, wherein, in any one of [Mode 57] to [Mode 69], R 5 is Hydrogen, [Mode 72] a compound wherein, in the formula (I), A is phenyl, naphthyl, pyridyl, anthracene Base, pyrimidinyl, pyridyl Benzothiazolyl, benzo Azyl, quinolyl, porphyrin, quinazolinyl, quin Porphyrin or benzotrien Further, the group may have one or more atoms or groups selected from the group B, and [method 73] wherein, in any one of [Mode 57] to [Mode 71], A is a phenyl group. , naphthyl, pyridyl, anthracene Base, pyrimidinyl, pyridyl Benzothiazolyl, benzo Azyl, quinolyl, porphyrin, quinazolinyl, quin Porphyrin or benzotrien The group may have one or more atoms or groups selected from the group B, and [method 74], wherein in the method 73, A may have one or more selected from the group B. Atom or a phenyl group, [Mode 75] a compound wherein, in [Mode 74], A is 2-fluoro-4-cyanophenyl, [Mode 76] a compound wherein [Mode 74] Wherein A is 4-trifluoromethylphenyl, [Mode 77] a compound wherein, in [Mode 74], A is 2-chloro-4-trifluoromethylphenyl, [Mode 78] a compound In [Mode 73], A is a pyridyl group which may have one or more atoms or groups selected from the B group, [Mode 79] a compound in which, in [Mode 78], A is 5- Trifluoromethylpyridin-2-yl, [Mode 80] A compound wherein, in [Mode 78], A is 2-chloro-5-trifluoromethylpyridin-2-yl, [Mode 81] a compound Wherein, in [Mode 78], A is 2-fluoro-5-trifluoromethylpyridin-2-yl, [Mode 82] a compound wherein, in [Mode 78], A is 2-fluoro- 5-Chloromethylpyridin-2-yl, [Mode 83] a compound in which In 73], A is a benzothiazolyl group which may have one or more atoms or groups selected from the group B, [Mode 84] A compound in which, in [Mode 83], A is a benzothiazolyl group, [ Mode 85] A compound wherein, in [Mode 83], A is 6-chlorobenzothiazolyl, [Mode 86] a compound wherein, in [Mode 73], A is selected from Group B. More than one atom or group of benzo Azolyl, [Mode 87] a compound wherein, in [Mode 86], A is 6-chlorobenzo Azolyl, [Mode 88] A compound wherein, in [Mode 73], A is a quinine which may have one or more atoms or groups selected from the B group. A phenyl group, [Mode 89] a compound wherein, in [Mode 88], A is 6-chloroquine [Formula 90] A compound wherein, in the formula (I), G is hydrogen or a group represented by the following formula

(式中,R6a、R7a及Wa表示與前述相同的意義。) (wherein R 6a , R 7a and W a have the same meanings as described above.)

[方式91]一種化合物,其中,在[方式57]至[方式90]之任一方式中,G是氫或下述式表示的基: [Aspect 91] A compound, wherein, in any one of [Mode 57] to [Mode 90], G is hydrogen or a group represented by the following formula:

(式中、R6a、R7a及Wa表示與前述相同的意義。) (wherein R 6a , R 7a and W a have the same meanings as described above.)

[方式92]一種化合物,其中,在[方式91]中,G是(C1-12烷基)羰基,[方式93]一種化合物,其中,在[方式91]中,G是丁醯基,[方式94]一種化合物,其中,在[方式91]中,G是2-甲基丁醯基, [方式95]一種化合物,其中,在[方式91]中,G是3-甲基丁醯基,[方式96]一種化合物,其中,在[方式91]中,G是戊醯基,[方式97]一種化合物,其中,在[方式91]中,G是2-甲基戊醯基,[方式98]一種化合物,其中,在[方式91]中,G是2-乙基戊醯基,[方式99]一種化合物,其中,在[方式91]中,G是2-丙基戊醯基,[方式100]一種化合物,其中,在[方式91]中,G是己醯基,[方式101]一種化合物,其中,在[方式91]中,G是2-甲基己醯基,[方式102]一種化合物,其中,在[方式91]中,G是2-乙基己醯基,[方式103]一種化合物,其中,在[方式91]中,G是3,5,5-三甲基己醯基,[方式104]一種化合物,其中,在[方式91]中,G是{(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-12烷基}羰基,[方式105]一種化合物,其中,在[方式91]中,G是苯乙醯基,[方式106]一種化合物,其中,在[方式91]中,G是3-苯丙醯基[方式107]一種化合物,其中,在[方式91]中,G是(可以具有由D群選出的1個以上的原子或基的C6-10芳氧基)羰基,[方式108]一種化合物,其中,在[方式91]中,G是苯氧基羰基,[方式109]一種化合物,其中,在[方式91]中,G是{(C1-6烷氧基)C1-6烷基}羰基,[方式110]一種化合物,其中,在[方式91]中,G是甲氧基乙醯基,[方式111]一種化合物,其中,在[方式91]中,G是乙氧基乙醯 基,[方式112]一種化合物,其中,在[方式91]中,G是丙氧基乙醯基,[方式113]一種化合物,其中,在[方式91]中,G是3-甲氧基丙醯基,[方式114]一種化合物,其中,在[方式91]中,G是3-乙氧基丙醯基[方式115]一種化合物,其中,在[方式91]中,G是3-甲氧基-2-甲基丙醯基,[方式116]一種化合物,其中,在[方式91]中,G是{(C1-6烷硫基)烷基}羰基,[方式117]一種化合物,其中,在[方式91]中,G是乙硫基乙醯基,[方式118]一種化合物,其中,在[方式91]中,G是3-(甲硫基)丙醯基,[方式119]一種化合物,其中,在[方式91]中,G是{(可以具有由D群選出的1個以上的原子或基的C6-10芳氧基)C1-12烷基}羰基,[方式120]一種化合物,其中,在[方式91]中,G是苯氧基乙醯基,[方式121]一種化合物,其中,在[方式91]中,G是[{(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-6烷氧基}C1-6烷基]羰基,[方式122]一種化合物,其中,在[方式91]中,G是苄氧基乙醯基, [方式123]一種化合物,其中,在[方式91]中,G是(可以具有由D群選出的1個以上的原子或基的C6-10芳基)羰基,[方式124]一種化合物,其中,在[方式91]中,G是2-氟苄醯基,[方式125]一種化合物,其中,在[方式91]中,G是3-氟苄醯基,[方式126]一種化合物,其中,在[方式91]中,G是4-氟苄醯基,[方式127]一種化合物,其中,在[方式91]中,G是2-氯苄醯基,[方式128]一種化合物,其中,在[方式91]中,G是3-氯苄醯基,[方式129]一種化合物,其中,在[方式91]中,G是4-氯苄醯基,[方式130]一種化合物,其中,在[方式91]中,G是2-溴苄醯基,[方式131]一種化合物,其中,在[方式91]中,G是4-溴苄醯基,[方式132]一種化合物,其中,在[方式91]中,G是2-乙基苄醯基,{方式133]一種化合物,其中,在[方式91]中,G是2-甲氧基苄醯基,[方式134]一種化合物,其中,在[方式91]中,G是3-甲氧基苄醯基,[方式135]一種化合物,其中,在[方式91]中,G是4-甲氧基苄醯基,[方式136]一種化合物,其中,在[方式91]中,G是2-乙氧基苄醯基,[方式137]一種化合物,其中,在[方式91]中,G是2-甲硫基苄醯基,[方式138]一種化合物,其中,在[方式91]中,G是4-氰基苄醯基, [方式139]一種化合物,其中,在[方式91]中,G是2-硝基苄醯基,[方式140]一種化合物,其中,在[方式91]中,G是4-硝基苄醯基,[方式141]一種化合物,其中,在[方式91]中,G是2-(三氟甲基)苄醯基,[方式142]一種化合物,其中,在[方式91]中,G是4-(三氟甲基)苄醯基,[方式143]一種化合物,其中,在[方式91]中,G是4-(三氟甲氧基)苄醯基,[方式144]一種化合物,其中,在[方式91]中,G是2,6-二氟苄醯基,[方式145]一種化合物,其中,在[方式91]中,G是2,3-二氯苄醯基,[方式146]一種化合物,其中,在[方式91]中,G是2,4-二氯苄醯基,[方式147]一種化合物,其中,在[方式91]中,G是2,5-二氯苄醯基,[方式148]一種化合物,其中,在[方式91]中,G是2,6-二氯苄醯基,[方式148]一種化合物,其中,在[方式91]中,G是3,4-二氯苄醯基,[方式150]一種化合物,其中,在[方式91]中,G是3,5-二氯苄醯基, [方式151]一種化合物,其中,在[方式91]中,G是2,6-二甲基苄醯基,[方式152]一種化合物,其中,在[方式91]中,G是2,6-二甲氧基苄醯基,[方式153]一種化合物,其中,在[方式91]中,G是甲烷磺醯基,[方式154]一種化合物,其中,在[方式91]中,G是苯磺醯基,[方式155]式(Ic)表示的嗒酮化合物: [式中,R12表示C1-3烷基,R22表示氫、C1-6烷基或C1-6烷氧基,R32表示C1-3烷基,R42及R52表示氫,A22表示單環式或二環式縮合環的芳基,或含有由氮、氧及硫所成的群選出的1或2個原子作為雜原子的單環式或二環式縮合環的雜芳基,該等的基可以具有由鹵原子及C1-3鹵烷基所成的群選出的1個以上的原子或基,G22表示與前述相同的意義] [Mode 92] A compound wherein, in [Mode 91], G is a (C 1-12 alkyl)carbonyl group, [Mode 93] a compound wherein, in [Mode 91], G is a butyl group, [method] 94] A compound wherein, in [Mode 91], G is 2-methylbutanyl, [Mode 95] a compound wherein, in [Mode 91], G is 3-methylbutanyl, [Mode 96] A compound wherein, in [Form 91], G is a amyl group, [Mode 97] a compound wherein, in [Mode 91], G is 2-methylpentanyl, [Mode 98] a compound Wherein, in [Mode 91], G is 2-ethylpentanyl, [Mode 99] a compound wherein, in [Mode 91], G is 2-propylpentyl, [Mode 100] A compound wherein, in [Form 91], G is a hexyl group, [Mode 101] a compound wherein, in [Mode 91], G is 2-methylhexanyl, [Mode 102] a compound Wherein, in [Mode 91], G is 2-ethylhexyl, [Mode 103] a compound wherein, in [Mode 91], G is 3,5,5-trimethylhexyl , [Mode 104] a compound in which [Mode 9 In 1], G is {(a C 6-10 aryl group which may have one or more atoms selected from the D group), a C 1-12 alkyl}carbonyl group, [Mode 105] a compound in which [ In the formula 91], G is a phenethyl group, [Mode 106] a compound wherein, in [Mode 91], G is a 3-phenylpropanyl group [Mode 107], wherein [Mode 91] Wherein G is (C 6-10 aryloxy)carbonyl which may have one or more atoms or groups selected from the D group, [Mode 108] a compound in which [Form 91], G is phenoxy A carbonyl group, [Mode 109] a compound wherein, in [Form 91], G is {(C 1-6 alkoxy) C 1-6 alkyl}carbonyl, [Mode 110] a compound wherein [Form 91] wherein G is a methoxyethyl group, [Mode 111] a compound wherein, in [Mode 91], G is an ethoxyethyl hydrazide group, [Mode 112] a compound wherein [Form 91] wherein G is a propoxyethyl group, [Mode 113] a compound wherein, in [Form 91], G is 3-methoxypropenyl, [Mode 114] a compound wherein , in [Mode 91], G is 3-ethoxypropanyl [Mode 115] Compounds, wherein, in the [embodiment 91], G is 3-methoxy-2-methylpropan-acyl, [116 embodiment] A compound wherein, in the [embodiment 91], G is {(C 1 -6 alkylthio)alkyl}carbonyl, [Mode 117] A compound wherein, in [Mode 91], G is ethylthioethyl, [Mode 118] a compound, wherein [Mode 91] Wherein G is a 3-(methylthio)propanyl group, [Mode 119] a compound wherein, in [Mode 91], G is {(may have one or more atoms or groups selected from the D group) C 6-10 aryloxy)C 1-12 alkyl}carbonyl, [Mode 120] A compound wherein, in [Mode 91], G is phenoxyethyl hydrazino, [Mode 121] a compound wherein In [Form 91], G is [{(C 6-10 aryl group which may have one or more atoms or groups selected from the D group) C 1-6 alkoxy} C 1-6 alkyl] Carbonyl, [Mode 122] A compound wherein, in [Mode 91], G is a benzyloxyethyl group, [Mode 123] a compound wherein, in [Mode 91], G is (may have a D a group of more than one atom or a C 6-10 aryl)carbonyl group, [Mode 124] a compound Wherein, in [Mode 91], G is 2-fluorobenzylidene, [Mode 125] a compound wherein, in [Mode 91], G is 3-fluorobenzylidene, [Mode 126] a compound Wherein, in [Mode 91], G is 4-fluorobenzylidene, [Mode 127] a compound wherein, in [Mode 91], G is 2-chlorobenzylidene, [Mode 128] a compound Wherein, in [Mode 91], G is 3-chlorobenzylidene, [Mode 129] a compound wherein, in [Mode 91], G is 4-chlorobenzylidene, [Mode 130] a compound Wherein, in [Mode 91], G is 2-bromobenzylidene, [Mode 131] a compound wherein, in [Mode 91], G is 4-bromobenzylidene, [Mode 132] a compound Wherein, in [Mode 91], G is 2-ethylbenzylidene, {Mode 133] a compound wherein, in [Mode 91], G is 2-methoxybenzylidene, [Mode 134] A compound wherein, in [Form 91], G is 3-methoxybenzylidene, [Mode 135] a compound wherein, in [Form 91], G is 4-methoxybenzylidene [Mode 136] a compound wherein, in [Mode 91], G is 2-ethoxy A compound according to [Mode 137], wherein, in [Mode 91], G is 2-methylthiobenzyl hydrazino, [Mode 138] a compound wherein [method 91], G is 4-Cyanobenzylidene, [Mode 139] A compound wherein, in [Form 91], G is 2-nitrobenzyl fluorenyl, [Mode 140] a compound, wherein, in [Mode 91], G is 4-nitrobenzyl fluorenyl, [Mode 141] a compound wherein, in [Mode 91], G is 2-(trifluoromethyl)benzyl fluorenyl, [Mode 142] a compound in which [Form 91] wherein G is 4-(trifluoromethyl)benzylhydrazine, [Mode 143] a compound wherein, in [Form 91], G is 4-(trifluoromethoxy)benzylhydrazine [Mode 144] A compound wherein, in [Mode 91], G is 2,6-difluorobenzylidene, [Mode 145] a compound wherein, in [Mode 91], G is 2, 3 - Benzylbenzyl, [Mode 146] A compound wherein, in [Form 91], G is 2,4-dichlorobenzylidene, [Mode 147] a compound wherein [Mode 91] , G is 2,5-dichlorobenzylidene, [Mode 148] a compound in which [Mode 91] G is 2,6-dichlorobenzylidene, [Mode 148] a compound wherein, in [Mode 91], G is 3,4-dichlorobenzylidene, [Mode 150] a compound in which [Form 91] wherein G is 3,5-dichlorobenzylidene, [Mode 151] a compound wherein, in [Mode 91], G is 2,6-dimethylbenzylidene, [Mode 152] A compound wherein, in [Mode 91], G is 2,6-dimethoxybenzylidene, [Mode 153] a compound wherein, in [Mode 91], G is a methanesulfonyl group, [Aspect 154] A compound wherein, in [Form 91], G is a phenylsulfonyl group, [Formula 155] a hydrazine represented by the formula (Ic) Ketone compounds: Wherein R 12 represents C 1-3 alkyl, R 22 represents hydrogen, C 1-6 alkyl or C 1-6 alkoxy, R 32 represents C 1-3 alkyl, and R 42 and R 52 represent Hydrogen, A 22 represents an aryl group of a monocyclic or bicyclic condensed ring, or a monocyclic or bicyclic condensed ring containing 1 or 2 atoms selected from a group consisting of nitrogen, oxygen and sulfur as a hetero atom. The heteroaryl group may have one or more atoms or groups selected from the group consisting of a halogen atom and a C 1-3 haloalkyl group, and G 22 represents the same meaning as described above.

[方式156]一種嗒酮化合物,其中,在[方式155]中,R1表示甲基,R2表示氫、甲基或甲氧基,A表示吡啶基、苯并噻唑基、苯并唑基或喹啉基。 [Mode 156] A kind of 嗒 A ketone compound, wherein, in [Mode 155], R 1 represents a methyl group, R 2 represents hydrogen, a methyl group or a methoxy group, and A represents a pyridyl group, a benzothiazolyl group, a benzo group. Azyl or quinolyl.

本發明的除草劑含有本發明化合物及惰性載體。就 惰性載體而言,可列舉固體載體、液體載體及氣體載體。本發明的除草劑通常再添加界面活性劑、固定劑、分散劑、安定劑等製劑用佐劑,製成為水合劑、顆粒水合劑、可流動性(flowable)劑、粒劑、乾式可流動性劑、乳劑、水性液劑、油劑、燻煙劑、氣溶膠劑、微膠囊劑等。本發明的除草劑中以重量比通常含有0.1至80%之本發明化合物。 The herbicides of the invention comprise a compound of the invention and an inert carrier. on Examples of the inert carrier include a solid carrier, a liquid carrier, and a gas carrier. The herbicide of the present invention is usually further added with a surfactant, a fixative, a dispersant, a stabilizer, and the like, and is prepared as a hydrating agent, a granule hydrating agent, a flowable agent, a granule, and a dry flowability. Agents, emulsions, aqueous liquids, oils, smokers, aerosols, microcapsules, and the like. The herbicide of the present invention usually contains 0.1 to 80% of the compound of the present invention in a weight ratio.

就惰性載體而言,可列舉固體載體、液體載體及氣體載體。 The inert carrier may, for example, be a solid carrier, a liquid carrier or a gas carrier.

就固體載體而言,例如可列舉黏土類(例如可列舉高嶺土、矽藻土、合成含水氧化矽、文挾黏土(Fubasami clay)、皂土、酸性白土)、滑石類、其他的無機礦物(例如絹雲母、石英粉末、硫磺粉末、活性碳、碳酸鈣、水合氧化矽)等微粉末或粒狀物,就液體載體而言,例如可列舉水、醇類(例如可列舉甲醇、乙醇)、酮類(例如可列舉丙酮、丁酮)、芳香族烴類(例如可列舉苯、甲苯、二甲苯、乙基苯、甲基萘)、脂肪族烴類(例如可列舉正己烷、環己烷、燈油)、酯類(例如可列舉乙酸乙酯、乙酸丁酯)、腈類(例如乙腈、異丁腈)、醚類(例如二烷、二異丙醚)、醯胺類(例如可列舉N,N-二甲基甲醯胺(以下簡稱為DMF)、二甲基乙醯胺)、鹵化烴類(例如可列舉二氯乙烷、三氯乙烯、四氯化碳)等。 Examples of the solid carrier include clays (for example, kaolin, diatomaceous earth, synthetic aqueous cerium oxide, fubasami clay, bentonite, acid white clay), talc, and other inorganic minerals (for example, strontium). A fine powder or a granule such as mica, quartz powder, sulfur powder, activated carbon, calcium carbonate or hydrated cerium oxide. Examples of the liquid carrier include water, alcohols (for example, methanol, ethanol), and ketones. (Examples include acetone, methyl ethyl ketone), aromatic hydrocarbons (for example, benzene, toluene, xylene, ethylbenzene, methylnaphthalene) and aliphatic hydrocarbons (for example, n-hexane, cyclohexane, and kerosene) ), esters (for example, ethyl acetate, butyl acetate), nitriles (such as acetonitrile, isobutyronitrile), ethers (for example, two Alkane, diisopropyl ether), decylamines (for example, N,N-dimethylformamide (hereinafter abbreviated as DMF), dimethylacetamide), halogenated hydrocarbons (for example, dichloroethane) Alkane, trichloroethylene, carbon tetrachloride, etc.

就界面活性劑而言,例如可列舉烷基硫酸酯類、烷基磺酸鹽、烷基芳基磺酸鹽、烷基芳基醚類及其聚氧基乙烯化物、聚氧基乙二醇醚類、多元醇酯類、糖醇衍生物等。 Examples of the surfactant include alkyl sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl aryl ethers, and polyoxyethylenes thereof, and polyoxyethylene glycols. Ethers, polyol esters, sugar alcohol derivatives, and the like.

就其他的製劑用佐劑而言,例如可列舉固定劑及分散劑,具體而言可列舉酪蛋白、明膠、多糖類(例如可列舉澱粉、 阿拉伯樹膠、纖維素衍生物、海藻酸)、木質素衍生物、皂土、糖類、合成水溶性高分子(例如可列舉聚乙烯醇、聚乙烯吡咯啶酮、聚丙烯酸類)、PAP(酸性磷酸異丙酯)、BHT(2,6-二-三級丁基-4-甲基苯酚)、BHA(2-三級丁基-4-甲氧基苯酚與3-三級丁基-4-甲氧基苯酚的混合物)、植物油、礦物油、脂肪酸或其酯等。 Examples of other preparation adjuvants include a fixing agent and a dispersing agent, and specific examples thereof include casein, gelatin, and polysaccharides (for example, starch, Acacia gum, cellulose derivative, alginic acid), lignin derivative, bentonite, sugar, synthetic water-soluble polymer (for example, polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acid), PAP (acidic phosphoric acid) Isopropyl ester), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (2-tert-butyl-4-methoxyphenol and 3-tertiary butyl-4- a mixture of methoxyphenol), vegetable oil, mineral oil, fatty acid or its ester, and the like.

本發明的雜草防治方法包含將本發明化合物的有效量施用在雜草或者雜草生長的場所或可能生長的場所的步驟。本發明的雜草防治方法中,通常,使用本發明的除草劑。就本發明的除草劑的施用方法而言,例如可列舉:以本發明的除草劑處理雜草的莖葉的方法,以本發明的除草劑處理雜草生長或可能生長的土壤表面的方法,以本發明的除草劑在雜草生長的土壤混和處理的方法,及以本發明的除草劑對在雜草生長或可能生長的場所蓄水的水田的表面水進行處理的方法。本發明的雜草防治方法中,相對於防治雜草的面積每10000m2通常施用本發明化合物1至5000g,理想是10至1000g。 The weed control method of the present invention comprises the step of applying an effective amount of the compound of the present invention to a place where weeds or weeds grow or a place where it may grow. In the weed control method of the present invention, the herbicide of the present invention is usually used. With regard to the method of applying the herbicide of the present invention, for example, a method of treating the stems and leaves of the weeds with the herbicide of the present invention, a method of treating the surface of the soil in which the weeds grow or may grow with the herbicide of the present invention, A method of mixing a herbicide of the present invention in a soil in which weeds grow, and a method of treating surface water of a paddy field which is stored in a place where weeds grow or may grow with the herbicide of the present invention. In the weed control method of the present invention, the compound of the present invention is usually applied in an amount of from 1 to 5,000 g, preferably from 10 to 1,000 g, per 10,000 m 2 relative to the area for controlling weeds.

本發明化合物可在栽培下述所列舉的「植物」的農耕地等使用。 The compound of the present invention can be used in the cultivation of agricultural fields such as "plants" listed below.

「植物」:農作物:玉米、稻、小麥、大麥、黑麥、燕麥、高梁、棉、大豆、落花生、蕎麥、甜菜、油菜、向日葵、甘蔗、菸草、啤酒花等。 "Plants": Crops: corn, rice, wheat, barley, rye, oats, sorghum, cotton, soybeans, groundnuts, buckwheat, sugar beets, canola, sunflower, sugar cane, tobacco, hops, etc.

蔬菜:茄科蔬菜(茄、番茄、甜椒、辣椒、馬鈴薯等)、葫蘆科蔬菜(胡瓜、南瓜、西葫蘆、西瓜、香瓜、東方甜瓜等)、十字花科蔬菜(蘿蔔、蕪菁、辣根、苤藍、大白菜、甘藍菜、芥菜、青花菜、花椰菜等)、菊科蔬菜(牛蒡、茼蒿、洋薊、萵苣 等)、百合科蔬菜(蔥、洋蔥、大蒜、蘆筍等)、繖形科蔬菜(胡蘿蔔、香芹、芹菜、歐防風等)、藜科蔬菜(菠菜、葉用甜菜等)、唇形花科蔬菜(紫蘇、薄荷、九層塔等)、豆科作物(豌豆、菜豆、紅豆、蠶豆、雞豆等)、草莓、甘薯、日本薯蕷、芋頭、蒟蒻、薑、秋葵等。 Vegetables: Solanaceae vegetables (egg, tomato, sweet pepper, pepper, potato, etc.), Cucurbitaceae vegetables (courgette, pumpkin, zucchini, watermelon, cantaloupe, oriental melon, etc.), cruciferous vegetables (radish, turnip, horseradish, Indigo, Chinese cabbage, kale, mustard, broccoli, broccoli, etc.), Asteraceae (burdock, artemisia, artichoke, lettuce) Etc.), Liliaceae vegetables (onions, onions, garlic, asparagus, etc.), Umbelliferous vegetables (carrots, parsley, celery, European windproof, etc.), Polygonaceae vegetables (spinach, leaf beet, etc.), Labiatae Vegetables (perilla, mint, nine-story tower, etc.), legumes (peas, kidney beans, red beans, broad beans, chickpeas, etc.), strawberries, sweet potatoes, Japanese yam, taro, medlar, ginger, okra, etc.

果樹:仁果類(蘋果、梨、西洋梨、榠樝、榲桲等)、核果類(桃、李、油桃、梅、櫻桃、杏、乾果李等)、柑橘類(溫州蜜柑、橙、檸檬、萊姆、葡萄柚等)、堅果類(栗、胡桃、榛、扁桃、開心果、腰果、澳洲胡桃等)、漿果類(藍莓、蔓越莓、黑莓、樹莓等)、葡萄、柿、橄欖、枇杷、香蕉、咖啡、海棗、椰子、油棕櫚等。 Fruit trees: pome fruits (apples, pears, pears, clams, clams, etc.), stone fruits (peach, plum, nectarine, plum, cherry, apricot, dried fruit, etc.), citrus (Wenzhou mandarin, orange, lemon) , lime, grapefruit, etc.), nuts (chestnuts, walnuts, alfalfa, almonds, pistachios, cashews, macadamia, etc.), berries (blueberries, cranberries, blackberries, raspberries, etc.), grapes, persimmons, Olives, alfalfa, bananas, coffee, dates, coconuts, oil palms, etc.

果樹以外的樹木:茶、桑、花木類(皋月杜鵑、茶花、繡球花、茶梅、日本莽草、櫻、北美鵝掌楸、紫薇、丹桂等),街道樹(梣樹、樺樹、大花四照花、尤加利、銀杏、紫丁香花、楓樹、櫟樹、楊樹、紫荊、楓香樹、懸鈴木、櫸樹、日本香柏、日本冷杉、日本鐵杉、杜松、松樹、魚鱗雲杉、日本紅豆杉、榆樹、日本七葉樹等)、珊瑚樹、羅漢松、日本柳杉、日本扁柏、變葉木(Croton)、冬青衛矛、光葉石楠等。 Trees other than fruit trees: tea, mulberry, flower and wood (皋月鹃, Camellia, Hydrangea, Chamo, Japanese yarrow, Sakura, Liriodendron, Lagerstroemia, Dangui, etc.), street trees (eucalyptus, birch , large flowers, four flowers, eucalyptus, ginkgo, lilac, maple, eucalyptus, poplar, bauhinia, sweet gum, sycamore, eucalyptus, Japanese cedar, Japanese fir, Japanese hemlock, juniper , pine, fish scale spruce, Japanese yew, eucalyptus, Japanese horse chestnut, etc.), coral tree, Podocarpus, Japanese cedar, Japanese cypress, Croton, holly euonymus, Photinia glabra.

其他:花卉類(薔薇、康乃馨、菊、洋桔梗、縷絲花、非洲菊、萬壽菊、一串紅、矮牽牛、馬鞭草、鬱金香、紫菀、龍膽、百合、三色菫、仙客來、蘭、鈴蘭、薰衣草、紫羅蘭、葉牡丹、報春花、一品紅、劍蘭、嘉德麗雅蘭、雛菊、大花蕙蘭、秋海棠等)、生質燃料植物(痲瘋樹、紅花、亞麻薺類、風傾草(switchgrass)、芒草、蘆竹、洋麻、木薯、柳等)、觀葉植物等。 Others: flowers (rose, carnation, chrysanthemum, eustoma, silk flower, gerbera, marigold, bunch of red, petunia, verbena, tulip, sable, gentian, lily, pansy, cyclamen, Orchid, lily of the valley, lavender, violet, leaf peony, primrose, poinsettia, gladioli, garland, daisy, cymbidium, begonia, etc.), biomass fuel plants (jatropha, safflower, flax, wind Grass (switchgrass), Miscanthus, Arundo, kenaf, cassava, willow, etc.), foliage plants, etc.

上述「植物」中也包含基因重組植物。 Genetically modified plants are also included in the above "plants".

本發明化合物可與其他的除草劑、藥害減輕劑、植物成長調節劑、殺蟲劑、殺蟎劑、殺線蟲劑、殺菌劑及/或增效劑混用或併用。 The compound of the present invention can be used in combination or in combination with other herbicides, phytotoxicity reducing agents, plant growth regulators, insecticides, acaricides, nematicides, bactericides and/or synergists.

就這種除草劑的有效成分而言,例如可列舉以下化合物。 As the active ingredient of such a herbicide, the following compounds are mentioned, for example.

(1)苯氧基脂肪酸系除草性化合物2,4-PA、MCP、MCPB、脫禾草(phenothiol)、2-(4-氯-2-甲基苯氧基)丙酸(mecoprop)、氟氯比(fluroxypyr)、三氯比(triclopyr)、克普草(clomeprop)、萘氧苯草胺(naproanilide)等;(2)苄酸系除草性化合物2,3,6-TBA、汰克草(dicamba)、畢克草(clopyralid)、畢克爛(picloram)、氯胺基吡啶酸(aminopyralid)、快克草(quinclorac)、氯甲喹啉酸(quinmerac)等;(3)尿素系除草性化合物達有龍(diuron)、理有龍(linuron)、綠麥隆(chlortoluron)、異丙隆(isoproturon)、可奪草(fluometuron)、愛速隆(isouron)、得匍隆(tebuthiuron)、甲基苯噻隆(methabenzthiazuron)、苄草隆(cumyluron)、汰草龍(daimuron)、甲基汰草龍(methyl-daimuron)等;(4)三系除草性化合物草脫淨(atrazine)、草殺淨(ametryn)、氰乃淨(cyanazine)、草滅淨(simazine)、普拔根(propazine)、西草淨(simetryn)、愛落殺(dimethametryn)、佈滅淨(prometryn)、滅必淨(metribuzin)、三氟草胺(triaziflam)、茚達能(indaziflam)等; (5)聯吡啶鎓(bipyridinium)系除草性化合物巴拉刈(paraquat)、敵草快(diquat)等;(6)羥基苄腈系除草性化合物溴苯腈(bromoxynil)、碘苯腈(ioxynil)等;(7)二硝基苯胺系除草性化合物施得圃(pendimethalin)、氨氟樂靈(prodiamine)、三福林(trifluralin)等;(8)有機磷系除草性化合物甲基胺草磷(amiprofos-methyl)、抑草磷(butamifos)、地散磷(bensulide)、哌草磷(piperophos)、莎稗磷(anilofos)、嘉磷塞(glyphosate)、固殺草(glufosinate)、固殺草-P(glufosinate-P)、畢拉草(bialaphos)等;(9)胺甲酸酯(carbamate)系除草性化合物燕麥敵(di-allate)、野麥畏(tri-allate)、EPTC、拔敵草(butylate)、佈殺丹(benthiocarb)、戊草丹(esprocarb)、稻得壯(molinate)、哌草丹(dimepiperate)、滅草靈(swep)、克普芬(chlorpropham)、甜菜寧(phenmedipham)、棉胺寧(phenisopham)、稗草丹(pyributicarb)、亞速爛(asulam)等;(10)醯胺系除草性化合物除草靈(propanil)、拿草特(propyzamide)、溴芬諾(bromobutide)、乙氧基苯草胺(etobenzanid)等;(11)氯乙醯苯胺系除草性化合物乙草胺(acetochlor)、拉草(alachlor)、丁基拉草(butachlor)、汰草滅(dimethenamid)、雷蒙得(propachlor)、滅草胺(metazachlor)、莫 多草(metolachlor)、普拉草(pretilachlor)、欣克草(thenylchlor)、烯草胺(pethoxamid)等;(12)二苯醚系除草性化合物亞喜芬鈉鹽(acifluorfen-sodium)、必芬諾(bifenox)、復祿芬(oxyfluorfen)、乳氟禾草靈(lactofen)、氟磺胺草醚(fomesafen)、甲氧基護谷(chlomethoxynil)、苯草醚(aclonifen)等;(13)環狀醯亞胺系除草性化合物樂滅草(oxadiazon)、吲哚酮草酯(cinidon-ethyl)、乙基克繁草(carfentrazone-ethyl)、甲磺草胺(sulfentrazone)、氟烯草酸戊酯(flumiclorac-pentyl)、丙炔氟草胺(flumioxazin)、乙基派芬草(pyraflufen-ethyl)、丙炔草酮(oxadiargyl)、環戊草酮(pentoxazone)、氟噻甲草酯(fluthiacet-methyl)、布芬草(butafenacil)、雙苯嘧草酮(benzfendizone)、醯苯草酮(bencarbazone)、殺芬草(saflufenacil)等;(14)吡唑系除草性化合物吡草酮(benzofenap)、吡唑特(pyrazolate)、普芬草(pyrazoxyfen)、吡草磺(topramezone)、磺醯草吡唑(pyrasulfotole)等;(15)三酮系除草性化合物異唑草酮(isoxaflutole)、苯並雙環酮(benzobicyclon)、磺草酮(sulcotrione)、甲基磺草酮(mesotrione)、環磺酮(tembotrione)、特呋三酮(tefuryltrione)、二環吡草酮(bicyclopyrone)等;(16)芳氧基苯氧基丙酸系除草性化合物炔草酯(clodinafop-propargyl)、丁基賽伏草(cyhalofop-butyl)、氯甲草(diclofop-methyl)、芬殺草(fenoxaprop-ethyl)、伏寄普(fluazifop-butyl)、甲基合氯氟(haloxyfop-methyl)、快伏草 (quizalofop-ethyl)、唑醯草胺(metamifop)等;(17)三酮肟(trione oxime)系除草性化合物亞汰草(alloxydim-sodium)、西殺草(sethoxydim)、丁苯草酮(butroxydim)、剋草同(clethodim)、克普定(cloproxydim)、環殺草(cycloxydim)、得殺草(tepraloxydim)、肟草酮(tralkoxydim)、氯苯噻草酮(profoxydim)等;(18)磺醯尿素系除草性化合物氯磺隆(chlorsulfuron)、甲基甲嘧磺隆(sulfometuron-methyl)、甲基甲磺隆(metsulfuron-methyl)、乙基氯嘧磺隆(chlorimuron-ethyl)、甲基苯磺隆(tribenuron-methyl)、醚苯磺隆(triasulfuron)、免速隆(bensulfuron-methyl)、甲基噻吩磺隆(thifensulfuron-methyl)、百速隆(pyrazosulfuron-ethyl)、甲基氟嘧磺隆(primisulfuron-methyl)、煙嘧磺隆(nicosulfuron)、醯嘧磺隆(amidosulfuron)、西速隆(cinosulfuron)、依速隆(imazosulfuron)、玉嘧磺隆(rimsulfuron)、合速隆(halosulfuron-methyl)、氟磺隆(prosulfuron)、甲基胺苯磺隆(ethametsulfuron-methyl)、甲基氟胺磺隆(triflusulfuron-methyl)、伏速隆(flazasulfuron)、環磺隆(cyclosulfamuron)、氟啶嘧磺隆(flupyrsulfuron)、磺醯磺隆(sulfosulfuron)、四唑嘧磺隆(azimsulfuron)、亞速隆(ethoxysulfuron)、環氧嘧磺隆(oxasulfuron)、甲基碘磺隆鈉鹽(iodosulfuron-methyl-sodium)、甲醯胺磺隆(foramsulfuron)、甲磺胺磺隆(mesosulfuron-methyl)、三氟啶磺隆(trifloxysulfuron)、三氟甲磺隆(tritosulfuron)、甲嘧苯胺磺隆(orthosulfamuron)、氟吡磺隆(flucetosulfuron)、咪唑嘧磺隆(propyrisulfuron)、雙醚氯吡嘧磺隆(metazosulfuron)、碘磺醯脲鈉鹽(iofensulfuron-sodium)等; (19)咪唑啉酮(imidazolinone)系除草性化合物咪草酸甲酯(imazamethabenz-methyl)、甲氧咪草煙(imazamox)、甲基咪草煙(imazapic)、依滅草(imazapyr)、滅草喹(imazaquin)、咪唑乙煙酸(imazethapyr)等;(20)磺酸胺系除草性化合物唑嘧磺草胺(flumetsulam)、磺草唑胺(metosulam)、雙氯磺草胺(diclosulam)、雙氟磺草胺(florasulam)、氯酯磺草胺酸甲酯cloransulam-methyl)、平速爛(penoxsulam)、啶磺草胺(pyroxsulam)等;(21)嘧啶基氧基苄酸系除草性化合物嘧草硫醚鈉(pyrithiobac-sodium)、雙草醚鈉(bispyribac-sodium)、嘧草醚(pyriminobac-methyl)、嘧啶草醚(pyribenzoxim)、環酯草醚(pyriftalid)、嘧啶硫蕃(pyrimisulfan)、氟酮磺草胺(triafamone)等;(22)其他系統的除草性化合物本達隆(bentazone)、克草(bromacil)、特草定(terbacil)、草克樂(chlorthiamid)、異草胺(isoxaben)、達諾殺(dinoseb)、殺草強(amitrole)、環庚草醚(cinmethylin)、三地芬(tridiphane)、得拉本(dalapon)、二氟吡隆鈉(diflufenzopyr-sodium)、汰硫草(dithiopyr)、噻唑煙酸(thiazopyr)、氟酮磺隆-鈉(flucarbazone-sodium)、丙苯磺隆鈉(propoxycarbazone-sodium)、滅芬草(mefenacet)、氟噻草胺(flufenacet)、四唑醯草胺(fentrazamide)、苯酮唑(cafenstrole)、茚草酮(indanofan)、草酮(oxaziclomefone)、呋草黃(benfuresate)、ACN、必汰草(pyridate)、氯草敏(chloridazon)、氟草敏(norflurazon)、呋草酮(flurtamone)、吡氟醯草胺(diflufenican)、氟吡醯草胺 (picolinafen)、氟丁醯草胺(beflubutamid)、可滅蹤(clomazone)、胺唑草酮(amicarbazone)、草吡唑(pinoxaden)、雙唑草腈(pyraclonil)、派羅克殺草碸(pyroxasulfone)、甲基噻酮磺隆(thiencarbazone-methyl)、氯丙嘧啶酸(aminocyclopyrachlor)、鹵苯胺唑(ipfencarbazone)、異噻草醚(methiozolin)、芬諾殺磺隆(fenoxasulfone)。 (1) phenoxy fatty acid herbicidal compounds 2,4-PA, MCP, MCPB, phenothiol, 2-(4-chloro-2-methylphenoxy)propionic acid (mecoprop), fluorine Fluoroxypyr, triclopyr, clomeprop, naproanilide, etc.; (2) benzylic acid herbicidal compound 2,3,6-TBA, rickett grass (dicamba), clopyralid, picloram, aminopyralid, quinclorac, quinmerac, etc.; (3) urea-based weeding The compounds are diuron, linuron, chlortoluron, isoproturon, fluometuron, isouron, and tebuthiuron. , methafenzthiazuron, cumyluron, daimuron, methyl-daimuron, etc.; (4) three Herbicidal compound atrazine, ametryn, cyanazine, simazine, propazine, simetryn, love to kill ( Dimethametryn), prometryn, metribuzin, three Triaziflam, indaziflam, etc.; (5) bipyridinium herbicidal compound paraquat, diquat, etc.; (6) hydroxybenzonitrile a herbicidal compound, bromoxynil, ioxynil, etc.; (7) a dinitroaniline herbicidal compound, pendimethalin, prodiamine, trifluralin, etc.; (8) organophosphorus herbicidal compounds amiprofos-methyl, butamifos, bensulide, piperophos, anilofos, jiaphos Glyphosate, glufosinate, glufosinate-P, bialaphos, etc.; (9) carbamate is a herbicidal compound oat enemy (di- Allate), tri-allate, EPTC, butarate, benthiocarb, esprocarb, molate, dimepiperate, extinction Swipe, chlorpropham, phenmedipham, phenisopham, pyributicarb, asulam, etc.; (10) guanamine herbicide Compounds such as propanil, propyzamide, bromobutide, etobenzanid, etc.; (11) chloroacetamide-containing herbicidal compound acetochlor, Alachlor, butachlor, dimethenamid, propachlor, metazachlor, metolachlor, pretilachlor, hin (thenylchlor), cetoxine, etc.; (12) diphenyl ether herbicidal compound acifluorfen-sodium, bifenox, oxyfluorfen, milk Lactofen, fomesafen, chlomethoxynil, aclifen, etc.; (13) cyclic quinone imine herbicidal compound oxadiazon ), cinidon-ethyl, carfentrazone-ethyl, sulfentrazone, flumiclorac-pentyl, flumioxazin ), pyraflufen-ethyl, propyne Oxadiargyl, cyclopentane Penoxoxazone, fluthiacet-methyl, butafenacil, benzfendizone, bencarbazone, saflufenacil, etc.; 14) pyrazole-based herbicidal compounds benzofenap, pyrazolate, pyrazoxyfen, topramezone, pyrosulfotole, etc.; (15) three Ketone herbicidal compound Isoxaflutole, benzobicyclon, sulcotrione, mesotrione, tembotrione, tefuryltrione, bicyclopyrene Bicyclopyrone, etc.; (16) aryloxyphenoxypropionic acid herbicidal compound clodinafop-propargyl, cyhalofop-butyl, diclofop-methyl, Fenoxaprop-ethyl, fluazifop-butyl, haloxyfop-methyl, quizalofop-ethyl, (13) Trione oxime is a herbicidal compound of alloxydim-sodium, sethoxydim, butroxydim, keto (clethodim), cloproxydim, cycloxydim, tepraloxydim, tralkoxydim, profoxydim, etc.; (18) sulfonium urea-based herbicide Compounds chlorsulfuron, sulfometuron-methyl, metsulfuron-methyl, chlorimuron-ethyl, methotrexate Tribenuron-methyl), triasulfuron, bensulfuron-methyl, thifensulfuron-methyl, pyrazosulfuron-ethyl, primisulfuron -methyl), nicosulfuron, amidosulfuron, cinosulfuron, imazosulfuron, rimsulfuron, halosulfuron-methyl , prosulfuron, ethametsulfuron-methyl, triflusulfuron-methyl ), flazasulfuron, cyclosulfamuron, flupyrsulfuron, sulfosulfuron, azimusulfuron, ethoxysulfuron, ring Oxalsulfuron, iodosulfuron-methyl-sodium, foramsulfuron, mesosulfuron-methyl, trifloxysulfuron , tritosulfuron, orthosulfamuron, flucetosulfuron, Propyrisulfuron, metazosulfuron, iofensulfuron-sodium, etc.; (19) imidazolinone is a herbicidal compound of methyl oxalate ( Imazamethabenz-methyl), imazamox, imazapic, imazapyr, imazaquin, imimathapyr, etc.; (20) sulfonate Acid amine herbicidal compound flumetsulam, metosulam, diclosulam, florasulam, chlorosulphos cloransulam -methyl), penoxsulam, pyroxulam, etc.; (21) pyrimidinyloxybenzyl acid herbicidal compound pyrithiobac-sodium, bispyribac -sodium), pyrimanobac-methyl, pyrimibenzoxim, pyrifalid, pyrimisulfan, triafamone, etc.; (22) other systems Herbicidal compounds bentazone, bromacil, terbacil, chlorthiamid, different Isoxaben, dinoseb, amitrol, cinmethylin, tridiphane, dalapon, diflufenzopyr- Sodium), dithiopyr, thiazopyr, flucarbazone-sodium, propoxycarbazone-sodium, mefenacet, flutica Flufenacet, fentrazamide, cafenstrole, indanofan, Oxaziclomefone, benfuresate, ACN, pyridate, chloridazon, norflurazon, flurtamone, diflufenican ), picolinafen, beflubutamid, clomazone, amicarbazone, pinoxaden, pyraclonil, Pyroxasulfone, thiencarbazone-methyl, aminocyclopyrachlor, ipfencarbazone, iso Methiozolin, fenoxasulfone.

就這種藥劑減輕劑的有效成分而言,例如可列舉以下的化合物。 As the active ingredient of such a drug reducing agent, for example, the following compounds can be mentioned.

解草酮(benoxacor)、解毒喹(cloquintocet-mexyl)、解草胺腈(cyometrinil)、二氯丙烯胺(dichlormid)、解草唑(fenchlorazole-ethyl)、解草啶(fenclorim)、解草安(flurazole)、呋喃解草唑(furilazole)、吡唑解草酯(mefenpyr-diethyl)、MG191、解草腈(oxabetrinil)、二丙烯草胺(allidochlor)、雙苯唑酸乙酯(isoxadifen-ethyl)、環丙磺胺(cyprosulfamide)、氟草肟(fluxofenim)、1,8-萘二甲酸酐(1,8-naphthalic anhydride)、AD-67。 Benoxacor, cloquintocet-mexyl, cyometrinil, dichlormid, fenchlorazole-ethyl, fenclorim, chlorpyrifos (flurazole), furilazole, mefenpyr-diethyl, MG191, oxabetrinil, allidochlor, diphenyl Isoxadifen-ethyl, cyprosulfamide, fluxofenim, 1,8-naphthalic anhydride, AD-67.

就這種植物成長調節劑的有效成分而言,例如可列舉以下的化合物。 Examples of the active ingredient of the plant growth regulator include the following compounds.

殺紋寧(hymexazol)、巴克素(paclobutrazol)、單克素(uniconazole-P)、依納素(inabenfide)、調環酸鈣(prohexadione-calcium)、艾維激素(aviglycine)、1-萘乙醯胺(naphthalene acetamide)、脫落酸(abscisic acid)、吲哚丁酸(indolebutyric acid)、吲熟酯(ethychlozate)、益收生長素(ethephon)、番茄美素(cloxyfonac)、克美素(chlormequat)、2,4-滴丙酸(dichlorprop)、吉貝素(gibberellins)、茉莉酸丙酯(prohydrojasmon)、苄腺嘌呤(benzyladenine)、福芬素(forchlorfenuron)、順丁烯二醯肼(maleic hydrazide)、過氧化鈣(calcium peroxide)、縮 節胺(mepiquat-chloride)、4-氯苯氧基乙酸(4-chlorophenoxyacetic acid,4-CPA)。 Hymexazol, paclobutrazol, uniconazole-P, inabenfide, prohexadione-calcium, aviglicine, 1-naphthyl Naphthalene acetamide, abscisic acid, indolebutyric acid, ethychlozate, ethephon, cloxyfonac, chlormequat , 2,4-dipropionic acid, gibberellins, prohydrojasmon, benzyladenine, forchlorfenuron, maleic hydrazide ), calcium peroxide, shrinkage Mepiquat-chloride, 4-chlorophenoxyacetic acid (4-CPA).

就這種殺蟲劑的有效成分而言,例如可列舉以下的化合物。 As the active ingredient of such an insecticide, the following compounds are mentioned, for example.

(1)有機磷化合物 (1) Organic phosphorus compounds

毆殺松(acephate)、脫甲基丁嘧啶磷(butathiofos)、氯氧磷(chlorethoxyfos)、毒蟲畏(chlorfenvinphos)、毒死蜱(chlorpyrifos)、甲基毒死蜱(chlorpyrifos-methyl)、氰乃松(cyanophos:CYAP)、大利松(diazinon)、除線磷(dichlofenthion:ECP)、二氯松(dichlorvos:DDVP)、大滅松(dimethoate)、甲基毒蟲畏(dimethylvinphos)、二硫松(disulfoton)、EPN,愛殺松(ethion)、普伏松(ethoprophos)、益多松(etrimfos)、芬殺松(fenthion:MPP)、撲滅松(fenitrothion:MEP)、福賽絕(fosthiazate)、福木松(formothion)、亞芬松(isofenphos)、加福松(isoxathion)、馬拉松(malathion)、倍硫磷亞碸(mesulfenfos)、滅大松(methidathion:DMTP)、亞素靈(monocrotophos)、乃力松(naled:BRP)、異亞碸磷(oxydeprofos:ESP)、巴拉松(parathion)、裕必松(phosalone)、益滅松(phosmet:PMP)、甲基嘧啶磷(pirimiphos-methyl)、必芬松(pyridafenthion)、喹硫磷(quinalphos)、賽達松(phenthoate:PAP)、佈飛松(profenofos)、丙蟲磷(propaphos)、普硫松(prothiofos)、白克松(pyraclofos)、蔬果磷(salithion)、硫基丙磷(sulprofos)、丁基嘧啶磷(tebupirimfos)、亞培松(temephos)、殺蟲畏(tetrachlorvinphos)、托福松(terbufos)、硫滅松(thiometon)、敵百蟲(trichlorphon:DEP)、繁米松(vamidothion)、福瑞松(phorate)、加奪松(cadusafos)。 Acephate, butathiofos, chlorethoxyfos, chlorfenvinphos, chlorpyrifos, chlorpyrifos-methyl, cyanosom : CYAP), diazinon, deichlofenthion (ECP), dichlorvos (DDVP), dimethoate, dimethylvinphos, disulfoton , EPN, ethion, ethoprophos, etrimfos, fenthion (MPP), fenitrothion (MEP), fosthiazate, buckwood Formothion, isofenphos, isoxathion, malathion, mesulfenfos, methidathion (DMTP), monocrotophos, nitsin (naled: BRP), oxydeprofos (ESP), parathion, phosalone, phosmet (PMP), pirimiphos-methyl, must Pyridafenthion, quinalphos, phenthoate (PAP), profenofos, Propaphos, prothiofos, pyraclofos, salithion, sulprofos, tebupirimfos, temephos, insecticide Tetrachlorvinphos, terbufos, thiometon, trichlorphon (DEP), vamidothion, phorate, and cadusafos.

(2)胺基甲酸酯化合物 (2) urethane compounds

棉鈴威(alanycarb)、免敵克(bendiocarb)、免扶克(benfuracarb)、BPMC、加保利(carbaryl)、加保扶(carbofuran)、丁基加保扶(carbosulfan)、地蟲威(cloethocarb)、愛芬克(ethiofencarb)、丁基滅必蝨(fenobucarb)、芬硫克(fenothiocarb)、芬諾克(fenoxycarb)、呋線威(furathiocarb)、滅必蝨(isoprocarb:MIPC)、治滅蝨(metolcarb)、納乃得(methomyl)、滅賜克(methiocarb)、毆殺滅(oxamyl)、比加普(pirimicarb)、安丹(propoxur:PHC)、XMC、硫敵克(thiodicarb)、滅爾蝨(xylylcarb)、得滅克(aldicarb)。 Alanycarb, bendiocarb, benfuracarb, BPMC, carbaryl, carbofuran, carbosulfan, cloethocarb , ethiofencarb, fenobucarb, fenothiocarb, fenoxycarb, furathiocarb, isoprocarb (MIPC), sputum (metolcarb), methomyl, methiocarb, oxamyl, pirimicarb, propoxur (PHC), XMC, thiodicarb, annihilation Xylylcarb, aldicarb.

(3)除蟲菊精類化合物 (3) Pyrethrin compounds

阿納寧(acrinathrin)、亞烈寧(allethrin)、貝他賽扶寧(beta-cyfluthrin)、畢芬寧(bifenthrin)、乙氰菊酯(cycloprothrin)、賽扶寧(cyfluthrin)、賽洛寧(cyhalothrin)、賽滅寧(cypermethrin)、益避寧(empenthrin)、第滅寧(deltamethrin)、益化利(esfenvalerate)、依芬寧(ethofenprox)、芬普寧(fenpropathrin)、芬化利(fenvalerate)、護賽寧(flucythrinate)、三氟醚菊酯(flufenoprox)、氟氯苯菊酯(flumethrin)、福化利(fluvalinate)、合芬寧(halfenprox)、依普寧(imiprothrin)、百滅寧(permethrin)、普亞列寧(prallethrin)、除蟲菊精(pyrethrins)、列滅寧(resmethrin)、Sigma-賽滅寧(sigma-cypermethrin)、矽護芬(silafluofen)、七氟菊酯(tefluthrin)、泰滅寧(tralomethrin)、拜富寧(transfluthrin)、治滅寧(tetramethrin)、酚丁滅蝨(phenothrin)、賽酚寧(cyphenothrin)、亞滅寧(alpha-cypermethrin)、傑他賽滅寧(zeta-cypermethrin)、賽洛寧(lambda-cyhalothrin)、伽瑪賽洛寧(gamma-cyhalothrin)、炔呋菊酯 (furamethrin)、福化利(tau-fluvalinate)、美特寧(metofluthrin)、丙氟菊酯(profluthrin)、四氟甲醚菊酯(dimefluthrin)、2,2-二甲基-3-(2-氰-1-丙烯基)環丙烷羧酸酯2,3,5,6-四氟-4-(甲氧基甲基)苄、2,2,3,3-四甲基環丙烷羧酸2,3,5,6-四氟-4-(甲氧基甲基)苄酯、丙三苯醚菊酯(protrifenbute)。 Acrinathrin, allethrin, beta-cyfluthrin, bifenthrin, cycloprothrin, cyfluthrin, cyhalothrin , cypermethrin, empenthrin, deltamethrin, esfenvalerate, ethofenprox, fenpropathrin, fenvalerate, care Flucythrinate, flufenoprox, flumethrin, fluvalinate, halfenprox, imiprothrin, permethrin , prallethrin, pyrethrins, resmethrin, sigma-cypermethrin, silafluofen, tefluthrin, thai Tralomethrin, transfluthrin, tetramethrin, phenothrin, cyphenothrin, alpha-cypermethrin, and statin Zeta-cypermethrin), lambda-cyhalothrin, gamma-cyhalothrin, normidine ester (furamethrin), tau-fluvalinate, metofluthrin, profluthrin, dimefluthrin, 2,2-dimethyl-3-(2 -cyano-1-propenyl)cyclopropanecarboxylate 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl, 2,2,3,3-tetramethylcyclopropanecarboxylic acid 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl ester, protrifenbute.

(4)沙蠶毒素化合物 (4) Nereis toxin compounds

培丹(cartap)、免速達(bensultap)、硫賜安(thiocyclam)、殺蟲單(monosultap)、殺蟲雙(bisultap)。 Cartap, bensultap, thiocyclam, monosultap, bisultap.

(5)類新尼古丁(neonicotinoid)化合物 (5) Neonicotinoid compounds

益達胺(imidacloprid)、烯啶蟲胺(nitenpyram)、亞滅培(acetamiprid)、賽速安(thiamethoxam)、賽果培(thiacloprid)、達特南(dinotefuran)、可尼丁(clothianidin)。 Imidacloprid, nitenpyram, acetamiprid, thiamethoxam, thiacloprid, dinotefuran, and clothianidin.

(6)苄醯基尿素化合物 (6) benzyl hydrazine urea compound

克福隆(chlorfluazuron)、雙三氟蟲脲(bistrifluron)、二福隆(diflubenzuron)、吡蟲隆(fluazuron)、氟蟎脲(flucycloxuron)、氟芬隆(flufenoxuron)、六伏隆(hexaflumuron)、祿芬隆(lufenuron)、諾伐隆(novaluron)、諾福隆(noviflumuron)、得福隆(teflubenzuron)、三福隆(triflumuron)。 Chlorfluazuron, bistrifluron, diflubenzuron, flulazuron, flucycloxuron, flufenoxuron, hexaflumuron , Lufenuron, novaluron, Noviflumuron, teflubenzuron, and triflumuron.

(7)苯基吡唑化合物 (7) Phenylpyrazole compound

乙醯蟲腈(acetoprole)、益斯普(ethiprole) Acetopyronitrile, ethiprole

芬普尼(fipronil)、甲烯氟蟲腈(vaniliprole)、吡啶氟蟲腈(pyriprole)、吡氟蟲腈(pyrafluprole)。 Fipronil, vaniliprole, pyriprazole, pyridin Pyrafluprole.

(8)Bt毒素 (8) Bt toxin

源自蘇力菌(Bacillus thuringiensis)的生芽胞及產生結晶毒 素,及該等的混合物。 Sprouts derived from Bacillus thuringiensis and producing crystal poison And the mixture of these.

(9)聯胺化合物 (9) hydrazine compound

可芬諾(chromafenozide)、合芬隆(halofenozide)、滅芬諾(methoxyfenozide)、得芬諾(tebufenozide)。 Chromofozide, halofenozide, methoxyfenozide, tebufenozide.

(10)有機氯化合物 (10) organochlorine compounds

阿特靈(aldrin)、地特靈(dieldrin)、可氯丹(chlordane)、DDT、得氯蟎(dienochlor)、安殺番(endosulfan)、甲氧氯(methoxychlor) Aldrin, dieldrin, chlordane, DDT, dienochlor, endosulfan, methoxychlor

(11)其他的殺蟲有效成分 (11) Other insecticidal active ingredients

機油(machine oil)、菸鹼硫酸鹽(nicotine sulfate);阿維菌素B(avermectin-B)、新殺蟎(bromopropylate)、布芬滅蝨(buprofezin)、克凡派(chlorphenapyr)、賽滅淨(cyromazine)、二氯二異丙謎(dichlorodiisopropyl ether,DCIP)、1,3-二氯丙烯(1,3-Dichloropropene,D-D)、因滅汀(emamectin-benzoate)、芬殺蟎(fenazaquin)、吡氟硫磷(flupyrazofos)、烯蟲乙酯(hydroprene)、烯蟲丙酯(methoprene)、因得克(indoxacarb)、惡蟲酮(metoxadiazone)、倍脈心(milbemycin-A)、派滅淨(pymetrozine)、啶蟲丙醚(pyridalyl)、百利普芬(pyriproxyfen)、賜諾殺(spinosad)、氟蟲胺(sulfluramid)、脫芬瑞(tolfenpyrad)、唑蚜威(triazamate)、氟大滅(flubendiamide)、雷皮菌素(lepimectin)、磷化鋁(aluminium phosphide)氧化亞砷(arsenous oxide)、苯克塞(benclothiaz)、氰胺化鈣(calcium cyanamide)、石灰硫黃合劑(calcium polysulfide)、DSP、氟尼胺(flonicamid)、富路林芬(flurimfen)、覆滅蟎(formetanate)、磷化氫(hydrogen phosphide)、安百畝(metam-ammonium)、斯美地(metam-sodium)、溴甲烷(methyl bromide)、油酸鉀(potassium oleate)、螺甲蟎酯(spiromesifen)、碸蟲 啶(Sulfoxaflor)、硫黃(sulfur)、美氟綜(metaflumizone)、賜派滅(spirotetramat)、吡氟喹啉酮(pyrifluquinazone)、賜諾特(spinetoram)、氯蟲苯甲醯胺(chlorantraniliprole)、曲洛比利(tralopyril)、汰芬隆(diafenthiuron)。 Machine oil, nicotine sulfate; avermectin-B, new bromopropylate, buprofezin, chlorphenapyr, race Cyromazine, dichlorodiisopropyl ether (DCIP), 1,3-dichloropropene (DD), emamectin-benzoate, fenazaquin , flupyrazofos, hydroprene, methoprene, indoxacarb, metoxadiazone, milbemycin-A, degenerate Pymetrozine, pyridalyl, pyriproxyfen, spinosad, sulfluramid, tolfenpyrad, triazamate, fluoride Flubendiamide, lepimectin, aluminium phosphide arsenous oxide, benclothiaz, calcium cyanamide, lime sulfur mixture ( Calcium polysulfide), DSP, flonicamid, flurimfen, formetanate, hydrogen (hydrogen) Phosphate), metam-ammonium, metam-sodium, methyl bromide, potassium oleate, spiromesifen, aphids Sulfoxaflor, sulfur, metaflumizone, spirotetramat, pyrifluquinazone, spinetoram, chlorantraniliprole , tralopyril, diafenthiuron.

式(A)表示的化合物: (式中,Xa1表示甲基、氯、溴或氟,Xa2表示氟、氯、溴、C1至C4鹵烷基或C1至C4鹵烷氧基,Xa3表示氟、氯或溴,Xa4表示可以經取代的C1至C4烷基、可以經取代的C3至C4烯基、可以經取代的C3至C4炔基、可以經取代的C3至C5環烷基烷基或氫,Xa5表示氫或甲基,Xa6表示氫、氟或氯,Xa7表示氫、氟或氯) a compound represented by the formula (A): (wherein, X a1 represents methyl, chlorine, bromine or fluorine, X a2 represents fluorine, chlorine, bromine, C 1 to C 4 haloalkyl or C 1 to C 4 haloalkoxy, and X a3 represents fluorine, chlorine Or bromine, X a4 represents a C 1 to C 4 alkyl group which may be substituted, a C 3 to C 4 alkenyl group which may be substituted, a C 3 to C 4 alkynyl group which may be substituted, a C 3 to C which may be substituted 5 cycloalkylalkyl or hydrogen, X a5 represents hydrogen or methyl, X a6 represents hydrogen, fluorine or chlorine, X a7 represents hydrogen, fluorine or chlorine)

式(B)表示的化合物: a compound represented by the formula (B):

(式中,Xb1表示Xb2-NH-C(=O)基、Xb2-C(=O)-NH-CH2基、Xb3-S(O)基、可以經取代的吡咯-1-基、可以經取代的咪唑-1-基、可以經取代的吡唑-1-基或可以經取代的1,2,4-三唑-1-基,Xb3表示2,2,2-三 氟乙基等可以經取代的C1至C4鹵烷基或環丙基等可以經取代的C3至C8環烷基,Xb3表示甲基等可以經取代的C1至C4烷基,Xb4表示氫、氯、氰基或甲基) (wherein, X b1 represents X b2 -NH-C(=O) group, X b2 -C(=O)-NH-CH 2 group, X b3 -S(O) group, substituted pyrrole-1 - group, may be substituted imidazol-1-yl, may be substituted pyrazol-1-yl or may be substituted triazol-1-yl, X b3 represents 2,2,2 a trifluoroethyl group or the like which may be substituted C 1 to C 4 haloalkyl or cyclopropyl, etc. may be substituted C 3 to C 8 cycloalkyl, and X b3 represents a methyl group or the like which may be substituted C 1 to C 4 Alkyl, X b4 represents hydrogen, chlorine, cyano or methyl)

式(C)表示的化合物: (式中,Xc1表示3,3,3-三氟丙基等可以經取代的C1至C4烷基、2,2,2-三氯乙氧基等可以經取代的C1至C4烷氧基、4-氰苯基等可以經取代的苯基或2-氯-3-吡啶基等可以經取代的吡啶基,Xc2表示甲基或三氟甲硫基,Xc3表示甲基或鹵素) a compound represented by the formula (C): (Wherein, X c1 represents a 3,3,3-trifluoropropyl group and the like can be substituted by C 1 to C 4 alkyl, 2,2,2-trichloroethoxycarbonyl and the like can be substituted by C 1 to C 4-alkoxy, 4-cyanophenyl and the like may be substituted phenyl or 2-chloro-3-pyridyl and the like may be substituted pyridyl group, X c2 represents methyl or trifluoromethylthio, X c3 represents methyl Base or halogen)

就這種殺蟎劑的有效成分而言,例如,可列舉以下的化合物。 As the active ingredient of such an acaricide, for example, the following compounds can be mentioned.

亞醌蟎(acequinocyl)、三亞蟎(amitraz)、西脫蟎(benzoximate)、必芬蟎(bifenazate)、新殺蟎(bromopropylate)、蟎離丹(chinomethionat)、克氯苯(chlorobenzilate)、CPCBS(chlorfenson)、克芬蟎(clofentezine)、賽芬蟎(cyflumetofen)、大克蟎(dicofol)、依殺蟎(etoxazole)、芬佈賜(fenbutatin oxide)、芬硫克(fenothiocarb)、芬普蟎(fenpyroximate)、嘧蟎酯(fluacrypyrim)、合芬寧(halfenprox)、合賽多(hexythiazox)、毆蟎多(propargite:BPPS)、瀏陽黴素複合體(polynactins)、畢達本(pyridaben)、畢汰芬(pyrimidifen)、得芬瑞(tebufenpyrad)、得脫蟎(tetradifon)、賜派芬(spirodiclofen)、螺甲蟎酯(spiromesifen)、賜派滅(spirotetramat)、磺胺蟎酯(amidoflumet)、及唑蟎氰(cyenopyrafen)。 Acequinocyl, amitraz, benzoximate, bifenazate, bromopropylate, chinomethionat, chlorobenzilate, PCBS ( Chlorfenson), clofentezine, cyflumetofen, dicofol, etoxazole, fenbutatin oxide, fenothiocarb, fenproxil Fenpyroximate), fluacrypyrim, halfenprox, hexythiazox, propargite (BPPS), polynactins, pyripaben, Pyrimidifen, tebufenpyrad, tetradifon, spirodiclofen, spiromesifen, spirotetramat, amidoflumet, and Cyanopyrafen.

就這種殺線蟲劑的有效成分而言,例如可列舉以下的化合物。 As the active ingredient of such a nematicide, for example, the following compounds can be mentioned.

DCIP、福賽絕(fosthiazate)、鹽酸左旋咪唑(levamisol)、異硫氰酸甲酯(methylisothiocyanate)、酒石酸甲噻嘧啶(morantel tartarate)、及咪氰磷(imicyafos)。 DCIP, fosthiazate, levamisol hydrochloride, methylisothiocyanate, morantel tartarate, and imicyafos.

就這種殺菌劑的有效成分而言,例如可列舉以下的化合物。 Examples of the active ingredient of such a bactericide include the following compounds.

(1)聚鹵烷硫基化合物 (1) Polyhaloalkylthio compounds

蓋普丹(captan)、福爾培(folpet)等。 Captan, folfet, etc.

(2)有機磷化合物 (2) Organic phosphorus compounds

IBP、EDDP、脫克松(tolclofos-methyl)等。 IBP, EDDP, tolclofos-methyl, and the like.

(3)苯并咪唑化合物, (3) benzimidazole compounds,

免賴得(benomyl)、貝芬替(carbendazim)、甲基多保淨(thiophanate-methyl)、噻苯咪唑(thiabendazole)等。 Benomyl, carbendazim, thiophanate-methyl, thiabendazole, and the like.

(4)羧醯胺化合物 (4) Carboxamide compound

萎鏽靈(carboxin)、滅普寧(mepronil)、福多寧(flutolanil)、賽氟滅(thifluzamid)、福拉比(furametpyr)、白列克(boscalid)、吡噻菌胺(penthiopyrad)等。 Carboxin, mepronil, fluolanil, thifluzamid, furametpyr, boscalid, penthiopyrad, and the like.

(5)二羧醯亞胺化合物 (5) Dicarboxy quinone imine compound

撲滅寧(procymidone)、依普同(iprodione)、免克寧(vinclozolin)等。 Procymidone, iprodione, vinclozolin, etc.

(6)醯基丙胺酸化合物 (6) mercaptoalanine compound

滅達樂(metalaxyl)等。 Metalaxyl and the like.

(7)唑化合物 (7) azole compound

三泰芬(triadimefon)、三泰隆(triadimenol)、普克利(propiconazole)、得克利(tebuconazole)、環克座(cyproconazole)、依普座(epoxiconazole)、丙硫菌唑(prothioconazole)、種菌唑(ipconazole)、賽福座(triflumizole)、撲克拉(prochloraz)、平克座(penconazole)、護矽得(flusilazole)、達克利(diniconazole)、溴克座(bromuconazole)、待克利(difenoconazole)、滅特座(metconazole)、四克利(tetraconazole)、邁克尼(myclobutanil)、芬克座(fenbuconazole)、菲克利(hexaconazole)、氟喹唑(fluquinconazole)、滅菌唑(triticonazole)、比多農(bitertanol)、依滅列(imazalil)、護汰芬(flutriafol)等。 Triadimefon, triadimenol, propiconazole, tebuconazole, cyproconazole, epoxiconazole, prothioconazole, inocastazole Ipconazole), triflumizole, prochloraz, penconazole, flusilazole, diniconazole, bromuconazole, difenoconazole, extinction Metconazole, tetraconazole, myclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol , Imazalil, flutriafol, etc.

(8)嗎啉化合物 (8) morpholine compound

十二環嗎啉(dodemorph)、三得芬(tridemorph)、芬普福(fenpropimorph)等。 Dodemorph, tridemorph, fenpropimorph, and the like.

(9)甲氧基丙烯酸酯類(strobilurin)化合物 (9) methoxy acrylate (strobilurin) compound

亞托敏(azoxystrobin)、克收欣(kresoxim-methyl)、苯氧菌胺(metominostrobin)、三氟敏(trifloxystrobin)、啶氧菌酯(picoxystrobin)、百克敏(pyraclostrobin)、氟嘧菌酯(fluoxastrobin)、醚菌胺(dimoxystrobin)等。 Azoxystrobin, kresoxim-methyl, metominostrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, fluoxastrobin Fluoxastrobin), dimoxystrobin, and the like.

(10)抗生素 (10) Antibiotics

維利黴素(validamycin A)、保米黴素(blasticidin S)、嘉賜黴素(kasugamycin)、保粒黴素(polyoxin)等。 Validamycin A, blasticidin S, kasugamycin, polyoxin, and the like.

(11)二硫代胺甲酸鹽化合物 (11) Dithiocarbamate compound

代森錳鋅(mancozeb)、錳乃浦(maneb)、秋蘭姆(thiuram)等。 Mancozeb, maneb, thiuram, etc.

(12)其他的殺菌有效成分 (12) Other bactericidal active ingredients

熱必斯(fthalide)、撲殺熱(probenazole)、亞賜圃(isoprothiolane)、 三賽唑(tricyclazole)、百快隆(pyroquilon)、富米綜(ferimzone)、阿拉酸式苯-S-甲基(acibenzolar S-methyl)、加普胺(carpropamid)、雙氯氰菌胺(diclocymet)、芬諾尼(fenoxanil)、噻醯菌胺(tiadinil)、達滅淨(diclomezine)、克枯爛(teclofthalam)、賓克隆(pencycuron)、歐索林酸(oxolinic acid)、TPN、賽福寧(triforine)、苯鏽啶(fenpropidin)、螺環菌胺(spiroxamine)、扶吉胺(fluazinam)、克熱淨(iminoctadine)、拌種咯(fenpiclonil)、咯菌腈(fludioxonil)、快諾芬(quinoxyfen)、環醯菌胺(fenhexamid)、矽噻菌胺(silthiofam)、丙氧喹啉(proquinazid)、環氟菌胺(cyflufenamid)、鹼性硫酸銅鈣(波爾多混合液;bordeaux mixture)、益發靈(dichlofluanid)、嘧菌環胺(cyprodinil)、嘧霉胺(pyrimethanil)、滅派林(mepanipyrim)、乙霉威(diethofencarb)、吡菌苯威(pyribencarb)、凡殺同(famoxadone)、咪唑菌酮(fenamidone)、苯醯菌胺(zoxamide)、噻唑菌胺(ethaboxam)、安美速(amisulbrom)、丙森辛(iprovalicarb)、苯噻菌胺酯(benthiavalicarb)、賽座滅(cyazofamid)、曼普胺(mandipropamid)、滅芬農(metrafenone)、氟吡菌醯胺(fluopiram)、聯苯吡菌胺(bixafen)等。 Fthalide, probenazole, isoprothiolane, Tricyclazole, pyroquilon, ferimzone, acibenzolar S-methyl, carpropamid, chloramphenicol ( Diclocymet), fenoxanil, tiadinil, diclomezine, teclofthalam, pencycuron, oxolinic acid, TPN, race Triforine, fenpropidin, spiroxamine, fluazinam, iminoctadine, fenpiclonil, fludioxonil, sinuo Quinoxyfen, fenhexamid, silthiofam, proquinazid, cyflufenamid, basic copper sulphate (bordeaux mixture; bordeaux mixture) , dichlofluanid, cyprodinil, pyrimethanil, mepanipyrim, diethofencarb, pyribencarb, famoxadone , fenamidone, zoxamide, ethaboxam, amisulbrom, propyl (iprovalicarb), benthiavalicarb, cyazofamid, mandipropamid, metrafenone, fluopiram, bixafen )Wait.

就這種增效劑之有效成分而言,例如可列舉以下的化合物。 As the active ingredient of such a synergist, the following compounds are mentioned, for example.

胡椒基丁氧化物(piperonyl butoxide)、增效散(sesamex)、亞碸(sulfoxide)、N-(2-乙基己基)-8,9,10-三降莰-5-烯-2,3-二甲醯亞胺(MGK 264)、N-得克利咪唑(N-declyimidazole)、WARF- N,N-二丁基對氯苯磺醯胺(WARF-antiresistant)、TBPT、TPP、IBP、PSCP、碘化甲烷(CH3I)、t-苯基丁烯酮(t-phenylbutenone)、順丁烯二酸二乙酯(diethylmaleate)、DMC、FDMC、ETP、及ETN。 Piperonyl butoxide, sesamex, sulfoxide, N-(2-ethylhexyl)-8,9,10-tris-5-ene-2,3 - dimethyl quinone imine (MGK 264), N-declyimidazole, WARF-N, N-dibutyl-p-chlorobenzene sulfonamide (WARF-antiresistant), TBPT, TPP, IBP, PSCP , methane iodide (CH 3 I), t-phenylbutenone (t-phenylbutenone), diethylmaleate, DMC, FDMC, ETP, and ETN.

就本發明的除草劑的防治對象而言,例如可列舉下列植物。 For the object of controlling the herbicide of the present invention, for example, the following plants can be mentioned.

升馬唐(Digitaria ciliaris)、牛筋草(Eleusine indica)、狗尾草(Setaria viridis)、大狗尾草(Setaria faberi)、御谷(Setaria glauca)、稗(Echinochloa crus-galli)、洋野黍(Panicum dichotomiflorum)、德州黍(Panicum texanum)、寬葉臂形草(Brachiaria platyphylla)、亞歷山大草(Brachiaria plantaginea)、信號草(Brachiaria decumbens)、詹森草(Sorghum halepense)、高梁(Andropogon sorghum)、狗牙根(Cynodon dactylon)、野燕麥(Avena fatua)、義大利黑麥草(Lolium multiflorum)、大穗看麥娘(Alopecurus myosuroides)、絹雀麥(Bromus tectorum)、貧育雀麥(Bromus sterilis)、小子虉草(Phalaris minor)、阿披拉草(Apera spica-venti)、早熟禾(Poa annua)、偃麥草(Agropyron repens)、紙莎草(Cyperus iria)、香附子(Cyperus rotundus)、油莎草(Cyperus esculentus)、馬齒莧(Portulaca oleracea)、反枝莧(Amaranthus retroflexus)、綠穗莧(Amaranthus hybridus)、長芒莧(Amaranthus palmeri)、西部莧(Amaranthus rudis)、苘麻(Abutilon theophrasti)、刺金午時花(Sida spinosa)、卷莖蓼(Fallopia convolvulus)、糙葉蓼(Polygonum scabrum)、賓州蓼(Persicaria pennsylvanica)、桃葉蓼(Persicaria vulgaris)、皺葉酸模(Rumex crispus)、大羊蹄(Rumex obtusifolius)、虎杖(Fallopia japonica)、藜(Chenopodium album)、地膚(Kochia scoparia)、睫穗蓼(Polygonum longisetum)、龍葵(Solanum nigrum)、曼陀羅花(Datura stramonium)、紫花牽牛(Ipomoea purpurea)、碗仔花(Ipomoea hederacea)、全緣葉牽牛(Ipomoea hederacea var.integriuscula)、白星薯(Ipomoea lacunosa)、田旋花(Convolvulus arvensis)、紫花野芝麻(Lamium purpureum)、寶蓋草(Lamium amplexicaule)、賓州蒼耳(Xanthium pensylvanicum)、野生向日葵(Helianthus annuus)、淡甘菊(Matricaria perforata or inodora)、洋甘菊(Matricaria chamomilla)、南茼蒿(Chrysanthemum segetum)、同花母菊(Matricaria matricarioides)、猪草(Ambrosia artemisiifolia)、三裂葉猪草(Ambrosia trifida)、加拿大蓬(Erigeron canadensis)、艾草(Artemisia princeps)、北美一枝黃花(Solidago altissima)、美洲假蓬(Conyza bonariensis)、田菁(Sesbania exaltata)、決明(Cassia obtusifolia)、南美山螞蝗(Desmodium tortuosum)、白三葉草(Trifolium repens)、葛(Pueraria lobata)、窄葉野豌豆(Vicia angustifolia)、鴨跖草(Commelina communis)、圓葉鴨跖草(Commelina benghalensis)、原拉拉藤(Galium aparine)、繁縷(Stellaria media)、野芥菜(Raphanus raphanistrum)、野芥(Sinapis arvensis)、薺菜(Capsella bursa-pastoris)、阿拉伯婆婆納(Veronica persica)、睫毛婆婆納(Veronica hederifolia)、野生堇菜(Viola arvensis)、三色堇(Viola tricolor)、虞美人(Papaver rhoeas)、歐洲勿忘草(Myosotis scorpioides)、西亞馬利筋(Asclepias syriaca)、澤漆(Euphorbia helioscopia)、大錦草(Chamaesyce nutans)、野老鸛草(Geranium carolinianum)、芹葉尨牛兒苗(Erodium cicutarium)、問荊(Equisetum arvense)、假稻(Leersia japonica)、稻稗(Echinochloa oryzicola)、台灣野稗(Echinochloa crus-galli var.formosensis)、千金子(Leptochloa chinensis)、異花莎草(Cyperus difformis)、水蝨草(Fimbristylis miliacea)、牛毛顫(Eleocharis acicularis)、螢藺(Scirpus juncoides)、猪毛草(Scirpus wallichii)、水莎草(Cyperus serotinus)、野荸薺(Eleocharis kuroguwai)、 扁禾干薦草(Bolboschoenus koshevnikovii)、三江薦草(Schoenoplectus nipponicus)、鴨舌草(Monochoria vaginalis)、陌上菜(Lindernia procumbens)、虻眼草(Dopatrium junceum)、節節菜(Rotala indica)、多花水莧菜(Ammannia multiflora)、三蕊溝繁縷(Elatine triandra)、假柳葉菜(Ludwigia epilobioides)、矮慈姑(Sagittaria pygmaea)、窄葉澤瀉(Alisma canaliculatum)、野慈姑(Sagittaria trifolia)、眼子菜(Potamogeton distinctus)、水芹菜(Oenanthe javanica)、水馬齒(Callitriche palustris)、狹葉母草(Lindernia micrantha)、美洲母草(Lindernia dubia)、鱧腸(Eclipta prostrata)、水竹葉(Murdannia keisak)、雙穗雀稗(Paspalum distichum)、蓉草(Leersia oryzoides)等雜草。 Digitaria ciliaris, Eleusine indica, Setaria viridis, Setaria faberi, Setaria glauca, Echinochloa crus-galli, Panicum dichotomiflorum ), Panicum texanum, Brachiaria platyphylla, Brachiaria plantaginea, Brachiaria decumbens, Sorghum halepense, Andropogon sorghum, Bermudagrass Cynodon dactylon), Avena fatua, Lolium multiflorum, Alopecurus myosuroides, Bromus tectorum, Bromus sterilis, Kidnapper (Phalaris minor), Apera spica-venti, Poa annua, Agropyron repens, Cyperus iria, Cyperus rotundus, Cyperus Esculentus), Portulaca oleracea, Amaranthus retroflexus, Amaranthus hybridus, Amaranthus palmeri, Amaranthus rudis, Castor Lon theophrasti), Sida spinosa, Fallopia convolvulus, Polygonum scabrum, Persicaria pennsylvanica, Persicaria vulgaris, Rumex crispus ), Rumex obtusifolius, Fallopia japonica, Chenopodium album, Kochia scoparia, Polygonum longisetum, Solanum nigrum, Datura stramonium, Ipomoea purpurea, Ipomoea hederacea, Ipomoea hederacea var.integriuscula, Ipomoea lacunosa, Convolvulus Arvensis), Lamium purpureum, Lamium amplexicaule, Xanthium pensylvanicum, Helianthus annuus, Matricaria perforata or inodora, Matricaria chamomilla , Chrysanthemum segetum, Matricaria matricarioides, Ambrosia artemisiifolia, Ambrosia trifida, Erigeron canadensis, Artemisia princeps, North America Yellow flower (Solidago altissima), Conyza bonariensis, Sesbania exaltata, Cassia obtusifolia, Desmodium tortuosum, Trifolium repens, Pueraria lobata, Vicia angustifolia, Commelina communis, Commelina benghalensis, Galium aparine, Stellaria media, Raphanus raphanistrum, wild mustard (Sinapis arvensis), amaranth (Capsella bursa-pastoris), Veronica persica, eyelashes (Ver) (onica hederifolia), wild leek (Viola arvensis), Viola tricolor, Papaver rhoeas, Myosotis scorpioides, Asclepias syriaca, Euphorbia helioscopia, Chamaesyce nutans, Geranium carolinianum, Erodium cicutarium, Equisetum arvense, Leersia japonica, Echinochloa oryzicola, Taiwan wild Echinochloa crus-galli var.formosensis, Leptochloa chinensis, Cyperus difformis, Fimbristylis miliacea, Eleocharis acicularis, Scirpus juncoides, pigs Scirpus wallichii, Cyperus serotinus, Eleocharis kuroguwai, Bolboschoenus koshevnikovii, Schoenoplectus nipponicus, Monochoria vaginalis, Lindernia procumbens, Dopatrium junceum, Rotala indica, Ammannia multiflora, Eladine triandra, Ludwigia epilobioides, Sagittaria pygmaea, Alisma canaliculatum, Sagittaria trifolia, eye Potamogeton distinctus, Oenanthe javanica, Callitriche palustris, Lindernia micrantha, Lindernia dubia, Eclipta prostrata, water bamboo leaves Weeds such as Murdannia keisak), Paspalum distichum, and Leersia oryzoides.

喜旱蓮子草(Alternanthera philoxeroides)、南美海绵(Limnobium spongia)、水蕨(water fern)(槐葉蘋(Salvinia)屬)、肥猪草(Pistia stratiotes)、美洲石胡荽(water pennywort)(天胡荽(Hydrocotyle)屬)、絲狀藻類(黑孢藻(Pithophora)屬、剛毛藻(Cladophora)屬))、金魚藻(Ceratophyllum demersum)、紫萍(浮萍(Lemna)屬)、白花穗蓴(Cabomba caroliniana)、黑藻(Hydrilla verticillata)、瓜達魯帕茨藻(Najas guadalupensis)、眼子菜(pondweed)類(菹草(Potamogeton crispus)、伊利洛斯眼子菜(Potamogeton illinoensis)、龍鬚草(Potamogeton pectinatus)等)、無根萍(water meal)(蕪萍(Wolffia)屬)、狐尾藻(watermilfoil)類(穗狀狐尾藻(Myriophyllum spicatum)、異葉狐尾藻(Myriophyllum heterophyllum)等)、鳳眼蓮(Eichhornia crassipes)等水生植物。蘚類、苔類、角苔類。藍細菌。蕨類。多年生作物(仁果類、核果類、漿果類、堅果類、柑橘類、啤酒花、葡萄等)的徒長枝(sucher)。 Alternanthera philoxeroides, Limnobium spongia, water fern (Salvinia genus), Pistia stratiotes, water pennywort (days) Hydrocotyle, filamentous algae (Pithophora, Cladophora), Ceratophyllum demersum, Zippin (Lemna), white flower (Cabomba caroliniana), Hydrilla verticillata, Najas guadalupensis, pondweed (Potamogeton crispus, Potamogeton illinoensis, dragon mustard) Grass (Potamogeton pectinatus), etc., water meal (Wolffia genus), watermilfoil (Myriophyllum spicatum), Myriophyllum heterophyllum Etc.), aquatic plants such as Eichhornia crassipes. Mosses, mosses, horns. Cyanobacteria. fern. Long-handed crops (such as pome fruits, stone fruits, berries, nuts, citrus, hops, grapes, etc.).

本發明化合物可由例如以下的製造法而製造。 The compound of the present invention can be produced, for example, by the following production method.

製造法1 Manufacturing Method 1

本發明化合物中G為氫的式(I-a)表示的化合物是由式(II)表示的化合物、式(III)表示的化合物及鹼的反應而製造。 The compound represented by the formula (I-a) wherein G is hydrogen in the compound of the present invention is produced by a reaction of a compound represented by the formula (II), a compound represented by the formula (III) and a base.

[式中,X1表示氟或氯,R1、R2、R3、R4、R5及A表示與前述相同的意義] Wherein X 1 represents fluorine or chlorine, and R 1 , R 2 , R 3 , R 4 , R 5 and A represent the same meaning as described above]

本反應通常是在溶媒中進行。就可使用之溶媒而言,例如可列舉苯、甲苯、二甲苯等芳香族烴類;二乙醚、二烷、四氫呋喃(以下,簡稱為THF)、二甲氧基乙烷等醚類;二甲基甲醯胺(以下,簡稱為DMF)等醯胺類;二甲基亞碸(以下,簡稱為DMSO)等亞碸類;乙腈等腈類;丙酮等酮類或該等的混合溶媒。 This reaction is usually carried out in a solvent. Examples of the solvent that can be used include aromatic hydrocarbons such as benzene, toluene, and xylene; diethyl ether and An ether such as an alkane, tetrahydrofuran (hereinafter abbreviated as THF) or dimethoxyethane; an amide such as dimethylformamide (hereinafter abbreviated as DMF); dimethyl hydrazine (hereinafter, abbreviated as DMSO) ) such as an anthraquinone; a nitrile such as acetonitrile; a ketone such as acetone or a mixed solvent thereof.

就本反應所使用的鹼而言,例如可列舉三級丁氧化鉀等金屬烷氧化物,碳酸鉀、碳酸銫、氫化鈉等無機鹼。 The base to be used in the reaction may, for example, be a metal alkoxide such as a tertiary potassium hydride or an inorganic base such as potassium carbonate, cesium carbonate or sodium hydride.

本反應所使用的式(III)表示的化合物的使用量,相對於式(II)表示的化合物,通常是0.5至3莫耳當量,理想是1至2莫耳當量。 The compound represented by the formula (III) used in the present reaction is usually used in an amount of from 0.5 to 3 mol equivalents, preferably from 1 to 2 mol equivalents, based on the compound represented by the formula (II).

本反應所使用的鹼的使用量是,相對於式(II)表示的化合物,通常是1至1.0莫耳當量,理想是1至3莫耳當量。 The amount of the base used in the reaction is usually from 1 to 1.0 mol equivalents, preferably from 1 to 3 mol equivalents, based on the compound represented by the formula (II).

本反應的反應溫度通常是0至200℃,理想是20至100℃。本反應的反應時間通常是10分鐘至30小時。 The reaction temperature of the reaction is usually from 0 to 200 ° C, preferably from 20 to 100 ° C. The reaction time of the reaction is usually from 10 minutes to 30 hours.

本反應結束後,可藉由進行例如在反應混合物中添加酸而中和,與水混合,以有機溶媒萃取,將所得的有機層處以乾燥、濃縮,以氧化矽凝膠管柱層析法的精製等操作,而分離式(I-a)表示的化合物。 After the completion of the reaction, it can be neutralized by, for example, adding an acid to the reaction mixture, mixed with water, extracted with an organic solvent, and the obtained organic layer is dried and concentrated to obtain a cerium oxide gel column chromatography. The compound represented by the formula (Ia) is isolated by an operation such as purification.

式(III)表示的化合物是公知的化合物,或可由公知的化合物製造。 The compound represented by the formula (III) is a known compound or may be produced from a known compound.

製造法2 Manufacturing method 2

本發明化合物中G為氫以外的基之式(I-b)表示的化合物,可由式(I-a)表示的化合物、式(IV)表示的化合物及鹼的反應而製造。 In the compound of the present invention, a compound represented by the formula (I-b) wherein G is a group other than hydrogen can be produced by a reaction of a compound represented by the formula (I-a), a compound represented by the formula (IV) and a base.

[式中,G1表示G的定義中之氫以外者,X2表示氯、溴、或碘,R1、R2、R3、R4、R5及A表示與前述相同的意義] Wherein G 1 represents hydrogen other than the definition of G, X 2 represents chlorine, bromine or iodine, and R 1 , R 2 , R 3 , R 4 , R 5 and A represent the same meaning as described above]

本反應通常是在溶媒中進行。就可使用的溶媒而言,例如可列舉苯、甲苯、二甲苯等芳香族烴類;二乙醚、二烷、THF、二甲氧基乙烷等醚類;DMF等醯胺類;DMSO等亞碸類;乙腈等腈類;丙酮等酮類或該等的混合溶媒。 This reaction is usually carried out in a solvent. Examples of the solvent that can be used include aromatic hydrocarbons such as benzene, toluene, and xylene; diethyl ether and An ether such as an alkane, THF or dimethoxyethane; a guanamine such as DMF; an anthracene such as DMSO; a nitrile such as acetonitrile; a ketone such as acetone or a mixed solvent thereof.

就本反應所使用的鹼而言,例如可列舉碳酸鉀、碳酸銫、氫化鈉等無機鹼;三乙胺、吡啶、1,8-二氮雜雙環[5.4.0]-7-十一烯等有機鹼。 Examples of the base to be used in the reaction include inorganic bases such as potassium carbonate, cesium carbonate, and sodium hydride; triethylamine, pyridine, and 1,8-diazabicyclo[5.4.0]-7-undecene. Such as organic bases.

本反應所使用的式(IV)表示的化合物的使用量相對於式(I-a)表示的化合物通常是0.5至10莫耳當量,理想是1至3莫耳當量。 本反應所使用的鹼的使用量相對於式(I-a)表示的化合物通常是0.5至10莫耳當量,理想是1至5莫耳當量。 The compound represented by the formula (IV) used in the present reaction is usually used in an amount of from 0.5 to 10 mol equivalents, preferably from 1 to 3 mol equivalents, based on the compound represented by the formula (I-a). The amount of the base to be used in the reaction is usually from 0.5 to 10 mol equivalents, preferably from 1 to 5 mol equivalents, based on the compound represented by the formula (I-a).

本反應的反應溫度通常是在-30至180℃,理想是-10至80℃。 The reaction temperature of the reaction is usually from -30 to 180 ° C, preferably from -10 to 80 ° C.

本反應的反應時間通常是在10分鐘至30小時。 The reaction time of the reaction is usually from 10 minutes to 30 hours.

本反應結束後,可藉由進行例如將反應混合物與水混合,以有機溶媒萃取,將所得的有機層乾燥、濃縮,以氧化矽凝膠管柱層析法的精製等操作,而分離式(I-b)表示的化合物。式(IV)表示的化合物是公知的化合物,或可由公知的化合物製造。 After the completion of the reaction, for example, the reaction mixture may be mixed with water, extracted with an organic solvent, and the obtained organic layer may be dried, concentrated, and purified by cerium oxide gel column chromatography, and separated. Compound represented by Ib). The compound represented by the formula (IV) is a known compound or may be produced from a known compound.

製造法3 Manufacturing method 3

本發明化合物中,式(I-c)表示的化合物可由式(I-a)表示的化合物與式(V)表示的化合物反應而製造。 In the compound of the present invention, the compound represented by the formula (I-c) can be produced by reacting a compound represented by the formula (I-a) with a compound represented by the formula (V).

[式中,R10表示C1-12烷基、C3-8環烷基、C2-12烯基、C2-12炔基、由可以具有由D群選出的1個以上的原子或基的C6-10芳基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-6烷基、(C3-8環烷基)C1-6烷基、(C1-6烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、(C1-6烷硫基)C1-6烷基、(C1-6烷基亞磺醯基)C1-6烷基、(C1-6烷基磺醯基)C1-6烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳氧基)C1-12烷基、(可以有具由D群選出的1個以上的原子或基的C6-10芳基硫基)C1-12烷基、{(可以具有由D群選出的1個以上的原 子或基的C6-10芳基)C1-6烷氧基}C1-6烷基或5至6員的雜芳基,R1、R2、R3、R4、R5、A及D群表示與前述相同的意義] Wherein R 10 represents a C 1-12 alkyl group, a C 3-8 cycloalkyl group, a C 2-12 alkenyl group, a C 2-12 alkynyl group, and may have one or more atoms selected from the D group or C 6-10 aryl group, (C 6-10 aryl group may have one or more atom or group selected from the group D) C 1-6 alkyl, (C 3-8 cycloalkyl) C 1 -6 alkyl, (C 1-6 alkoxy) C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, (C 1-6 alkylthio) C 1- 6 alkyl, (C 1-6 alkylsulfinyl) C 1-6 alkyl, (C 1-6 alkylsulfonyl) C 1-6 alkyl, (may have 1 selected from group D one or more atoms or a C 6-10 aryloxy group) C 1-12 alkyl, (optionally having one or more atom or group selected from the group D C 6-10 arylthio) C 1 -12 alkyl, {(C 6-10 aryl which may have 1 or more atoms selected from the D group) C 1-6 alkoxy} C 1-6 alkyl or 5 to 6 membered hetero The aryl group, R 1 , R 2 , R 3 , R 4 , R 5 , A and D groups represent the same meaning as described above]

本反應通常是在溶媒中進行。就可使用的溶媒而言,例如可列舉苯、甲苯、二甲苯等芳香族烴類;二乙醚、二烷、THF、二甲氧基乙烷等醚類;DMF等醯胺類;DMSO等亞碸類;乙腈等腈類;丙酮等酮類或該等的混合溶媒。 This reaction is usually carried out in a solvent. Examples of the solvent that can be used include aromatic hydrocarbons such as benzene, toluene, and xylene; diethyl ether and An ether such as an alkane, THF or dimethoxyethane; a guanamine such as DMF; an anthracene such as DMSO; a nitrile such as acetonitrile; a ketone such as acetone or a mixed solvent thereof.

本反應也可使用鹼。就可使用的鹼而言,例如可列舉碳酸鉀、碳酸銫、氫化鈉等無機鹼;三乙胺、吡啶、1,8-二氮雜雙環[5.4.0]-7-十一烯等有機鹼。本反應所使用的鹼的使用量相對於式(I-a)表示的化合物通常是0.5至10莫耳當量。 A base can also be used in the reaction. Examples of the base which can be used include inorganic bases such as potassium carbonate, cesium carbonate and sodium hydride; and organic groups such as triethylamine, pyridine and 1,8-diazabicyclo[5.4.0]-7-undecene. Alkali. The amount of the base used in the reaction is usually from 0.5 to 10 mol equivalents based on the compound represented by the formula (I-a).

式(V)表示的化合物的使用量通常相對於式(I-a)表示的化合物為1至20莫耳當量。 The compound represented by the formula (V) is usually used in an amount of from 1 to 20 mol equivalents based on the compound represented by the formula (I-a).

本反應的反應溫度通常是-30至180℃。本反應的反應時間通常是10分鐘至30小時。 The reaction temperature of this reaction is usually from -30 to 180 °C. The reaction time of the reaction is usually from 10 minutes to 30 hours.

本反應結束後,可藉由進行例如將反應混合物與水混合,以有機溶媒萃取,將所得的有機層乾燥、濃縮,以氧化矽凝膠管柱層析法精製等操作,而分離式(I-c)表示的化合物。式(V)表示的化合物是公知的化合物,或可由公知的化合物製造。 After completion of the reaction, for example, the reaction mixture may be mixed with water, extracted with an organic solvent, and the obtained organic layer may be dried, concentrated, and purified by cerium oxide gel column chromatography, and the separation method (Ic) ) the compound indicated. The compound represented by the formula (V) is a known compound or may be produced from a known compound.

由上述的製造法1至3製造的各化合物,有也可藉由其他的公知的手段,例如轉溶、結晶化、再結晶化、層析法等方法而分離/精製的情況。 Each of the compounds produced by the above Production Methods 1 to 3 may be isolated/purified by other known means such as a method such as dissolving, crystallization, recrystallization, or chromatography.

將本發明化合物的中間體的製造方法作為參考製造法而在下面記載。 The method for producing the intermediate of the compound of the present invention is described below as a reference production method.

參考製造法1 Reference manufacturing method 1

式(II)表示的化合物,可藉由例如式(VI)表示的化合物與酸反應而製造。 The compound represented by the formula (II) can be produced by, for example, reacting a compound represented by the formula (VI) with an acid.

[式中,R15表示C1-6烷基或苄基,R16表示氫、C1-6烷基或苄基,R1、R2、R3、R4及R5表示與前述相同的意義] Wherein R 15 represents a C 1-6 alkyl group or a benzyl group, R 16 represents hydrogen, a C 1-6 alkyl group or a benzyl group, and R 1 , R 2 , R 3 , R 4 and R 5 represent the same as defined above. Meaning]

就本反應所使用的酸而言,例如可列舉鹽酸或溴化氫酸。本反應使用的酸的使用量相對於式(VI)表示的他合物通常是1至20莫耳當量。 As the acid to be used in the reaction, for example, hydrochloric acid or hydrogen bromide may be mentioned. The acid used in the present reaction is usually used in an amount of from 1 to 20 mol equivalents based on the compound represented by the formula (VI).

本反應是在無溶媒下或在溶媒中進行。就可使用的溶媒而言,例如可列舉乙酸、丙酸等有機酸,水或該等的混合溶媒。 The reaction is carried out in the absence of a solvent or in a solvent. Examples of the usable solvent include organic acids such as acetic acid and propionic acid, and water or mixed solvents thereof.

本反應的反應溫度通常是30至180℃、理想是50至130℃。本反應的反應時間通常是10分鐘至30小時。 The reaction temperature of the reaction is usually from 30 to 180 ° C, preferably from 50 to 130 ° C. The reaction time of the reaction is usually from 10 minutes to 30 hours.

本反應結束後,可藉由進行例如將反應混合物與水混合,以有機溶媒萃取,將所得的有機層乾燥、濃縮,以氧化矽凝膠管柱層析法精製等操作,而分離式(II)表示的化合物。 After completion of the reaction, for example, the reaction mixture may be mixed with water, extracted with an organic solvent, and the obtained organic layer may be dried, concentrated, and purified by cerium oxide gel column chromatography, and separated (II). ) the compound indicated.

式(VI)表示的化合物是公知的化合物,或可由公知的化合物製造。也可例如依照EP2204366A或WO2009/035150所述的方法而製造。 The compound represented by the formula (VI) is a known compound or may be produced from a known compound. It can also be produced, for example, in accordance with the method described in EP 2204366 A or WO 2009/035150.

參考製造法2 Reference Manufacturing Method 2

式(VI)表示的化合物中的式(VI-a)表示的化合物,可藉由例如式(VII)表示的化合物與式(VIII)表示的化合物在觸媒及鹼的存在 下反應而製造。 The compound represented by the formula (VI-a) in the compound represented by the formula (VI) can be present in the presence of a catalyst and a base by, for example, a compound represented by the formula (VII) and a compound represented by the formula (VIII). Manufactured by the next reaction.

[式中,X2、R1、R2、R3、R4、R5及R15表示與前述相同的意義] [wherein, X 2 , R 1 , R 2 , R 3 , R 4 , R 5 and R 15 have the same meanings as described above]

本反應通常是在溶媒中進行。就可使用的溶媒而言,例如可列舉苯、甲苯等芳香族烴類;甲醇、乙醇、丙醇等醇類;二乙醚、二烷、THF、二甲氧基乙烷等醚類;丙酮、丁酮等酮類:DMF等醯胺類;DMSO等亞碸類;水或該等的混合溶媒。 This reaction is usually carried out in a solvent. Examples of the solvent that can be used include aromatic hydrocarbons such as benzene and toluene; alcohols such as methanol, ethanol, and propanol; diethyl ether and An ether such as an alkane, THF or dimethoxyethane; a ketone such as acetone or methyl ethyl ketone: a guanamine such as DMF; an anthraquinone such as DMSO; water or a mixed solvent thereof.

就本反應所使用的鹼而言,例如可列舉碳酸鈉、碳酸鉀、碳酸氫鈉、碳酸銫、磷酸鉀等無機鹼。使用的鹼的使用量相對於式(VII)表示的化合物通常是1至10莫耳當量,理想是1至5莫耳當量。 The base to be used in the reaction may, for example, be an inorganic base such as sodium carbonate, potassium carbonate, sodium hydrogencarbonate, cesium carbonate or potassium phosphate. The base to be used is usually used in an amount of from 1 to 10 mol equivalents, preferably from 1 to 5 mol equivalents, based on the compound represented by the formula (VII).

就本反應所使用的觸媒而言,例如可列舉乙酸鈀(II)、四(三苯膦)鈀、三(二亞苄基丙酮)二鈀等鈀觸媒等。所用的觸媒的使用量相對於(VII)表示的化合物通常是0.001至0.5莫耳當量,理想是0.01至0.2莫耳當量。 The catalyst used in the reaction may, for example, be a palladium catalyst such as palladium (II) acetate, tetrakis(triphenylphosphine)palladium or tris(dibenzylideneacetone)dipalladium. The amount of the catalyst to be used is usually 0.001 to 0.5 mol equivalent, and preferably 0.01 to 0.2 mol equivalent, based on the compound represented by (VII).

在本反應中也可添加配位體。就所使用的配位體而言,例如可列舉2-二環己基膦基-2’,6’-二甲氧聯苯等。所使用的配位體的使用量相對於式(VII)表示的化合物通常是0.002至1莫耳當量,理想是0.02至0.4莫耳當量。 A ligand can also be added in this reaction. Examples of the ligand to be used include 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl and the like. The amount of the ligand to be used is usually 0.002 to 1 mol equivalent, and preferably 0.02 to 0.4 mol equivalent, based on the compound represented by the formula (VII).

就本反應所使用的式(VIII)表示的化合物的使用量相對於式(VII)表示的化合物通常是0.5至2莫耳當量,理想是1至1.5莫耳 當量。 The compound represented by the formula (VIII) used in the present reaction is usually used in an amount of from 0.5 to 2 mol equivalents, preferably from 1 to 1.5 mols, based on the compound represented by the formula (VII). equivalent.

本反應的反應溫度通常是0至180℃,理想是30至150℃。本反應的反應時間通常是10分鐘至100小時。 The reaction temperature of the reaction is usually from 0 to 180 ° C, preferably from 30 to 150 ° C. The reaction time of the reaction is usually from 10 minutes to 100 hours.

本反應結束後,可藉由進行例如將反應混合物與水混合,以有機溶媒萃取,將所得的有機層乾燥、濃縮,以氧化矽凝膠管柱層析法精製等操作,而分離式(VI-a)表示的化合物。 After completion of the reaction, for example, the reaction mixture may be mixed with water, extracted with an organic solvent, and the obtained organic layer may be dried, concentrated, and purified by cerium oxide gel column chromatography, and separated (VI). a compound represented by -a).

式(VIII)表示的化合物是公知的化合物,或可由公知的化合物製造。 The compound represented by the formula (VIII) is a known compound or may be produced from a known compound.

式(VII)表示的化合物是公知的化合物,或可由公知的化合物製造。例如可依照J.Heterocycl.Chem、33巻、1579至1582頁(1996年)等所述的方法,或遵照該等的方法而製造。 The compound represented by the formula (VII) is a known compound or may be produced from a known compound. For example, it can be produced according to the method described in J. Heterocycl. Chem, 33, pages 1579 to 1582 (1996), or the like.

參考製造法3 Reference Manufacturing Method 3

式(VII)表示的化合物中R2為O-R17、X2為氯的式(XV)表示的化合物,可藉由例如以下的反應方案製造。 The compound represented by the formula (XV) wherein R 2 is OR 17 and X 2 is chlorine in the compound represented by the formula (VII) can be produced, for example, by the following reaction scheme.

[式中,X3表示氯、溴、碘、可以具有鹵素的C1-3烷基磺醯基氧基(例如可列舉甲基磺醯基氧基、三氟甲基磺醯基氧基等)、苯磺醯基或對甲苯磺醯基,R17表示C1-6烷基、C1-6鹵烷基、C3-8環烷基、 (C3-8環烷基)C1-6烷基、(C1-6烷硫基)C1-6烷基、(C1-6烷氧基)C1-6烷基、C3-6烯基、C3-6炔基、氰基C1-6烷基、(C1-6烷氧基)羰基C1-6烷基、胺甲醯基C1-6烷基、[(C1-6烷基)胺基羰基]C1-6烷基、或(二(C1-6烷基)胺基羰基)C1-6烷基,R1及R15表示與前述相同的意義。] In the formula, X 3 represents chlorine, bromine, iodine, or a C 1-3 alkylsulfonyloxy group which may have a halogen (for example, a methylsulfonyloxy group, a trifluoromethylsulfonyloxy group, etc.) , phenylsulfonyl or p-toluenesulfonyl, R 17 represents C 1-6 alkyl, C 1-6 haloalkyl, C 3-8 cycloalkyl, (C 3-8 cycloalkyl) C 1 -6 alkyl, (C 1-6 alkylthio) C 1-6 alkyl, (C 1-6 alkoxy) C 1-6 alkyl, C 3-6 alkenyl, C 3-6 alkynyl , cyano C 1-6 alkyl, (C 1-6 alkoxy)carbonyl C 1-6 alkyl, amine mercapto C 1-6 alkyl, [(C 1-6 alkyl)aminocarbonyl C 1-6 alkyl or (di(C 1-6 alkyl)aminocarbonyl) C 1-6 alkyl, and R 1 and R 15 have the same meanings as defined above. ]

步驟1是可藉由使式(IX)表示的化合物與式(X)表示的化合物反應而製造式(XI)表示的化合物。本反應是順丁烯二酸酐與聯胺化合物的脫水縮合反應,可在已知的條件下反應。例如可遵照US7816357B所述的方法製造。 Step 1 is a method of producing a compound represented by the formula (XI) by reacting a compound represented by the formula (IX) with a compound represented by the formula (X). This reaction is a dehydration condensation reaction of maleic anhydride with a hydrazine compound, and can be reacted under known conditions. For example, it can be manufactured in accordance with the method described in US7816357B.

步驟2是可藉由使式(XI)表示的化合物與式(XII)表示的化合物在鹼的存在下反應而製造式(XIII)表示的化合物。本反應可在已知的條件下反應。例如,可遵照WO2012/091156所述的方法製造。 Step 2 is a method of producing a compound represented by the formula (XIII) by reacting a compound represented by the formula (XI) with a compound represented by the formula (XII) in the presence of a base. This reaction can be carried out under known conditions. For example, it can be manufactured in accordance with the method described in WO2012/091156.

步驟3是可藉由使式(XIII)表示的化合物及式(XIV)表示的化合物在鹼的存在下反應而製造式(XV)表示的化合物。 In the step 3, a compound represented by the formula (XV) can be produced by reacting a compound represented by the formula (XIII) and a compound represented by the formula (XIV) in the presence of a base.

本反應通常是在溶媒中進行。就可使用的溶媒而言,例如可列舉甲醇、乙醇、丙醇等醇類;二乙醚、二烷、THF、二甲氧基乙烷等醚類;DMF等醯胺類;DMSO等亞碸類或該等的混合溶媒。 This reaction is usually carried out in a solvent. Examples of the solvent that can be used include alcohols such as methanol, ethanol, and propanol; diethyl ether and An ether such as an alkane, THF or dimethoxyethane; a guanamine such as DMF; an anthraquinone such as DMSO or a mixed solvent thereof.

就本反應所使用的鹼而言,例如可列舉甲氧化鈉、三級丁氧化鉀及氫化鈉等。本反應所使用的鹼的使用量相對於式(XIII)表示的化合物通常是0.5至10莫耳當量,理想是1至1.5莫耳當量。 Examples of the base used in the reaction include sodium methoxide, tertiary potassium pentoxide, and sodium hydride. The amount of the base used in the reaction is usually from 0.5 to 10 mol equivalents, preferably from 1 to 1.5 mol equivalents, based on the compound represented by the formula (XIII).

本反應的反應溫度通常是-30至100℃。本反應的反應時間通常是10分鐘至50小時。 The reaction temperature of the reaction is usually from -30 to 100 °C. The reaction time of the reaction is usually from 10 minutes to 50 hours.

本反應結束後,可藉由進行例如將反應混合物與水混合,以有機溶媒萃取,將所得的有機層乾燥、濃縮等操作,而分離式(XV) 表示的化合物。 After the completion of the reaction, for example, the reaction mixture is mixed with water, extracted with an organic solvent, and the obtained organic layer is dried, concentrated, and the like, and the separation formula (XV) is carried out. The compound represented.

下面表示本發明化合物的具體例。 Specific examples of the compound of the present invention are shown below.

1)一種嗒酮化合物,其中,在式(I1)至(I51)中,G是氫,而A是苯基、2-氟苯基、3-氟苯基、4-氟苯基、2-氯苯基、3-氯 苯基、4-氯苯基、2-溴苯基、3-溴苯基、4-溴苯基、2-甲基苯基、3-甲基苯基、4-甲基苯基、2-三氟甲基苯基、3-三氟甲基苯基、4-三氟甲基苯基、2-甲氧基苯基、3-甲氧基苯基、4-甲氧基苯基、2-三氟甲氧基苯基、3-三氟甲氧基苯基、4-三氟甲氧基苯基、2-硝苯基、3-硝苯基、4-硝苯基、2-氰苯基、3-氰苯基、4-氰苯基、2-氟-4-氯苯基、2-氟-4-氰苯基、2-氟-4-三氟甲基苯基、2,4-二氯苯基、2-氯-4-氰苯基、2-氯-4-三氟甲基苯基、2-吡啶基、3-吡啶基、4-吡啶基、3-氟吡啶-2-基、4-氟吡啶-2-基、5-氟吡啶-2-基、6-氟吡啶-2-基、3-氯吡啶-2-基、4-氯吡啶-2-基、5-氯吡啶-2-基、6-氯吡啶-2-基、3-三氟甲基吡啶-2-基、4-三氟甲基吡啶-2-基、5-三氟甲基吡啶-2-基、6-三氟甲基吡啶-2-基、3,5-二氟吡啶2-基、3-氟-5-氯-吡啶-2-基、3-氟-5-三氟甲基-吡啶-2-基、3-氯-5-氟吡啶-2-基、3,5-二氯吡啶-2-基、3-氯-5-三氟甲基吡啶-2-基、2-嘧啶基、5-氟嘧啶、5-氯嘧啶基、6-氯嗒-3-基、2-喹啉基、6-氟喹啉-2-基、7-氟喹啉-2-基、6-氯喹啉-2-基、7-氯喹啉-2-基、6-三氟甲基喹啉-2-基、7-三氟甲基喹啉-2-基、喹啉-2-基、6-氟喹啉-2-基、6-氯喹啉-2-基、6-三氟甲基喹啉-2-基、喹唑啉-2-基、6-氟喹唑啉-2-基、6-氯喹唑啉-2-基、6-三氟甲基喹唑啉-2-基、苯并唑-2-基、5-氟苯并唑-2-基、5-氯苯并唑-2-基、5-三氟甲基苯并唑-2-基、6-氟苯并唑-2-基、6-氯苯并唑-2-基、6-三氟甲基苯并唑-2-基、苯并噻唑-2-基、5-氟苯并噻唑-2-基、5-氯苯并噻唑-2-基、5-三氟甲基苯并噻唑-2-基、6-氟苯并噻唑-2-基、6-氯苯并噻唑-2-基、6-三氟甲基苯并噻唑-2-基、苯并[1,2,4]三-3-基、6-氟苯并[1,2,4]三-3-基、6-氯苯并[1,2,4]三-3-基、7-氟苯并[1,2,4] 三-3-基或7-氯苯并[1,2,4]三-3-基。 1) A kind of 嗒 a ketone compound wherein, in the formulae (I 1 ) to (I 51 ), G is hydrogen, and A is phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorobenzene Base, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-methylphenyl, 3-methylphenyl, 4-methyl Phenyl, 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxy Phenylphenyl, 2-trifluoromethoxyphenyl, 3-trifluoromethoxyphenyl, 4-trifluoromethoxyphenyl, 2-nitrophenyl, 3-nitrophenyl, 4-nitrobenzene Base, 2-cyanophenyl, 3-cyanophenyl, 4-cyanophenyl, 2-fluoro-4-chlorophenyl, 2-fluoro-4-cyanophenyl, 2-fluoro-4-trifluoromethyl Phenyl, 2,4-dichlorophenyl, 2-chloro-4-cyanophenyl, 2-chloro-4-trifluoromethylphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 3-fluoropyridin-2-yl, 4-fluoropyridin-2-yl, 5-fluoropyridin-2-yl, 6-fluoropyridin-2-yl, 3-chloropyridin-2-yl, 4-chloropyridine- 2-yl, 5-chloropyridin-2-yl, 6-chloropyridin-2-yl, 3-trifluoromethylpyridin-2-yl, 4-trifluoromethylpyridin-2-yl, 5-trifluoro Methylpyridin-2-yl, 6-trifluoromethylpyridin-2-yl 3,5-difluoropyridine 2-yl, 3-fluoro-5-chloro-pyridin-2-yl, 3-fluoro-5-trifluoromethyl-pyridin-2-yl, 3-chloro-5-fluoropyridine -2-yl, 3,5-dichloropyridin-2-yl, 3-chloro-5-trifluoromethylpyridin-2-yl, 2-pyrimidinyl, 5-fluoropyrimidine, 5-chloropyrimidinyl, 6 -chlorine 3-yl, 2-quinolyl, 6-fluoroquinolin-2-yl, 7-fluoroquinolin-2-yl, 6-chloroquinolin-2-yl, 7-chloroquinolin-2-yl, 6 -trifluoromethylquinolin-2-yl, 7-trifluoromethylquinolin-2-yl, quin Porphyrin-2-yl, 6-fluoroquine Phenyl-2-yl, 6-chloroquine Oxa-2-yl, 6-trifluoromethylquin Benzin-2-yl, quinazolin-2-yl, 6-fluoroquinazolin-2-yl, 6-chloroquinazolin-2-yl, 6-trifluoromethylquinazolin-2-yl, benzene and Zin-2-yl, 5-fluorobenzo Zin-2-yl, 5-chlorobenzo Zyridin-2-yl, 5-trifluoromethylbenzo Zin-2-yl, 6-fluorobenzo Zin-2-yl, 6-chlorobenzo Zin-2-yl, 6-trifluoromethylbenzo Zin-2-yl, benzothiazol-2-yl, 5-fluorobenzothiazol-2-yl, 5-chlorobenzothiazol-2-yl, 5-trifluoromethylbenzothiazol-2-yl, 6-fluorobenzothiazol-2-yl, 6-chlorobenzothiazol-2-yl, 6-trifluoromethylbenzothiazol-2-yl, benzo[1,2,4]tri -3-yl, 6-fluorobenzo[1,2,4]3 3-yl, 6-chlorobenzo[1,2,4]3 -3-yl, 7-fluorobenzo[1,2,4] -3-yl or 7-chlorobenzo[1,2,4] -3- base.

2)一種嗒酮化合物,其中,式(I1)至(I51)中,A是4-三氟甲基苯基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 2) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is 4-trifluoromethylphenyl, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, a propyl fluorenyl group, a butyl fluorenyl group, an isobutyl fluorenyl group, Isoamyl, trimethylethenyl, 2,2-dimethylbutyryl, 3,3-dimethylbutanyl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, benzyl Mercapto, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, phenylethenyl, methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl, three Butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, phenylsulfonyl, p-Toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

3)一種嗒酮化合物,其中,式(I1)至(I51)中,A是2-氟-4-氰苯基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 3) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is 2-fluoro-4-cyanophenyl, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, a propyl fluorenyl group, a butyl fluorenyl group, an isobutyl fluorenyl group. , isoamyl, trimethylethenyl, 2,2-dimethylbutanyl, 3,3-dimethylbutanyl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, Benzylidene, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, phenylethenyl, methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl, Tertiary butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, benzenesulfonyl , p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

4)一種嗒酮化合物,其中,式(I1)至(I51)中,A是2-氯-4-三氟甲基苯基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異 戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 4) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is 2-chloro-4-trifluoromethylphenyl, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, a propyl fluorenyl group, and a butyl fluorenyl group. , Isobutyl fluorenyl, isoamyl decyl, trimethylethenyl, 2,2-dimethylbutanyl, 3,3-dimethylbutanyl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, ring Hexylcarbonyl, benzindenyl, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, phenylethylhydrazine, methoxycarbonyl, ethoxycarbonyl, isopropoxy Carbocarbonyl, tertiary butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, benzene Sulfonyl, p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

5)一種嗒酮化合物,其中,式(I1)至(I51)中,A是5-三氟甲基吡啶-2-基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 5) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is 5-trifluoromethylpyridin-2-yl, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, a propyl fluorenyl group, a butyl fluorenyl group, Isobutyl fluorenyl, isoamyl decyl, trimethyl ethinyl, 2,2-dimethylbutanyl, 3,3-dimethylbutanyl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexyl Carbonyl, benzamidine, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, phenylethenyl, methoxycarbonyl, ethoxycarbonyl, isopropoxy Carbonyl, tertiary butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, benzenesulfonate Indenyl, p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

6)一種嗒酮化合物,其中,式(I1)至(I51)中,A是2-氟-5-三氟甲基吡啶-2-基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基 羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 6) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is 2-fluoro-5-trifluoromethylpyridin-2-yl, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, a propylene group Base, butyl sulfhydryl, isobutyl fluorenyl, isoamyl decyl, trimethyl ethinyl, 2,2-dimethylbutyryl, 3,3-dimethylbutyryl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentyl Carbonyl, cyclohexylcarbonyl, benzindenyl, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, phenylethylhydrazine, methoxycarbonyl, ethoxycarbonyl, Isopropoxycarbonyl, tert-butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonate Base, phenylsulfonyl, p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

7)一種嗒酮化合物,其中,式(I1)至(I51)中,A是2-氯-5-三氟甲基吡啶-2-基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2-甲基丁醯基、3-甲基丁醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、戊醯基、2-甲基戊醯基、2-乙基戊醯基、2-丙基戊醯基、己醯基、2-甲基己醯基、2-乙基己醯基、苯基乙醯基、3-苯基丙醯基、甲氧基乙醯基、乙氧基乙醯基、丙氧基乙醯基、3-甲氧基丙醯基、3-乙氧基丙醯基、3-甲氧基-2-甲基丙醯基、乙硫基乙醯基、3-(甲硫基)丙醯基、苯氧基乙醯基、苄氧基乙醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-氟苄醯基、3-氟苄醯基、4-氟苄醯基、2-氯苄醯基、3-氯苄醯基、4-氯苄醯基、2-溴苄醯基、4-溴苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、2-乙基苄醯基、2-甲氧基苄醯基、3-甲氧基苄醯基、4-甲氧基苄醯基、2-乙氧基苄醯基、2-甲硫基苄醯基、4-氰基苄醯基、2-硝基苄醯基、4-硝基苄醯基、2-(三氟甲基)苄醯基、4-(三氟甲基)苄醯基、4-(三氟甲氧基)苄醯基、2,6-二氟苄醯基、2,3-二氯苄醯基、2,4-二氯苄醯基、2,5-二氯苄醯基、2,6-二氯苄醯基、3,4-二氯苄醯基、3,5-二氯苄醯基、2,6-二甲基苄醯基、2,6-二甲氧基苄醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、 對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 7) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is 2-chloro-5-trifluoromethylpyridin-2-yl, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, and a propyl hydrazine group. Base, butyl sulfhydryl, isobutyl fluorenyl, isoamyl sulfhydryl, trimethyl ethane fluorenyl, 2-methylbutyl fluorenyl, 3-methylbutyl fluorenyl, 2,2-dimethylbutyl fluorenyl, 3,3-dimethylbutyl fluorenyl, pentyl Sulfhydryl, 2-methylpentanyl, 2-ethylpentanyl, 2-propylpentyl, hexyl, 2-methylhexyl, 2-ethylhexyl, phenyl Sulfhydryl, 3-phenylpropenyl, methoxyethyl, ethoxyethyl, propoxyethyl, 3-methoxypropenyl, 3-ethoxypropyl, 3-methoxy-2-methylpropanyl, ethylthiomethyl, 3-(methylthio)propanyl, phenoxyethyl, benzyloxyethyl, cyclopropylcarbonyl , cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, benzindenyl, 2-fluorobenzylidene, 3-fluorobenzylidene, 4-fluorobenzylidene, 2-chlorobenzylidene, 3-chloro Benzyl hydrazino, 4-chlorobenzyl hydrazino, 2-bromobenzylhydrazine, 4-bromobenzylhydrazine, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, 2 -ethylbenzylidene, 2-methoxybenzidine , 3-methoxybenzylidene, 4-methoxybenzylidene, 2-ethoxybenzylidene, 2-methylthiobenzylhydrazone, 4-cyanobenzylidene, 2-nitrobenzyl Indenyl, 4-nitrobenzylhydrazino, 2-(trifluoromethyl)benzylidene, 4-(trifluoromethyl)benzylidene, 4-(trifluoromethoxy)benzylidene, 2, 6-difluorobenzylhydrazone, 2,3-dichlorobenzylidene, 2,4-dichlorobenzylhydrazine, 2,5-dichlorobenzylhydrazino, 2,6-dichlorobenzylidene, 3, 4-Dichlorobenzylhydrazone, 3,5-dichlorobenzylhydrazone, 2,6-dimethylbenzylhydrazino, 2,6-dimethoxybenzylidene, methoxycarbonyl, ethoxycarbonyl , isopropoxycarbonyl, tertiary butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonate Mercapto, phenylsulfonyl, p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

8)一種嗒酮化合物,其中,式(I1)至(I51)中,A是6-氯喹啉-2-基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 8) A kind of 嗒 a ketone compound wherein, in the formulae (I 1 ) to (I 51 ), A is 6-chloroquine 啉-2-yl, and G is ethyl fluorenyl, trifluoroethyl fluorenyl, propyl fluorenyl, butyl fluorenyl, isobutyl decyl, isoamyl decyl, trimethyl ethinyl, 2,2-dimethylbutenyl, 3 ,3-dimethylbutyryl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, benzindenyl, 2-methylbenzylidene, 3-methylbenzylidene, 4-methyl Benzylidene, phenylethylhydrazine, methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl, tert-butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylamino Carbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, benzenesulfonyl, p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or - Nitrobenzyl.

9)一種嗒酮化合物,其中,式(I1)至(I51)中,A是6-氯苯并唑-2-基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 9) A kind of 嗒 a ketone compound wherein, in the formulae (I 1 ) to (I 51 ), A is 6-chlorobenzone Carb-2-yl, and G is ethyl fluorenyl, trifluoroethyl fluorenyl, propyl fluorenyl, butyl fluorenyl, isobutyl decyl, isoamyl decyl, trimethyl ethinyl, 2,2-dimethylbutenyl, 3 ,3-dimethylbutyryl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, benzindenyl, 2-methylbenzylidene, 3-methylbenzylidene, 4-methyl Benzylidene, phenylethylhydrazine, methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl, tert-butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylamino Carbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, benzenesulfonyl, p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or - Nitrobenzyl.

10)一種嗒酮化合物,其中,式(I1)至(I51)中,A是苯并噻唑-2-基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異 戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 10) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is a benzothiazol-2-yl group, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, a propyl fluorenyl group, a butyl fluorenyl group, an isobutyl fluorenyl group, and an isobutyl group. Pentamidine, trimethylethenyl, 2,2-dimethylbutanyl, 3,3-dimethylbutanyl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, benzamidine Base, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, phenylethylhydrazine, methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl, tertiary Butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, phenylsulfonyl, Toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

11)一種嗒酮化合物,其中,式(I1)至(I51)中,A是6-氯苯并噻唑-2-基,而G是乙醯基、三氟乙醯基、丙醯基、丁醯基、異丁醯基、異戊醯基、三甲基乙醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基、苄醯基、2-甲基苄醯基、3-甲基苄醯基、4-甲基苄醯基、苯基乙醯基、甲氧基羰基、乙氧基羰基、異丙氧基羰基、三級丁氧基羰基、苯氧基羰基、烯丙氧基羰基、二甲基胺基羰基、二甲基胺基硫基羰基、甲烷磺醯基、三氟甲烷磺醯基、苯磺醯基、對甲苯磺醯基、甲氧基甲基、乙氧基甲基、苄基或2-硝基苄基。 11) A kind of 嗒 a ketone compound, wherein, in the formulae (I 1 ) to (I 51 ), A is 6-chlorobenzothiazol-2-yl, and G is an ethyl fluorenyl group, a trifluoroethyl fluorenyl group, a propyl fluorenyl group, a butyl fluorenyl group, and a different Butyl, isoamyl, trimethylethenyl, 2,2-dimethylbutanyl, 3,3-dimethylbutanyl, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl , benzindenyl, 2-methylbenzylidene, 3-methylbenzylidene, 4-methylbenzylidene, phenylethylhydrazine, methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl , tertiary butoxycarbonyl, phenoxycarbonyl, allyloxycarbonyl, dimethylaminocarbonyl, dimethylaminothiocarbonyl, methanesulfonyl, trifluoromethanesulfonyl, benzenesulfonate Base, p-toluenesulfonyl, methoxymethyl, ethoxymethyl, benzyl or 2-nitrobenzyl.

(實施例) (Example)

下面表示製造例、參考例、製劑例及試驗例,以更具體說明本發明,但本發明並不受該等的例所限定。 The production examples, the reference examples, the formulation examples, and the test examples are shown below to more specifically illustrate the present invention, but the present invention is not limited by the examples.

製造例及參考例中,室溫通常是表示10至30℃。1H NMR就是表示質子核磁共振譜,內標準是使用四甲基矽烷,化學位移(δ)以ppm表示。 In the production examples and the reference examples, the room temperature usually means 10 to 30 °C. 1 H NMR is a proton nuclear magnetic resonance spectrum. The internal standard is tetramethyl decane, and the chemical shift ( δ ) is expressed in ppm.

製造例及參考例中所用的代號是有如下的意義。 The code used in the manufacturing example and the reference example has the following meanings.

CDCl3:氘代三氯甲烷;DMSO-d6:氘代二甲亞碸;s:單峰;d:雙峰;t:三峰;q:四峰;brs:寬幅單峰;dd:雙雙峰:m:多重峰;J:耦合常數;MTBE:三級丁基甲基醚;DMF:N,N-二甲基甲醯胺;THF:四氫呋喃;Me:甲基;Et:乙基;Pr:丙基;i-Pr:異丙基;c-Pr:環丙基;Bu:丁基;c-Bu:環丁基;n-:正;t-:三級;t-Bu:三級丁基;Pen:戊基;c-Pen:環戊基;Hex:己基;c-Hex:環己基;Ph:苯基;Bn:苄基。 CDCl 3 : deuterated chloroform; DMSO-d 6 : deuterated dimethyl hydrazine; s: single peak; d: doublet; t: triplet; q: four peaks; brs: broad single peak; dd: both Peak: m: multiplet; J: coupling constant; MTBE: tertiary butyl methyl ether; DMF: N,N-dimethylformamide; THF: tetrahydrofuran; Me: methyl; Et: ethyl; i-Pr: isopropyl; c-Pr: cyclopropyl; Bu: butyl; c-Bu: cyclobutyl; n-: positive; t-: tertiary; t-Bu: tertiary butyl Pen: pentyl; c-Pen: cyclopentyl; Hex: hexyl; c-Hex: cyclohexyl; Ph: phenyl; Bn: benzyl.

製造例1 Manufacturing example 1

4-(2-乙基-4-(4-氰-2-氟苯氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-1))的合成 4-(2-ethyl-4-(4-cyano-2-fluorophenoxy)phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-indole Synthesis of ketone (compound (I-1))

將4-(2-乙基-4-羥苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(II-1)500mg、3,4-二氟苄腈294mg、碳酸銫751mg及DMF 3ml的混合溶液在70℃下攪拌30分鐘。將該反應液冷卻至室溫,添加2N鹽酸成為酸性後,以MTBE萃取2次,將合併之有機層以水、飽和食鹽水依次清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將所得的殘渣以氧化矽凝膠管柱層析法精製,獲得化合物(I-1)273mg。 4-(2-Ethyl-4-hydroxyphenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime A mixed solution of a ketone (500 mg of the compound (II-1), 294 mg of 3,4-difluorobenzonitrile, 751 mg of cesium carbonate and 3 ml of DMF was stirred at 70 ° C for 30 minutes. The reaction solution was cooled to room temperature, and 2N hydrochloric acid was added thereto. After acidification, it was extracted twice with MTBE, and the combined organic layers were washed successively with water and brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. 273 mg of the compound (I-1) was obtained.

1H NMR(CDCl3)δ ppm:1.10(3H,t,J=7.6Hz),2.34(3H,s),2.38-2.58(2H,m),3.75(3H,s),5.77(1H,br s),6.95(1H,dd,J=8.3,2.4Hz),7.08-7.18(3H,m),7.40-7.44(1H,m),7.50(1H,dd,J=9.9,1.7Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.10 (3H, t, J = 7.6 Hz), 2.34 (3H, s), 2.38-2.58 (2H, m), 3.75 (3H, s), 5.77 (1H, br s), 6.95 (1H, dd, J = 8.3, 2.4 Hz), 7.08-7.18 (3H, m), 7.40-7.44 (1H, m), 7.50 (1H, dd, J = 9.9, 1.7 Hz).

製造例2 Manufacturing Example 2

使用4-氟三氟甲苯(4-fluorobenzotrifluoride)取代3,4-二氟苄腈,依照製造例1進行操作,獲得4-(2-乙基-4-(4-三氟甲基苯氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-2))。 Substituting 4-fluorobenzotrifluoride for 3,4-difluorobenzonitrile, according to Production Example 1, 4-(2-ethyl-4-(4-trifluoromethylphenoxy) group was obtained. Phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-2)).

1H NMR(CDCl3)δ ppm:1.11(3H,t,J=7.6Hz),2.34(3H,s),2.39-2.58(2H,m),3.76(3H,s),5.46(1H,br s),6.96(1H,dd,J=8.3,2.7Hz),7.08-7.17(4H,m),7.61(2H,d,J=8.5Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.11 (3H, t, J = 7.6 Hz), 2.34 (3H, s), 2.39-2.58 (2H, m), 3.76 (3H, s), 5.46 (1H, br s), 6.96 (1H, dd, J = 8.3, 2.7 Hz), 7.08-7.17 (4H, m), 7.61 (2H, d, J = 8.5 Hz).

製造例3 Manufacturing Example 3

使用3-氯-4-氟三氟甲苯取代3,4-二氟苄腈,依照製造例1進行操作而獲得4-(2-乙基-4-(2-氯-4-三氟甲基苯氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-3))。 3-(3-ethyl-4-(2-chloro-4-trifluoromethyl) 4-(4-ethyl-4-(2-chloro-4-trifluoromethyl) was obtained by the procedure of Preparation 1 using 3-chloro-4-fluorobenzotrifluoride. Phenoxy)phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-3)).

1H NMR(CDCl3)δ ppm:1.11(3H,t,J=7.6Hz),2.34(3H,s),2.39-2.59(2H,m),3.77(3H,s),5.47(1H,br s),6.93(1H,dd,J=8.5,2.6Hz),7.10(1H,d,J=2.6Hz),7.12(1H,d,J=8.5Hz),7.15(1H,d,J=8.5Hz),7.49(1H,d,J=8.5Hz),7.76(1H,s). 1 H NMR (CDCl 3 ) δ ppm: 1.11 (3H, t, J = 7.6 Hz), 2.34 (3H, s), 2.39-2.59 (2H, m), 3.77 (3H, s), 5.47 (1H, br s), 6.93 (1H, dd, J = 8.5, 2.6 Hz), 7.10 (1H, d, J = 2.6 Hz), 7.12 (1H, d, J = 8.5 Hz), 7.15 (1H, d, J = 8.5) Hz), 7.49 (1H, d, J = 8.5 Hz), 7.76 (1H, s).

製造例4 Manufacturing Example 4

使用2-氯-5-三氟甲基吡啶取代3,4-二氟苄腈,依照製造例1 進行操作而獲得4-(2-乙基-4-(5-三氟甲基吡啶-2-基氧基)氟)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-4))。 Substituting 2-chloro-5-trifluoromethylpyridine for 3,4-difluorobenzonitrile, according to Production Example 1, 4-(2-ethyl-4-(5-trifluoromethylpyridine-2) was obtained. -yloxy)fluoro)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-4)).

1H NMR(CDCl3)δ ppm:1.12(3H,t,J=7.6Hz),2.33(3H,s),2.40-2.60(2H,m),3.76(3H,s),6.42(1H,br s),7.05-7.11(2H,m),7.17(1H,d,J=2.2Hz),7.19(1H,d,J=8.3Hz),7.94(1H,dd,J=8.7,2.6Hz),8.38-8.40(1H,m). 1 H NMR (CDCl 3 ) δ ppm: 1.12 (3H, t, J = 7.6 Hz), 2.33 (3H, s), 2.40-2.60 (2H, m), 3.76 (3H, s), 6.42 (1H, br s), 7.05-7.11 (2H, m), 7.17 (1H, d, J = 2.2 Hz), 7.19 (1H, d, J = 8.3 Hz), 7.94 (1H, dd, J = 8.7, 2.6 Hz), 8.38-8.40 (1H, m).

製造例5 Manufacturing Example 5

使用2,5-二氯-3-氟吡啶取代3,4-二氟苄腈,依照製造例進行操作而獲得4-(2-乙基-4-(3-氟-5-氯吡啶-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-5))。 Substituting 2,5-dichloro-3-fluoropyridine for 3,4-difluorobenzonitrile, and operating according to the production example to obtain 4-(2-ethyl-4-(3-fluoro-5-chloropyridine-2) -yloxy)phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-5)).

1H NMR(CDCl3)δ ppm:1.12(3H,t,J=7.6Hz),2.34(3H,s),2.40-2.60(2H,m),3.76(3H,s),5.52(1H,s),6.94(1H,dd,J=8.3,2.5Hz),7.10(1H,d,J=2.5Hz),7.18(1H,d,J=8.3Hz),7.36(1H,d,J=2.2Hz),8.16(1H,d,J=2.2Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.12 (3H, t, J = 7.6 Hz), 2.34 (3H, s), 2.40-2.60 (2H, m), 3.76 (3H, s), 5.52 (1H, s ), 6.94 (1H, dd, J = 8.3, 2.5 Hz), 7.10 (1H, d, J = 2.5 Hz), 7.18 (1H, d, J = 8.3 Hz), 7.36 (1H, d, J = 2.2 Hz) ), 8.16 (1H, d, J = 2.2Hz).

製造例6 Manufacturing Example 6

使用2,3-二氟-5-三氟甲基吡啶取代3,4-二氟苄腈,依照製造例1進行操作而獲得4-(2-乙基-4-(3-氟-5-三氟甲基吡啶-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-6))。 Substituting 2,3-difluoro-5-trifluoromethylpyridine for 3,4-difluorobenzonitrile, and operating according to Production Example 1, 4-(2-ethyl-4-(3-fluoro-5-) was obtained. Trifluoromethylpyridin-2-yloxy)phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-6)).

1H NMR(CDCl3)δ ppm:1.14(3H,t,J=7.5Hz),2.34(3H,s),2.40-2.65(2H,m),3.76(3H,s),6.38(1H,br s),7.12(1H,dd,J=8.2,2.4Hz),7.19-7.24(2H,m),7.72(1H,dd,J=9.3,1.8Hz),8.14(1H,d,J=1.8Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.14 (3H, t, J = 7.5 Hz), 2.34 (3H, s), 2.40-2.65 (2H, m), 3.76 (3H, s), 6.38 (1H, br s), 7.12 (1H, dd, J = 8.2, 2.4 Hz), 7.19-7.24 (2H, m), 7.72 (1H, dd, J = 9.3, 1.8 Hz), 8.14 (1H, d, J = 1.8 Hz) ).

製造例7 Manufacturing Example 7

使用2,3-二氯-5-三氟甲基吡啶取代3,4-二氟苄腈,依照製造例1進行操作而獲得4-(2-乙基-4-(3-氯-5-三氟甲基吡啶-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-7))。 Substitution of 2,3-dichloro-5-trifluoromethylpyridine for 3,4-difluorobenzonitrile was carried out in accordance with Preparation Example 1 to give 4-(2-ethyl-4-(3-chloro-5-). Trifluoromethylpyridin-2-yloxy)phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-7)).

1H NMR(CDCl3)δ ppm:1.14(3H,t,J=7.6Hz),2.34(3H,s),2.42-2.62(2H,m),3.77(3H,s),6.43(1H,br s),7.11(1H,dd,J=8.2,2.5Hz),7.20(1H,d,J=2.5Hz),7.23(1H,d,J=8.2Hz),8.02(1H,d,J=2.1Hz),8.22-8.24(1H,m). 1 H NMR (CDCl 3 ) δ ppm: 1.14 (3H, t, J = 7.6 Hz), 2.34 (3H, s), 2.42 - 2.62 (2H, m), 3.77 (3H, s), 6.43 (1H, br s), 7.11 (1H, dd, J = 8.2, 2.5 Hz), 7.20 (1H, d, J = 2.5 Hz), 7.23 (1H, d, J = 8.2 Hz), 8.02 (1H, d, J = 2.1) Hz), 8.22-8.24 (1H, m).

製造例8 Manufacturing Example 8

使用2,6-二氯喹啉取代3,4-二氟苄腈,依照製造例1進行操作而獲得4-(2-乙基-4-(6-氯喹啉-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-8))。 Use 2,6-dichloroquine The phenyl group was substituted with 3,4-difluorobenzonitrile, and the procedure of Production Example 1 was carried out to obtain 4-(2-ethyl-4-(6-chloroquine). Oxalin-2-yloxy)phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-8)).

1H NMR(CDCl3)δ ppm:1.14(3H,t,J=7.6Hz),2.36(3H,s),2.43-2.64(2H,m),3.78(3H,s),7.00(1H,br s),7.19(1H,dd,J=8.3,2.3Hz),7.23-7.27(2H,m),7.61(1H,dd,J=8.9,2.3Hz),7.66(1H,d,J=8.9Hz),8.07(1H,d,J=2.3Hz),8.73(1H,s). 1 H NMR (CDCl 3 ) δ ppm: 1.14 (3H, t, J = 7.6 Hz), 2.36 (3H, s), 2.43-2.64 (2H, m), 3.78 (3H, s), 7.00 (1H, br s), 7.19 (1H, dd, J = 8.3, 2.3 Hz), 7.23 - 7.27 (2H, m), 7.61 (1H, dd, J = 8.9, 2.3 Hz), 7.66 (1H, d, J = 8.9 Hz) ), 8.07 (1H, d, J = 2.3 Hz), 8.73 (1H, s).

製造例9 Manufacturing Example 9

使用2,6-二氯苯并唑取代3,4-二氟苄腈,依照製造例1進行操作而獲得4-(2-乙基-4-(6-氯苯并唑-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-9))。 Use 2,6-dichlorobenzo The azole was substituted for 3,4-difluorobenzonitrile, and the procedure of Production Example 1 was carried out to obtain 4-(2-ethyl-4-(6-chlorobenzo). Zin-2-yloxy)phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-9)).

1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.5Hz),2.34(3H,s),2.44-2.63(2H,m),3.76(3H,s),6.27(1H,br s),7.24-7.29(2H,m),7.35-7.39(2H,m),7.41(1H,d,J=2.4Hz),7.48(1H,d,J=1.9Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.5 Hz), 2.34 (3H, s), 2.44-2.63 (2H, m), 3.76 (3H, s), 6.27 (1H, br s), 7.24-7.29 (2H, m), 7.35-7.39 (2H, m), 7.41 (1H, d, J = 2.4 Hz), 7.48 (1H, d, J = 1.9 Hz).

製造例10 Manufacturing Example 10

使用2-氯苯并噻唑取代3,4-二氟苄腈,依照製造例1進行操作而獲得4-(2-乙基-4-(苯并噻唑-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-10))。 4-(2-ethyl-4-(benzothiazol-2-yloxy)phenyl)- was obtained by the operation of Production Example 1 using 2-chlorobenzothiazole in place of 3,4-difluorobenzonitrile. 2,6-dimethyl-5-hydroxy-3(2H)-嗒 Ketone (compound (I-10)).

1H NMR(CDCl3)δ ppm:1.15(3H,t,J=7.5Hz),2.35(3H,s),2.43-2.63(2H,m),3.77(3H,s),6.15(1H,br s),7.23(1H,d,J=8.5Hz),7.28-7.34(2H,m),7.37-7.43(2H,m),7.68(1H,d,J=8.0Hz),7.71(1H,d,J=8.0Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.15 (3H, t, J = 7.5 Hz), 2.35 (3H, s), 2.43-2.63 (2H, m), 3.77 (3H, s), 6.15 (1H, br s), 7.23 (1H, d, J = 8.5 Hz), 7.28-7.34 (2H, m), 7.37-7.43 (2H, m), 7.68 (1H, d, J = 8.0 Hz), 7.71 (1H, d , J=8.0Hz).

製造例11 Manufacturing Example 11

使用2,6-二氯苯并噻唑取代3,4-二氟苄腈,依照製造例1進行 操作而獲得4-(2-乙基-4-(6-氯苯并噻唑-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)嗒酮(化合物(I-11))。 Using 2,6-dichlorobenzothiazole in place of 3,4-difluorobenzonitrile, the procedure of Production Example 1 was carried out to obtain 4-(2-ethyl-4-(6-chlorobenzothiazol-2-yloxy). Phenyl)-2,6-dimethyl-5-hydroxy-3(2H)嗒 Ketone (compound (I-11)).

1H NMR(CDCl3)δ ppm:1.15(3H,t,J=7.6Hz),2.34(3H,s),2.42-2.62(2H,m),3.76(3H,s),6.04(1H,br s),7.23(1H,d,J=8.5Hz),7.32(1H,dd,J=8.5,2.4Hz),7.34-7.38(2H,m),7.59(1H,d,J=8.7Hz),7.68(1H,d,J=1.9Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.15 (3H, t, J = 7.6 Hz), 2.34 (3H, s), 2.42 - 2.62 (2H, m), 3.76 (3H, s), 6.04 (1H, br s), 7.23 (1H, d, J = 8.5 Hz), 7.32 (1H, dd, J = 8.5, 2.4 Hz), 7.34 - 7.38 (2H, m), 7.59 (1H, d, J = 8.7 Hz), 7.68 (1H, d, J = 1.9 Hz).

製造例12 Manufacturing Example 12

使用4-(2-甲基-4-羥苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物II-2)取代替化合物II-1,依照製造例7進行操作而獲得4-(2-甲基-4-(3-氯-5-三氟甲基吡啶-2-基氧基)苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮(化合物(I-12))。 Using 4-(2-methyl-4-hydroxyphenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime The ketone (Compound II-2) was replaced by the compound II-1, and the product was obtained according to Preparation 7 to give 4-(2-methyl-4-(3-chloro-5-trifluoromethylpyridin-2-yloxy). Phenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime Ketone (compound (I-12)).

1H NMR(CDCl3)δ ppm:2.22(3H,s),2.34(3H,s),3.77(3H,s),6.11(1H,s),7.11(1H,dd,J=8.5,2.4Hz),7.17(1H,d,J=2.4Hz),7.25(1H,d,J=8.5Hz),8.01(1H,d,J=2.2Hz),8.23-8.27(1H,m). 1 H NMR (CDCl 3 ) δ ppm: 2.22 (3H, s), 2.34 (3H, s), 3.77 (3H, s), 6.11 (1H, s), 7.11 (1H, dd, J = 8.5, 2.4 Hz ), 7.17 (1H, d, J = 2.4 Hz), 7.25 (1H, d, J = 8.5 Hz), 8.01 (1H, d, J = 2.2 Hz), 8.23 - 8.27 (1H, m).

製造例13 Manufacturing Example 13

使用4-(2-乙基-4-羥苯基)-2-甲基-6-甲氧基-5-羥基-3(2H)-嗒酮(化合物II-3)取代化合物II-1,依照製造例7進行操作而獲得4-(2-乙基-4-(3-氯-5-三氟甲基吡啶-2-基氧基)苯基)-2-甲基-6-甲氧基-5-羥基-3(2H)-嗒酮(化合物(I-13))。 4-(2-Ethyl-4-hydroxyphenyl)-2-methyl-6-methoxy-5-hydroxy-3(2H)-oxime The ketone (Compound II-3) was substituted for the compound II-1, and the procedure of Production Example 7 was carried out to obtain 4-(2-ethyl-4-(3-chloro-5-trifluoromethylpyridin-2-yloxy). Phenyl)-2-methyl-6-methoxy-5-hydroxy-3(2H)-oxime Ketone (compound (I-13)).

1H NMR(CDCl3)δ ppm:1.14(3H,t,J=7.5Hz),2.44-2.62(2H,m),3.69(3H,s),3.99(3H,s),6.36(1H,br s),7.07(1H,dd,J=8.5,2.4Hz),7.16(1H,d,J=2.4Hz),7.21(1H,d,J=8.5Hz),7.98(1H,d,J=2.1Hz),8.24-8.27(1H,m). 1 H NMR (CDCl 3 ) δ ppm: 1.14 (3H, t, J = 7.5 Hz), 2.44-2.62 (2H, m), 3.69 (3H, s), 3.99 (3H, s), 6.36 (1H, br s), 7.07 (1H, dd, J = 8.5, 2.4 Hz), 7.16 (1H, d, J = 2.4 Hz), 7.21 (1H, d, J = 8.5 Hz), 7.98 (1H, d, J = 2.1) Hz), 8.24 - 8.27 (1H, m).

製造例14 Manufacturing Example 14

4-(2-乙基-4-(3-氯-5-三氟甲基吡啶-2-基氧基)苯基)-2,6-二甲基-5-乙醯氧基-3(2H)-嗒酮(化合物(I-14-1))的合成 4-(2-Ethyl-4-(3-chloro-5-trifluoromethylpyridin-2-yloxy)phenyl)-2,6-dimethyl-5-ethyloxy-3 2H)-嗒 Synthesis of ketone (compound (I-14-1))

在將化合物(I-7)300mg及三乙胺0.28ml溶解於THF 3ml中而成的溶液中,在室溫下滴入乙醯氯0.97ml而攪拌30分鐘。將該反應混合物以精製矽藻土過濾,將濾液減壓濃縮。將殘渣以氧化矽凝膠管柱層析法(己烷:乙酸乙酯=3:1)精製,獲得化合物(I-14-1)的固體295mg。 In a solution obtained by dissolving 300 mg of the compound (I-7) and 0.28 ml of triethylamine in 3 ml of THF, 0.97 ml of acetamidine chloride was added dropwise at room temperature, followed by stirring for 30 minutes. The reaction mixture was filtered over EtOAc (EtOAc)EtOAc. The residue was purified by yttrium gel column chromatography (hexane: ethyl acetate = 3:1) to afford 295 mg of Compound (I-14-1).

1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.03(3H,s),2.27(3H,s),2.38-2.65(2H,m),3.82(3H,s),7.02(1H,dd,J=8.5,2.3Hz),7.09(1H,d,J=8.5Hz),7.14(1H,d,J=2.3Hz),7.99(1H,d,J=2.3Hz),8.25-8.28(1H,m). 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.03 (3H, s), 2.27 (3H, s), 2.38-2.65 (2H, m), 3.82 (3H, s ), 7.02 (1H, dd, J = 8.5, 2.3 Hz), 7.09 (1H, d, J = 8.5 Hz), 7.14 (1H, d, J = 2.3 Hz), 7.99 (1H, d, J = 2.3 Hz) ), 8.25-8.28 (1H, m).

將使用式X2-G1表示的化合物取代乙醯氯,且依照製造例14而製造的本發明化合物的物性值,與化合物(I-14-1)一起表示於第1表。 The physical property value of the compound of the present invention produced in accordance with Production Example 14 using a compound represented by the formula X 2 -G 1 in place of ethyl chloroform, is shown in Table 1 together with the compound (I-14-1).

(I-14-1);1H NMR(CDCl3)在製造例14中記述。 (I-14-1); 1 H NMR (CDCl 3 ) is described in Production Example 14.

(I-14-2);1H NMR(CDCl3)δ ppm:0.99(3H,t,J=7.7Hz),1.16(3H,t,J=7.6Hz),2.26(3H,s),2.29(2H,q,J=7.7Hz),2.38-2.62(2H,m),3.83(3H,s),7.01(1H,dd,J=8.3,2.4Hz),7.08(1H,d,J=8.3Hz),7.13(1H,d,J=2.4Hz),7.98(1H,d,J=2.1Hz),8.22-8.24(1H,m). (I-14-2); 1 H NMR (CDCl 3 ) δ ppm: 0.99 (3H, t, J = 7.7 Hz), 1.16 (3H, t, J = 7.6 Hz), 2.26 (3H, s), 2.29 (2H,q,J=7.7Hz), 2.38-2.62(2H,m),3.83(3H,s),7.01(1H,dd,J=8.3,2.4Hz),7.08(1H,d,J=8.3 Hz), 7.13 (1H, d, J = 2.4 Hz), 7.98 (1H, d, J = 2.1 Hz), 8.22 - 8.24 (1H, m).

(I-14-3);1H NMR(CDCl3)δ ppm:0.97-1.03(6H,m),1.16(3H,t,J=7.6Hz),2.25(3H,s),2.38-2.61(3H,m),3.83(3H,s),7.00(1H,dd,J=8.2,2.3Hz),7.08(1H,d,J=8.2Hz),7.12(1H,d,J=2.3Hz),7.97(1H,d,J=2.3Hz),8.18-8.21(1H,m). (I-14-3); 1 H NMR (CDCl 3 ) δ ppm: 0.97-1.03 (6H, m), 1.16 (3H, t, J = 7.6 Hz), 2.25 (3H, s), 2.38-2.61 ( 3H, m), 3.83 (3H, s), 7.00 (1H, dd, J = 8.2, 2.3 Hz), 7.08 (1H, d, J = 8.2 Hz), 7.12 (1H, d, J = 2.3 Hz), 7.97 (1H, d, J = 2.3 Hz), 8.18-8.21 (1H, m).

(I-14-4);1H NMR(CDCl3)δ ppm:1.05(9H,s),1.15(3H,t,J=7.6Hz),2.24(3H,s),2.38-2.61(2H,m),3.83(3H,s),6.99(1H,dd,J=8.4,2.3Hz),7.07(1H,d,J=8.4Hz),7.10(1H,d,J=2.3Hz),7.97(1H,d,J=2.1Hz),8.16-8.19(1H,m). (I-14-4); 1 H NMR (CDCl 3 ) δ ppm: 1.05 (9H, s), 1.15 (3H, t, J = 7.6 Hz), 2.24 (3H, s), 2.38-2.61 (2H, m), 3.83 (3H, s), 6.99 (1H, dd, J = 8.4, 2.3 Hz), 7.07 (1H, d, J = 8.4 Hz), 7.10 (1H, d, J = 2.3 Hz), 7.97 ( 1H, d, J = 2.1 Hz), 8.16-8.19 (1H, m).

(I-14-5);1H NMR(CDCl3)δ ppm:0.80(3H,t,J=7.4 Hz),1.16(3H,t,J=7.6Hz),1.43-1.53(2H,m),2.23-2.30(5H,m),2.38-2.62(2H,m),3.83(3H,s),7.01(1H,dd,J=8.4,2.4Hz),7.09(1H,d,J=8.4Hz),7.13(1H,d,J=2.4Hz),7.98(1H,d,J=2.0Hz),8.22-8.25(1H,m). (I-14-5); 1 H NMR (CDCl 3 ) δ ppm: 0.80 (3H, t, J = 7.4 Hz), 1.16 (3H, t, J = 7.6 Hz), 1.43-1.53 (2H, m) , 2.23-2.30(5H,m), 2.38-2.62(2H,m),3.83(3H,s),7.01(1H,dd,J=8.4,2.4Hz),7.09(1H,d,J=8.4Hz ), 7.13 (1H, d, J = 2.4 Hz), 7.98 (1H, d, J = 2.0 Hz), 8.22 - 8.25 (1H, m).

(I-14-6);1H NMR(CDCl3)δ ppm:0.72-0.78(3H,m),0.94-0.99(3H,m),1.15(3H,t,J=7.6Hz),1.27-1.39(1H,m),1.45-1.59(1H,m),2.26(3H,s),2.31-2.62(3H,m),3.83(3H,s),7.00(1H,dd,J=8.4,2.4Hz),7.06-7.10(1H,m),7.11(1H,d,J=2.4Hz),7.97(1H,d,J=2.3Hz),8.19-8.21(1H,m). (I-14-6); 1 H NMR (CDCl 3 ) δ ppm: 0.72-0.78 (3H, m), 0.94-0.99 (3H, m), 1.15 (3H, t, J = 7.6 Hz), 1.27- 1.39 (1H, m), 1.45-1.59 (1H, m), 2.26 (3H, s), 2.31-2.62 (3H, m), 3.83 (3H, s), 7.00 (1H, dd, J = 8.4, 2.4 Hz), 7.06-7.10 (1H, m), 7.11 (1H, d, J = 2.4 Hz), 7.97 (1H, d, J = 2.3 Hz), 8.19-8.21 (1H, m).

(I-14-7);1H NMR(CDCl3)δ ppm:0.80(6H,d,J=6.9Hz),1.16(3H,t,J=7.6Hz),1.85-1.97(1H,m),2.17(2H,d,J=6.9Hz),2.26(3H,s),2.38-2.63(2H,m),3.82(3H,s),7.01(1H,dd,J=8.2,2.1Hz),7.09(1H,d,J=8.2Hz),7.12(1H,d,J=2.1Hz),7.98(1H,d,J=1.6Hz),8.20-8.26(1H,m). (I-14-7); 1 H NMR (CDCl 3 ) δ ppm: 0.80 (6H, d, J = 6.9 Hz), 1.16 (3H, t, J = 7.6 Hz), 1.85-1.97 (1H, m) , 2.17 (2H, d, J = 6.9 Hz), 2.26 (3H, s), 2.38 - 2.63 (2H, m), 3.82 (3H, s), 7.01 (1H, dd, J = 8.2, 2.1 Hz), 7.09 (1H, d, J = 8.2 Hz), 7.12 (1H, d, J = 2.1 Hz), 7.98 (1H, d, J = 1.6 Hz), 8.20-8.26 (1H, m).

(I-14-8);1H NMR(CDCl3)δ ppm:0.83(3H,t,J=7.4Hz),1.10-1.21(5H,m),1.37-1.46(2H,m),2.25(3H,s),2.28(2H,t,J=7.4Hz),2.38-2.62(2H,m),3.82(3H,s),7.01(1H,dd,J=8.3,2.4Hz),7.08(1H,d,J=8.4Hz),7.13(1H,d,J=2.5Hz),7.98(1H,d,J=2.0Hz),8.23-8.26(1H,m). (I-14-8); 1 H NMR (CDCl 3 ) δ ppm: 0.83 (3H, t, J = 7.4 Hz), 1.10-1.21 (5H, m), 1.37-1.46 (2H, m), 2.25 ( 3H, s), 2.28 (2H, t, J = 7.4 Hz), 2.38-2.62 (2H, m), 3.82 (3H, s), 7.01 (1H, dd, J = 8.3, 2.4 Hz), 7.08 (1H) , d, J = 8.4 Hz), 7.13 (1H, d, J = 2.5 Hz), 7.98 (1H, d, J = 2.0 Hz), 8.23 - 8.26 (1H, m).

(I-14-9);1H NMR(CDCl3)δ ppm:0.77-0.86(3H,m),0.96(3H,d,J=6.9Hz),1.04-1.29(6H,m),1.40-1.53(1H,m),2.25(3H,s),2.38-2.61(3H,m),3.83(3H,s),7.00(1H,dd,J=8.2,2.2Hz),7.06-7.10(1H,m),7.12(1H,d,J=2.2Hz),7.97(1H,d,J=2.1Hz),8.19-8.23(1H,m). (I-14-9); 1 H NMR (CDCl 3 ) δ ppm: 0.77-0.86 (3H, m), 0.96 (3H, d, J = 6.9 Hz), 1.04-1.29 (6H, m), 1.40- 1.53 (1H, m), 2.25 (3H, s), 2.38-2.61 (3H, m), 3.83 (3H, s), 7.00 (1H, dd, J = 8.2, 2.2 Hz), 7.06-7.10 (1H, m), 7.12 (1H, d, J = 2.2 Hz), 7.97 (1H, d, J = 2.1 Hz), 8.19-8.23 (1H, m).

(I-14-10);1H NMR(CDCl3)δ ppm:0.73(3H,t,J=7.4Hz),0.81(3H,t,J=6.9Hz),1.01-1.11(2H,m),1.15(3H,t,J=7.5Hz),1.25-1.51(4H,m),2.23-2.33(4H,m),2.39-2.61(2H,m),3.82(3H,s),7.01(1H,dd,J=8.4,2.3Hz),7.09(1H,d,J=8.4Hz),7.12(1H,d,J=2.3Hz),7.97(1H,d,J=2.3Hz),8.21-8.24(1H,m). (I-14-10); 1 H NMR (CDCl 3 ) δ ppm: 0.73 (3H, t, J = 7.4 Hz), 0.81 (3H, t, J = 6.9 Hz), 1.01-1.11 (2H, m) , 1.15 (3H, t, J = 7.5 Hz), 1.25-1.51 (4H, m), 2.23-2.33 (4H, m), 2.39-2.61 (2H, m), 3.82 (3H, s), 7.01 (1H) , dd, J = 8.4, 2.3 Hz), 7.09 (1H, d, J = 8.4 Hz), 7.12 (1H, d, J = 2.3 Hz), 7.97 (1H, d, J = 2.3 Hz), 8.21-8.24 (1H,m).

(I-14-11);1H NMR(CDCl3)δ ppm:0.80(6H,t,J=7.2Hz),1.01-1.11(4H,m),1.15(3H,t,J=7.6Hz),1.23-1.45(4H,m),2.26(3H,s),2.31-2.61(3H,m),3.82(3H,s),7.01(1H,dd,J=8.4,2.4Hz),7.09(1H,d,J=8.4Hz),7.12(1H,d,J=2.4Hz),7.97(1H,d,J=2.3Hz),8.22-8.25(1H,m). (I-14-11); 1 H NMR (CDCl 3 ) δ ppm: 0.80 (6H, t, J = 7.2 Hz), 1.01-1.11 (4H, m), 1.15 (3H, t, J = 7.6 Hz) , 1.23-1.45 (4H, m), 2.26 (3H, s), 2.31-2.61 (3H, m), 3.82 (3H, s), 7.01 (1H, dd, J = 8.4, 2.4 Hz), 7.09 (1H , d, J = 8.4 Hz), 7.12 (1H, d, J = 2.4 Hz), 7.97 (1H, d, J = 2.3 Hz), 8.22 - 8.25 (1H, m).

(I-14-12);1H NMR(CDCl3)δ ppm:0.84(3H,t,J=7.1Hz),1.07-1.28(7H,m),1.37-1.48(2H,m),2.23-2.30(5H,m),2.38-2.62(2H,m),3.83(3H,s),7.01(1H,dd,J=8.3,2.4Hz),7.08(1H,d,J=8.2Hz),7.13(1H,d,J=2.3Hz),7.98(1H,d,J=1.8Hz),8.23-8.27(1H,m). (I-14-12); 1 H NMR (CDCl 3 ) δ ppm: 0.84 (3H, t, J = 7.1 Hz), 1.07-1.28 (7H, m), 1.37-1.48 (2H, m), 2.23 2.30 (5H, m), 2.38-2.62 (2H, m), 3.83 (3H, s), 7.01 (1H, dd, J = 8.3, 2.4 Hz), 7.08 (1H, d, J = 8.2 Hz), 7.13 (1H, d, J = 2.3 Hz), 7.98 (1H, d, J = 1.8 Hz), 8.23 - 8.27 (1H, m).

(I-14-13);1H NMR(CDCl3)δ ppm:0.80-0.88(3H,m),0.96(3H,d,J=7.0Hz),1.01-1.30(8H,m),1.41-1.53(1H,m),2.25(3H,s),2.36-2.61(3H,m),3.83(3H,s),7.00(1H,dd,J=8.3,2.4Hz),7.06-7.14(2H,m),7.97(1H,d,J=2.0Hz),8.19-8.23(1H,m). (I-14-13); 1 H NMR (CDCl 3 ) δ ppm: 0.80-0.88 (3H, m), 0.96 (3H, d, J = 7.0 Hz), 1.01-1.30 (8H, m), 1.41- 1.53 (1H, m), 2.25 (3H, s), 2.36-2.61 (3H, m), 3.83 (3H, s), 7.00 (1H, dd, J = 8.3, 2.4 Hz), 7.06-7.14 (2H, m), 7.97 (1H, d, J = 2.0 Hz), 8.19-8.23 (1H, m).

(I-14-14);1H NMR(CDCl3)δ ppm:0.72(3H,t,J=7.4Hz),0.80-0.89(3H,m),0.98-1.51(11H,m),2.22-2.32(4H,m),2.39-2.62(2H,m),3.82(3H,s),7.01(1H,dd,J=8.3,2.2Hz),7.07-7.14(2H,m),7.97(1H,d,J=1.8Hz),8.21-8.25(1H,m). (I-14-14); 1 H NMR (CDCl 3 ) δ ppm: 0.72 (3H, t, J = 7.4 Hz), 0.80-0.89 (3H, m), 0.98-1.51 (11H, m), 2.22 2.32 (4H, m), 2.39-2.62 (2H, m), 3.82 (3H, s), 7.01 (1H, dd, J = 8.3, 2.2 Hz), 7.07-7.14 (2H, m), 7.97 (1H, d, J = 1.8 Hz), 8.21-8.25 (1H, m).

(I-14-15);1H NMR(CDCl3)δ ppm:0.85(3H,t,J=7.1Hz),1.09-1.30(9H,m),1.37-1.47(2H,m),2.23-2.31(5H,m),2.38-2.63(2H,m),3.82(3H,s),7.01(1H,dd,J=8.4,2.3Hz),7.08(1H,d,J=8.4Hz),7.13(1H,d,J=2.3Hz),7.98(1H,d,J=2.0Hz),8.23-8.27(1H,m). (I-14-15); 1 H NMR (CDCl 3 ) δ ppm: 0.85 (3H, t, J = 7.1 Hz), 1.09-1.30 (9H, m), 1.37-1.47 (2H, m), 2.23 2.31 (5H, m), 2.38-2.63 (2H, m), 3.82 (3H, s), 7.01 (1H, dd, J = 8.4, 2.3 Hz), 7.08 (1H, d, J = 8.4 Hz), 7.13 (1H, d, J = 2.3 Hz), 7.98 (1H, d, J = 2.0 Hz), 8.23 - 8.27 (1H, m).

(I-14-16);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.28(3H,s),2.39-2.63(2H,m),3.24(3H,s),3.84(3H,s),3.97(2H,s),7.02(1H,dd,J=8.4,2.4Hz),7.10(1H,d,J=8.4Hz),7.14(1H,d,J=2.4Hz),7.98(1H,d,J=2.0Hz),8.21-8.24(1H,m). (I-14-16); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.28 (3H, s), 2.39-2.63 (2H, m), 3.24 (3H, s), 3.84 (3H, s), 3.97 (2H, s), 7.02 (1H, dd, J = 8.4, 2.4 Hz), 7.10 (1H, d, J = 8.4 Hz), 7.14 (1H, d, J) =2.4 Hz), 7.98 (1H, d, J = 2.0 Hz), 8.21-8.24 (1H, m).

(I-14-17);1H NMR(CDCl3)δ ppm:1.10-1.22(6H,m),2.27(3H,s),2.38-2.63(2H,m),3.26-3.41(2H,m),3.83(3H,s),4.01(2H,s),7.02(1H,dd,J=8.3,2.2Hz),7.09(1H,d,J=8.3Hz),7.14(1H,d,J=2.2Hz),7.99(1H,d,J=1.8Hz),8.21-8.26(1H,m). (I-14-17); 1 H NMR (CDCl 3 ) δ ppm: 1.10 - 1.22 (6H, m), 2.27 (3H, s), 2.38 - 2.63 (2H, m), 3.26 - 3.41 (2H, m ), 3.83 (3H, s), 4.01 (2H, s), 7.02 (1H, dd, J = 8.3, 2.2 Hz), 7.09 (1H, d, J = 8.3 Hz), 7.14 (1H, d, J = 2.2Hz), 7.99 (1H, d, J = 1.8Hz), 8.21-8.26 (1H, m).

(I-14-18);1H NMR(CDCl3)δ ppm:0.88(3H,t,J=7.4Hz),1.16(3H,t,J=7.6Hz),1.49-1.59(2H,m),2.27(3H,s),2.39-2.62(2H,m),3.17-3.28(2H,m),3.83(3H,s),4.00(2H,s),7.02(1H,dd,J=8.4,2.3Hz),7.09(1H,d,J=8.4Hz),7.14(1H,d,J=2.3Hz),7.98(1H,d,J=2.1Hz),8.23-8.25(1H,m). (I-14-18); 1 H NMR (CDCl 3 ) δ ppm: 0.88 (3H, t, J = 7.4 Hz), 1.16 (3H, t, J = 7.6 Hz), 1.49-1.59 (2H, m) , 2.27 (3H, s), 2.39-2.62 (2H, m), 3.17-3.28 (2H, m), 3.83 (3H, s), 4.00 (2H, s), 7.02 (1H, dd, J = 8.4, 2.3 Hz), 7.09 (1H, d, J = 8.4 Hz), 7.14 (1H, d, J = 2.3 Hz), 7.98 (1H, d, J = 2.1 Hz), 8.23 - 8.25 (1H, m).

(I-14-19);1H NMR(CDCl3)δ ppm:1.16(6H,t,J=7.5Hz),2.26-2.63(7H,m),3.17(2H,s),3.83(3H,s),7.02(1H,dd,J=8.4,2.3Hz),7.10(1H,d,J=8.4Hz),7.14(1H,d,J=2.3Hz),7.98(1H,d,J=2.0Hz),8.23-8.28(1H,m). (I-14-19); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (6H, t, J = 7.5 Hz), 2.26-2.63 (7H, m), 3.17 (2H, s), 3.83 (3H, s), 7.02 (1H, dd, J = 8.4, 2.3 Hz), 7.10 (1H, d, J = 8.4 Hz), 7.14 (1H, d, J = 2.3 Hz), 7.98 (1H, d, J = 2.0) Hz), 8.23-8.28 (1H, m).

(I-14-20);1H NMR(CDCl3)δ ppm:1.08(3H,t,J=7.5Hz),2.16(3H,s),2.27-2.38(1H,m),2.42-2.54(1H,m),3.58(2H,s),3.81(3H,s),6.94(1H,dd,J=8.4,2.3Hz),6.99-7.04(3H,m),7.07(1H,d,J=2.3Hz),7.24-7.30(3H,m),8.00(1H,d,J=2.3Hz),8.20-8.24(1H,m). (I-14-20); 1 H NMR (CDCl 3 ) δ ppm: 1.08 (3H, t, J = 7.5 Hz), 2.16 (3H, s), 2.27-2.38 (1H, m), 2.42-2.54 ( 1H, m), 3.58 (2H, s), 3.81 (3H, s), 6.94 (1H, dd, J = 8.4, 2.3 Hz), 6.99-7.04 (3H, m), 7.07 (1H, d, J = 2.3Hz), 7.24-7.30(3H,m), 8.00(1H,d,J=2.3Hz), 8.20-8.24(1H,m).

(I-14-21);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.27(3H,s),2.40-2.63(2H,m),3.84(3H,s),4.04(2H,s),4.33(2H,s),7.02(1H,dd,J=8.4,2.3Hz),7.11(1H,d,J=8.4Hz),7.15(1H,d,J=2.3Hz),7.20-7.25(2H,m),7.28-7.36(3H,m),7.96(1H,d,J=1.8Hz),8.01-8.04(1H,m). (I-14-21); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.27 (3H, s), 2.40-2.63 (2H, m), 3.84 (3H, s), 4.04 (2H, s), 4.33 (2H, s), 7.02 (1H, dd, J = 8.4, 2.3 Hz), 7.11 (1H, d, J = 8.4 Hz), 7.15 (1H, d, J) =2.3 Hz), 7.20-7.25 (2H, m), 7.28-7.36 (3H, m), 7.96 (1H, d, J = 1.8 Hz), 8.01-8.04 (1H, m).

(I-14-22);1H NMR(CDCl3)δ ppm:1.12(3H,t,J=7.6Hz),2.26(3H,s),2.35-2.61(2H,m),3.83(3H,s),4.57(2H,s),6.62(2H,d,J=8.7Hz),6.99(1H,t,J=7.4Hz),7.04(1H,dd,J=8.3,2.2Hz),7.11(1H,d,J=8.3Hz),7.16(1H,d,J=2.2Hz),7.25(2H,dd,J=8.7,7.4Hz),7.99(1H,d,J=2.3Hz),8.12-8.15(1H,m). (I-14-22); 1 H NMR (CDCl 3 ) δ ppm: 1.12 (3H, t, J = 7.6 Hz), 2.26 (3H, s), 2.35-2.61 (2H, m), 3.83 (3H, s), 4.57 (2H, s), 6.62 (2H, d, J = 8.7 Hz), 6.99 (1H, t, J = 7.4 Hz), 7.04 (1H, dd, J = 8.3, 2.2 Hz), 7.11 ( 1H, d, J = 8.3 Hz), 7.16 (1H, d, J = 2.2 Hz), 7.25 (2H, dd, J = 8.7, 7.4 Hz), 7.99 (1H, d, J = 2.3 Hz), 8.12 8.15 (1H, m).

(I-14-23);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.27(3H,s),2.38-2.62(4H,m),3.27(3H,s),3.49(2H,t,J=6.3Hz),3.83(3H,s),7.01(1H,dd,J=8.4,2.3Hz),7.08(1H,d,J=8.4Hz),7.13(1H,d,J=2.3Hz),7.98(1H,d,J=2.3Hz),8.24-8.27(1H,m). (I-14-23); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.27 (3H, s), 2.38-2.62 (4H, m), 3.27 (3H, s), 3.49 (2H, t, J = 6.3 Hz), 3.83 (3H, s), 7.01 (1H, dd, J = 8.4, 2.3 Hz), 7.08 (1H, d, J = 8.4 Hz), 7.13 ( 1H, d, J = 2.3 Hz), 7.98 (1H, d, J = 2.3 Hz), 8.24 - 8.27 (1H, m).

(I-14-24);1H NMR(CDCl3)δ ppm:1.11-1.20(6H,m),2.27(3H,s),2.38-2.62(4H,m),3.43(2H,q,J=7.0Hz),3.51-3.57(2H,m),3.83(3H,s).7.01(1H,dd,J=8.4,2.3Hz),7.08(1H,d,J=8.4Hz),7.13(1H,d,J=2.3Hz),7.98(1H,d,J=2.1Hz),8.24-8.28(1H,m). (I-14-24); 1 H NMR (CDCl 3 ) δ ppm: 1.11-1.20 (6H, m), 2.27 (3H, s), 2.38-2.62 (4H, m), 3.43 (2H, q, J =7.0Hz), 3.51-3.57(2H,m), 3.83(3H,s).7.01(1H,dd,J=8.4,2.3Hz),7.08(1H,d,J=8.4Hz),7.13(1H , d, J = 2.3 Hz), 7.98 (1H, d, J = 2.1 Hz), 8.24 - 8.28 (1H, m).

(I-14-25);1H NMR(CDCl3)δ ppm:0.85-0.93(3H,m),1.16(3H,t,J=7.6Hz),2.26(3H,s),2.38-2.61(2H,m),2.68-2.78(1H,m),3.25-3.33(4H,m),3.37-3.46(1H,m),3.83(3H,s),6.98-7.03(1H,m),7.06-7.14(2H,m),7.97(1H,d,J=2.3Hz),8.18-8.22(1H,m). (I-14-25); 1 H NMR (CDCl 3 ) δ ppm: 0.85-0.93 (3H, m), 1.16 (3H, t, J = 7.6 Hz), 2.26 (3H, s), 2.38-2.61 ( 2H, m), 2.68-2.78 (1H, m), 3.25-3.33 (4H, m), 3.37-3.46 (1H, m), 3.83 (3H, s), 6.98-7.03 (1H, m), 7.06- 7.14(2H,m), 7.97(1H,d,J=2.3Hz), 8.18-8.22(1H,m).

(I-14-26);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.05(3H,s),2.28(3H,s),2.38-2.62(6H,m),3.83(3H,s),7.01(1H,dd,J=8.4,2.3Hz),7.08(1H,d,J=8.4Hz),7.13(1H,d,J=2.3Hz),7.98(1H,d,J=2.0Hz),8.28-8.31(1H,m). (I-14-26); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.05 (3H, s), 2.28 (3H, s), 2.38-2.62 (6H, m), 3.83 (3H, s), 7.01 (1H, dd, J = 8.4, 2.3 Hz), 7.08 (1H, d, J = 8.4 Hz), 7.13 (1H, d, J = 2.3 Hz), 7.98 ( 1H, d, J = 2.0 Hz), 8.28-8.31 (1H, m).

(I-14-27);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.15(3H,s),2.37-2.62(4H,m),2.67-2.74(2H,m),3.82(3H,s),6.99(1H,dd,J=8.4,2.5Hz),7.06-7.14(4H,m),7.18-7.30(3H,m),7.91-7.93(1H,m),7.95(1H,d,J=2.0Hz). (I-14-27); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.15 (3H, s), 2.37-2.62 (4H, m), 2.67-2.74 ( 2H,m), 3.82 (3H, s), 6.99 (1H, dd, J=8.4, 2.5 Hz), 7.06-7.14 (4H, m), 7.18-7.30 (3H, m), 7.91-7.93 (1H, m), 7.95 (1H, d, J = 2.0 Hz).

(I-14-28);1H NMR(CDCl3)δ ppm:1.15(3H,t,J=7.6Hz),2.28(3H,s),2.38-2.62(2H,m),2.75(2H,t,J=6.3Hz),3.83(3H,s),4.03-4.10(2H,m),6.81(2H,d,J=7.7Hz),6.95(1H,t,J=7.7Hz),7.00(1H,dd,J=8.4,2.3Hz),7.09(1H,d,J=8.4Hz),7.13(1H,d,J=2.3Hz),7.26(2H,t,J=7.7Hz),7.97(1H,d,J=2.3Hz),8.15-8.19(1H,m). (I-14-28); 1 H NMR (CDCl 3 ) δ ppm: 1.15 (3H, t, J = 7.6 Hz), 2.28 (3H, s), 2.38-2.62 (2H, m), 2.75 (2H, t, J = 6.3 Hz), 3.83 (3H, s), 4.03-4.10 (2H, m), 6.81 (2H, d, J = 7.7 Hz), 6.95 (1H, t, J = 7.7 Hz), 7.00 ( 1H, dd, J = 8.4, 2.3 Hz), 7.09 (1H, d, J = 8.4 Hz), 7.13 (1H, d, J = 2.3 Hz), 7.26 (2H, t, J = 7.7 Hz), 7.97 ( 1H, d, J = 2.3 Hz), 8.15-8.19 (1H, m).

(I-14-29);1H NMR(CDCl3)δ ppm:0.79-0.93(4H,m),1.15(3H,t,J=7.6Hz),1.55-1.65(1H,m),2.26(3H,s),2.37-2.48(1H,m),2.50-2.61(1H,m),3.82(3H,s),7.02(1H,dd,J=8.2,2.3Hz),7.07(1H,d,J=8.2Hz),7.14(1H,d,J=2.3Hz),7.98(1H,d,J=2.1Hz),8.24-8.26(1H,m). (I-14-29); 1 H NMR (CDCl 3 ) δ ppm: 0.79-0.93 (4H, m), 1.15 (3H, t, J = 7.6 Hz), 1.55-1.65 (1H, m), 2.26 ( 3H, s), 2.37-2.48 (1H, m), 2.50-2.61 (1H, m), 3.82 (3H, s), 7.02 (1H, dd, J = 8.2, 2.3 Hz), 7.07 (1H, d, J = 8.2 Hz), 7.14 (1H, d, J = 2.3 Hz), 7.98 (1H, d, J = 2.1 Hz), 8.24 - 8.26 (1H, m).

(I-14-30);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),1.74-2.16(6H,m),2.25(3H,s),2.39-2.62(2H,m),3.08-3.18(1H,m),3.83(3H,s),7.01(1H,dd,J=8.5,2.3Hz),7.10(1H,d,J=8.5Hz),7.12(1H,d,J=2.3Hz),7.97(1H,d,J=2.3Hz),8.17-8.19(1H,m). (I-14-30); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 1.74-2.16 (6H, m), 2.25 (3H, s), 2.39-2.62 ( 2H,m), 3.08-3.18(1H,m),3.83(3H,s),7.01(1H,dd,J=8.5,2.3Hz), 7.10(1H,d,J=8.5Hz),7.12(1H , d, J = 2.3 Hz), 7.97 (1H, d, J = 2.3 Hz), 8.17-8.19 (1H, m).

(I-14-31);1H NMR(CDCl3)δ ppm:1.15(3H,t,J=7.6Hz),1.42-1.61(6H,m),1.68-1.81(2H,m),2.25(3H,s),2.38-2.61(2H,m),2.67-2.78(1H,m),3.83(3H,s),7.00(1H,dd,J=8.3,2.4Hz),7.07(1H,d,J=8.3Hz),7.12(1H,d,J=2.4Hz),7.98(1H,d,J=2.3Hz),8.20-8.22(1H,m). (I-14-31); 1 H NMR (CDCl 3 ) δ ppm: 1.15 (3H, t, J = 7.6 Hz), 1.42-1.61 (6H, m), 1.68-1.81 (2H, m), 2.25 ( 3H, s), 2.38-2.61 (2H, m), 2.67-2.78 (1H, m), 3.83 (3H, s), 7.00 (1H, dd, J = 8.3, 2.4 Hz), 7.07 (1H, d, J = 8.3 Hz), 7.12 (1H, d, J = 2.4 Hz), 7.98 (1H, d, J = 2.3 Hz), 8.20-8.22 (1H, m).

(I-14-32);1H NMR(CDCl3)δ ppm:1.10-1.31(8H,m),1.56-1.72(5H,m),2.24(3H,s),2.25-2.34(1H,m),2.38-2.48(1H,m),2.50-2.61(1H,m),3.82(3H,s),7.00(1H,dd,J=8.3,2.4Hz),7.07(1H,d,J=8.3Hz),7.12(1H,d,J=2.4Hz),7.98(1H,d,J=2.1Hz),8.19-8.22(1H,m). (I-14-32); 1 H NMR (CDCl 3 ) δ ppm: 1.10-1.31 (8H, m), 1.56-1.72 (5H, m), 2.24 (3H, s), 2.25-2.34 (1H, m ), 2.38-2.48 (1H, m), 2.50-2.61 (1H, m), 3.82 (3H, s), 7.00 (1H, dd, J = 8.3, 2.4 Hz), 7.07 (1H, d, J = 8.3) Hz), 7.12 (1H, d, J = 2.4 Hz), 7.98 (1H, d, J = 2.1 Hz), 8.19-8.22 (1H, m).

(I-14-33);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.29(3H,s),2.46-2.56(1H,m),2.58-2.68(1H,m),3.86(3H,s),6.93(1H,dd,J=8.5,2.4Hz),7.07(1H,d,J=2.4Hz),7.16(1H,d,J=8.5Hz),7.44(2H,t,J=7.8Hz),7.62(1H,t,J=7.8Hz),7.90(2H,d,J=7.8Hz),7.93(1H,d,J=2.2Hz),8.11-8.13(1H,m). (I-14-33); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.46-2.56 (1H, m), 2.58-2.68 ( 1H, m), 3.86 (3H, s), 6.93 (1H, dd, J = 8.5, 2.4 Hz), 7.07 (1H, d, J = 2.4 Hz), 7.16 (1H, d, J = 8.5 Hz), 7.44 (2H, t, J = 7.8 Hz), 7.62 (1H, t, J = 7.8 Hz), 7.90 (2H, d, J = 7.8 Hz), 7.93 (1H, d, J = 2.2 Hz), 8.11 8.13 (1H, m).

(I-14-34);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.33(3H,s),2.44-2.68(2H,m),3.86(3H,s),6.96(1H,dd,J=8.3,2.4Hz),7.07-7.22(4H,m),7.54-7.63(1H,m),7.67-7.75(1H,m),7.95(1H,d,J=2.0Hz),8.12-8.18(1H,m). (I-14-34); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.33 (3H, s), 2.44-2.68 (2H, m), 3.86 (3H, s), 6.96 (1H, dd, J = 8.3, 2.4 Hz), 7.07-7.22 (4H, m), 7.54-7.63 (1H, m), 7.67-7.75 (1H, m), 7.95 (1H, d, J=2.0Hz), 8.12-8.18(1H,m).

(I-14-35);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.30(3H,s),2.44-2.69(2H,m),3.87(3H,s),6.94(1H,dd,J=8.4,2.4Hz),7.08(1H,d,J=2.4Hz),7.14(1H,d,J=8.4Hz),7.29-7.36(1H,m),7.39-7.46(1H,m),7.53-7.59(1H,m),7.68-7.73(1H,m),7.94(1H,d,J=1.8Hz),8.12-8.17(1H,m). (I-14-35); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.30 (3H, s), 2.44-2.69 (2H, m), 3.87 (3H, s), 6.94 (1H, dd, J = 8.4, 2.4 Hz), 7.08 (1H, d, J = 2.4 Hz), 7.14 (1H, d, J = 8.4 Hz), 7.29-7.36 (1H, m), 7.39-7.46 (1H, m), 7.53-7.59 (1H, m), 7.68-7.73 (1H, m), 7.94 (1H, d, J = 1.8 Hz), 8.12-8.17 (1H, m).

(I-14-36);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.5Hz),2.29(3H,s),2.44-2.68(2H,m),3.86(3H,s),6.93(1H,dd,J=8.4,2.5Hz),7.06-7.16(4H,m),7.89-7.96(3H,m),8.13-8.17(1H,m). (I-14-36); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.5 Hz), 2.29 (3H, s), 2.44-2.68 (2H, m), 3.86 (3H, s), 6.93 (1H, dd, J = 8.4, 2.5 Hz), 7.06-7.16 (4H, m), 7.89-7.96 (3H, m), 8.13-8.17 (1H, m).

(I-14-37);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.37(3H,s),2.43-2.67(2H,m),3.87(3H,s),7.00(1H,dd,J=8.3,2.5Hz),7.13(1H,d,J=2.5Hz),7.17(1H,d,J=8.3Hz),7.22-7.28(1H,m),7.34(1H,d,J=7.7Hz),7.44-7.48(2H,m),7.97(1H,d,J=2.3Hz),8.17-8.20(1H,m). (I-14-37); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.37 (3H, s), 2.43-2.67 (2H, m), 3.87 (3H, s), 7.00 (1H, dd, J = 8.3, 2.5 Hz), 7.13 (1H, d, J = 2.5 Hz), 7.17 (1H, d, J = 8.3 Hz), 7.22 - 7.28 (1H, m), 7.34 (1H, d, J = 7.7 Hz), 7.44 - 7.48 (2H, m), 7.97 (1H, d, J = 2.3 Hz), 8.17-8.20 (1H, m).

(I-14-38);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.29(3H,s),2.45-2.68(2H,m),3.87(3H,s),6.94(1H,dd,J=8.3,2.4Hz),7.08(1H,d,J=2.4Hz),7.14(1H,d,J=8.3Hz),7.39(1H,t,J=8.1Hz),7.57-7.61(1H,m),7.76-7.80(1H,m),7.87(1H,t,J=1.7Hz),7.94(1H,t,J=1.0Hz),8.14-8.16(1H,m). (I-14-38); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.45-2.68 (2H, m), 3.87 (3H, s), 6.94 (1H, dd, J = 8.3, 2.4 Hz), 7.08 (1H, d, J = 2.4 Hz), 7.14 (1H, d, J = 8.3 Hz), 7.39 (1H, t, J = 8.1) Hz), 7.57-7.61 (1H, m), 7.76-7.80 (1H, m), 7.87 (1H, t, J = 1.7 Hz), 7.94 (1H, t, J = 1.0 Hz), 8.14 - 8.16 (1H , m).

(I-14-39);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.29(3H,s),2.43-2.68(2H,m),3.86(3H,s),6.93(1H,dd,J=8.4,2.4Hz),7.07(1H,d,J=2.4Hz),7.13(1H,d,J=8.4Hz),7.41(2H,d,J=8.5Hz),7.82(2H,d,J=8.5Hz),7.94(1H,d,J=2.0Hz),8.12-8.16(1H,m). (I-14-39); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.43-2.68 (2H, m), 3.86 (3H, s), 6.93 (1H, dd, J = 8.4, 2.4 Hz), 7.07 (1H, d, J = 2.4 Hz), 7.13 (1H, d, J = 8.4 Hz), 7.41 (2H, d, J = 8.5) Hz), 7.82 (2H, d, J = 8.5 Hz), 7.94 (1H, d, J = 2.0 Hz), 8.12-8.16 (1H, m).

(I-14-40);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.38(3H,s),2.44-2.66(2H,m),3.87(3H,s),7.01(1H,dd,J=8.3,2.4Hz),7.14(1H,d,J=2.4Hz),7.17(1H,d,J=8.3Hz),7.24-7.32(2H,m),7.34-7.39(1H,m),7.66(1H,d,J=8.0Hz),7.97(1H,d,J=2.3Hz),8.17-8.21(1H,m). (I-14-40); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.38 (3H, s), 2.44-2.66 (2H, m), 3.87 (3H, s), 7.01 (1H, dd, J = 8.3, 2.4 Hz), 7.14 (1H, d, J = 2.4 Hz), 7.17 (1H, d, J = 8.3 Hz), 7.24 - 7.32 (2H, m), 7.34-7.39 (1H, m), 7.66 (1H, d, J = 8.0 Hz), 7.97 (1H, d, J = 2.3 Hz), 8.17-8.21 (1H, m).

(I-14-41);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.29(3H,s),2.43-2.68(2H,m),3.86(3H,s),6.92(1H,dd,J=8.4,2.5Hz),7.07(1H,d,J=2.5Hz),7.12(1H,d,J=8.4Hz),7.58(2H,d,J=8.7Hz),7.74(2H,d,J=8.7Hz),7.94(1H,d,J=2.0Hz),8.13-8.16(1H,m). (I-14-41); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.43-2.68 (2H, m), 3.86 (3H, s), 6.92 (1H, dd, J = 8.4, 2.5 Hz), 7.07 (1H, d, J = 2.5 Hz), 7.12 (1H, d, J = 8.4 Hz), 7.58 (2H, d, J = 8.7) Hz), 7.74 (2H, d, J = 8.7 Hz), 7.94 (1H, d, J = 2.0 Hz), 8.13-8.16 (1H, m).

(I-14-42);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.33(3H,s),2.42(3H,s),2.46-2.68(2H,m),3.86(3H,s),6.96(1H,dd,J=8.5,2.4Hz),7.10(1H,d,J=2.4Hz),7.16(1H,d,J=8.5Hz),7.19-7.29(2H,m),7.44(1H,t,J=7.4Hz),7.66(1H,d,J=7.6Hz),7.95(1H,d,J=2.1Hz),8.13-8.17(1H,m). (I-14-42); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.33 (3H, s), 2.42 (3H, s), 2.46-2.68 (2H, m), 3.86 (3H, s), 6.96 (1H, dd, J = 8.5, 2.4 Hz), 7.10 (1H, d, J = 2.4 Hz), 7.16 (1H, d, J = 8.5 Hz), 7.19- 7.29 (2H, m), 7.44 (1H, t, J = 7.4 Hz), 7.66 (1H, d, J = 7.6 Hz), 7.95 (1H, d, J = 2.1 Hz), 8.13-8.17 (1H, m ).

(I-14-43);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.29(3H,s),2.38(3H,s),2.46-2.69(2H,m),3.86(3H,s),6.94(1H,dd,J=8.4,2.4Hz),7.08(1H,d,J=2.4Hz),7.16(1H,d,J=8.4Hz),7.32(1H,t,J=7.8Hz),7.42(1H,d,J=7.7Hz),7.67-7.72(2H,m),7.93(1H,d,J=2.0Hz),8.11-8.14(1H,m). (I-14-43); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.38 (3H, s), 2.46-2.69 (2H, m), 3.86 (3H, s), 6.94 (1H, dd, J = 8.4, 2.4 Hz), 7.08 (1H, d, J = 2.4 Hz), 7.16 (1H, d, J = 8.4 Hz), 7.32 ( 1H, t, J = 7.8 Hz), 7.42 (1H, d, J = 7.7 Hz), 7.67-7.72 (2H, m), 7.93 (1H, d, J = 2.0 Hz), 8.11-8.14 (1H, m ).

(I-14-44);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.29(3H,s),2.41(3H,s),2.47-2.69(2H,m),3.86(3H,s),6.92(1H,dd,J=8.5,2.3Hz),7.06(1H,d,J=2.3Hz),7.15(1H,d,J=8.5Hz),7.23(2H,d,J=8.1Hz),7.79(2H,d,J=8.1Hz),7.93(1H,d,J=2.1Hz),8.08-8.12(1H,m). (I-14-44); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.41 (3H, s), 2.47-2.69 (2H, m), 3.86 (3H, s), 6.92 (1H, dd, J = 8.5, 2.3 Hz), 7.06 (1H, d, J = 2.3 Hz), 7.15 (1H, d, J = 8.5 Hz), 7.23 ( 2H, d, J = 8.1 Hz), 7.79 (2H, d, J = 8.1 Hz), 7.93 (1H, d, J = 2.1 Hz), 8.08-8.12 (1H, m).

(I-14-45);1H NMR(CDCl3)δ ppm:1.11(3H,t,J=7.5Hz),1.17(3H,t,J=7.6Hz),2.33(3H,s),2.45-2.68(3H,m),2.74-2.85(2H,m),3.86(3H,s),6.97(1H,dd,J=8.3,2.4Hz),7.11(1H,d,J=2.4Hz),7.15-7.23(2H,m),7.27(1H,d,J=7.6Hz),7.48(1H,t,J=7.6Hz),7.60(1H,d,J=7.6Hz),7.95(1H,d,J=1.8Hz),8.13-8.17(1H,m). (I-14-45); 1 H NMR (CDCl 3 ) δ ppm: 1.11 (3H, t, J = 7.5 Hz), 1.17 (3H, t, J = 7.6 Hz), 2.33 (3H, s), 2.45 -2.68 (3H, m), 2.74-2.85 (2H, m), 3.86 (3H, s), 6.97 (1H, dd, J = 8.3, 2.4 Hz), 7.11 (1H, d, J = 2.4 Hz), 7.15-7.23(2H,m), 7.27(1H,d,J=7.6Hz), 7.48(1H,t,J=7.6Hz), 7.60(1H,d,J=7.6Hz),7.95(1H,d , J = 1.8 Hz), 8.13-8.17 (1H, m).

(I-14-46);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.33(3H,s),2.45-2.67(2H,m),3.84(3H,s),3.86(3H,s),6.91(1H,t,J=7.5Hz),6.94-6.99(2H,m),7.11(1H,d,J=2.3Hz),7.18(1H,d,J=8.4Hz),7.43-7.47(1H,m),7.48-7.54(1H,m),7.95(1H,d,J=2.0Hz),8.15-8.19(1H,m). (I-14-46); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.33 (3H, s), 2.45-2.67 (2H, m), 3.84 (3H, s), 3.86 (3H, s), 6.91 (1H, t, J = 7.5 Hz), 6.94-6.99 (2H, m), 7.11 (1H, d, J = 2.3 Hz), 7.18 (1H, d, J) = 8.4 Hz), 7.43 - 7.47 (1H, m), 7.48 - 7.54 (1H, m), 7.95 (1H, d, J = 2.0 Hz), 8.15-8.19 (1H, m).

(I-14-47);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.30(3H,s),2.45-2.68(2H,m),3.81(3H,s),3.86(3H,s),6.94(1H,dd,J=8.4,2.4Hz),7.08(1H,d,J=2.4Hz),7.12-7.17(2H,m),7.31-7.38(2H,m),7.47-7.51(1H,m),7.93(1H,d,J=2.3Hz),8.12-8.16(1H,m). (I-14-47); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.30 (3H, s), 2.45-2.68 (2H, m), 3.81 (3H, s), 3.86 (3H, s), 6.94 (1H, dd, J = 8.4, 2.4 Hz), 7.08 (1H, d, J = 2.4 Hz), 7.12 - 7.17 (2H, m), 7.31 - 7.38 (2H , m), 7.47-7.51 (1H, m), 7.93 (1H, d, J = 2.3 Hz), 8.12-8.16 (1H, m).

(I-14-48);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.29(3H,s),2.44-2.69(2H,m),3.86(6H,s),6.88-6.95(3H,m),7.07(1H,d,J=2.5Hz),7.15(1H,d,J=8.2Hz),7.86(2H,d,J=8.9Hz),7.93(1H,d,J=1.8Hz),8.12-8.15(1H,m). (I-14-48); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.44-2.69 (2H, m), 3.86 (6H, s), 6.88-6.95 (3H, m), 7.07 (1H, d, J = 2.5 Hz), 7.15 (1H, d, J = 8.2 Hz), 7.86 (2H, d, J = 8.9 Hz), 7.93 ( 1H, d, J = 1.8 Hz), 8.12 - 8.15 (1H, m).

(I-14-49);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),1.40(3H,t,J=7.0Hz),2.35(3H,s),2.44-2.68(2H,m),3.85(3H,s),4.08(2H,q,J=7.0Hz),6.85-6.99(3H,m),7.11(1H,d,J=2.3Hz),7.18(1H,d,J=8.2Hz),7.38(1H,dd,J=7.9,1.8Hz),7.44-7.50(1H,m),7.95(1H,d,J=2.1Hz),8.17-8.19(1H,m). (I-14-49); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 1.40 (3H, t, J = 7.0 Hz), 2.35 (3H, s), 2.44 -2.68 (2H, m), 3.85 (3H, s), 4.08 (2H, q, J = 7.0 Hz), 6.85-6.99 (3H, m), 7.11 (1H, d, J = 2.3 Hz), 7.18 ( 1H, d, J = 8.2 Hz), 7.38 (1H, dd, J = 7.9, 1.8 Hz), 7.44 - 7.50 (1H, m), 7.95 (1H, d, J = 2.1 Hz), 8.17-8.19 (1H , m).

(I-14-50);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.5Hz),2.32(3H,s),2.44(3H,s),2.46-2.68(2H,m),3.86(3H,s),6.95(1H,dd,J=8.4,2.4Hz),7.08-7.13(2H,m),7.17(1H,d,J=8.4Hz),7.27(1H,d,J=7.9Hz),7.51(1H,t,J=7.9Hz),7.69(1H,d,J=7.9Hz),7.94(1H,d,J=2.3Hz),8.14-8.17(1H,m). (I-14-50); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.5 Hz), 2.32 (3H, s), 2.44 (3H, s), 2.46-2.68 (2H, m), 3.86 (3H, s), 6.95 (1H, dd, J = 8.4, 2.4 Hz), 7.08-7.13 (2H, m), 7.17 (1H, d, J = 8.4 Hz), 7.27 (1H, d , J = 7.9 Hz), 7.51 (1H, t, J = 7.9 Hz), 7.69 (1H, d, J = 7.9 Hz), 7.94 (1H, d, J = 2.3 Hz), 8.14 - 8.17 (1H, m ).

(I-14-51);1H NMR(CDCl3)δ ppm:1.17(3H,t,J=7.6Hz),2.29(3H,s),2.43-2.68(2H,m),3.87(3H,s),6.93(1H,dd,J=8.4,2.4Hz),7.09(1H,d,J=2.4Hz),7.12(1H,d,J=8.4Hz),7.75(2H,d,J=8.8Hz),7.95(1H,d,J=2.0Hz),7.99(2H,d,J=8.8Hz),8.15-8.17(1H,m). (I-14-51); 1 H NMR (CDCl 3 ) δ ppm: 1.17 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.43-2.68 (2H, m), 3.87 (3H, s), 6.93 (1H, dd, J = 8.4, 2.4 Hz), 7.09 (1H, d, J = 2.4 Hz), 7.12 (1H, d, J = 8.4 Hz), 7.75 (2H, d, J = 8.8) Hz), 7.95 (1H, d, J = 2.0 Hz), 7.99 (2H, d, J = 8.8 Hz), 8.15-8.17 (1H, m).

(I-14-52);1H NMR(CDCl3)δ ppm:1.15(3H,t,J=7.5Hz),2.41-2.66(5H,m),3.87(3H,s),6.69(1H,d,J=7.6Hz),7.05(1H,dd,J=8.3,2.4Hz),7.14-7.21(2H,m),7.54(1H,t,J=7.6Hz),7.65(1H,t,J=7.6Hz),8.00-8.07(2H,m),8.20-8.24(1H,m). (I-14-52); 1 H NMR (CDCl 3 ) δ ppm: 1.15 (3H, t, J = 7.5 Hz), 2.41-2.66 (5H, m), 3.87 (3H, s), 6.69 (1H, d, J = 7.6 Hz), 7.05 (1H, dd, J = 8.3, 2.4 Hz), 7.14 - 7.21 (2H, m), 7.54 (1H, t, J = 7.6 Hz), 7.65 (1H, t, J) =7.6 Hz), 8.00-8.07 (2H, m), 8.20-8.24 (1H, m).

(I-14-53);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.31(3H,s),2.44-2.69(2H,m),3.88(3H,s),6.94(1H,dd,J=8.4,2.4Hz),7.09(1H,d,J=2.4Hz),7.13(1H,d,J=8.4Hz),7.95(1H,d,J=2.0Hz),8.06(2H,d,J=8.6Hz),8.15-8.17(1H,m),8.29(2H,d,J=8.6Hz). (I-14-53); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.31 (3H, s), 2.44-2.69 (2H, m), 3.88 (3H, s), 6.94 (1H, dd, J = 8.4, 2.4 Hz), 7.09 (1H, d, J = 2.4 Hz), 7.13 (1H, d, J = 8.4 Hz), 7.95 (1H, d, J = 2.0) Hz), 8.06 (2H, d, J = 8.6 Hz), 8.15-8.17 (1H, m), 8.29 (2H, d, J = 8.6 Hz).

(I-14-54);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.5Hz),2.36(3H,s),2.43-2.66(2H,m),3.87(3H,s),7.00-7.07(2H,m),7.15-7.19(2H,m),7.49(1H,t,J=7.8Hz),7.64(1H,t,J=7.8Hz),7.77(1H,d,J=7.8Hz),7.99(1H,d,J=2.0Hz),8.17-8.21(1H,m). (I-14-54); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.5 Hz), 2.36 (3H, s), 2.43-2.66 (2H, m), 3.87 (3H, s), 7.00-7.07 (2H, m), 7.15-7.19 (2H, m), 7.49 (1H, t, J = 7.8 Hz), 7.64 (1H, t, J = 7.8 Hz), 7.77 (1H, d , J = 7.8 Hz), 7.99 (1H, d, J = 2.0 Hz), 8.17 - 8.21 (1H, m).

(I-14-55);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.30(3H,s),2.44-2.69(2H,m),3.87(3H,s),6.93(1H,dd,J=8.4,2.4Hz),7.08(1H,d,J=2.4Hz),7.14(1H,d,J=8.4Hz),7.71(2H,d,J=8.3Hz),7.94(1H,d,J=2.0Hz),8.00(2H,d,J=8.3Hz),8.08-8.12(1H,m). (I-14-55); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.30 (3H, s), 2.44-2.69 (2H, m), 3.87 (3H, s), 6.93 (1H, dd, J = 8.4, 2.4 Hz), 7.08 (1H, d, J = 2.4 Hz), 7.14 (1H, d, J = 8.4 Hz), 7.71 (2H, d, J = 8.3) Hz), 7.94 (1H, d, J = 2.0 Hz), 8.00 (2H, d, J = 8.3 Hz), 8.08-8.12 (1H, m).

(I-14-56);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.4Hz),2.29(3H,s),2.44-2.68(2H,m),3.87(3H,s),6.94(1H,dd,J=8.5,2.5Hz),7.08(1H,d,J=2.5Hz),7.13(1H,d,J=8.5Hz),7.26(2H,d,J=8.0Hz),7.92-7.97(3H,m),8.12-8.14(1H,m). (I-14-56); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.4 Hz), 2.29 (3H, s), 2.44-2.68 (2H, m), 3.87 (3H, s), 6.94 (1H, dd, J = 8.5, 2.5 Hz), 7.08 (1H, d, J = 2.5 Hz), 7.13 (1H, d, J = 8.5 Hz), 7.26 (2H, d, J = 8.0) Hz), 7.92-7.97 (3H, m), 8.12-8.14 (1H, m).

(I-14-57);1H NMR(CDCl3)δ ppm:1.15(3H,t,J=7.5Hz),2.37(3H,s),2.42-2.66(2H,m),3.86(3H,s),6.95(2H,t,J=8.3Hz),7.00(1H,dd,J=8.4,2.4Hz),7.12(1H,d,J=2.4Hz),7.15(1H,d,J=8.4Hz),7.44-7.53(1H,m),7.97(1H,d,J=2.3Hz),8.19-8.22(1H,m). (I-14-57); 1 H NMR (CDCl 3 ) δ ppm: 1.15 (3H, t, J = 7.5 Hz), 2.37 (3H, s), 2.42-2.66 (2H, m), 3.86 (3H, s), 6.95 (2H, t, J = 8.3 Hz), 7.00 (1H, dd, J = 8.4, 2.4 Hz), 7.12 (1H, d, J = 2.4 Hz), 7.15 (1H, d, J = 8.4) Hz), 7.44 - 7.53 (1H, m), 7.97 (1H, d, J = 2.3 Hz), 8.19-8.22 (1H, m).

(I-14-58);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.5Hz),2.37(3H,s),2.43-2.66(2H,m),3.87(3H,s),7.01(1H,dd,J=8.4,2.5Hz),7.10-7.22(4H,m),7.62(1H,dd,J=7.9,1.8Hz),7.98(1H,d,J=2.3Hz),8.20-8.24(1H,m). (I-14-58); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.5 Hz), 2.37 (3H, s), 2.43-2.66 (2H, m), 3.87 (3H, s), 7.01 (1H, dd, J=8.4, 2.5 Hz), 7.10-7.22 (4H, m), 7.62 (1H, dd, J=7.9, 1.8 Hz), 7.98 (1H, d, J = 2.3 Hz) ), 8.20-8.24 (1H, m).

(I-14-59);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.35(3H,s),2.42-2.66(2H,m),3.87(3H,s),6.99(1H,dd,J=8.3,2.4Hz),7.11-7.16(2H,m),7.23(1H,dd,J=8.6,1.9Hz),7.31(1H,d,J=8.6Hz),7.48(1H,d,J=1.9Hz),7.97(1H,d,J=1.8Hz),8.16-8.21(1H,m). (I-14-59); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.35 (3H, s), 2.42-2.66 (2H, m), 3.87 (3H, s), 6.99 (1H, dd, J = 8.3, 2.4 Hz), 7.11-7.16 (2H, m), 7.23 (1H, dd, J = 8.6, 1.9 Hz), 7.31 (1H, d, J = 8.6 Hz) ), 7.48 (1H, d, J = 1.9 Hz), 7.97 (1H, d, J = 1.8 Hz), 8.16 - 8.21 (1H, m).

(I-14-60);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.36(3H,s),2.43-2.67(2H,m),3.87(3H,s),7.02(1H,dd,J=8.5,2.3Hz),7.13-7.18(2H,m),7.31(1H,d,J=2.3Hz),7.36-7.45(2H,m),7.96(1H,d,J=2.1Hz),8.16-8.20(1H,m). (I-14-60); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.36 (3H, s), 2.43-2.67 (2H, m), 3.87 (3H, s), 7.02 (1H, dd, J = 8.5, 2.3 Hz), 7.13-7.18 (2H, m), 7.31 (1H, d, J = 2.3 Hz), 7.36-7.45 (2H, m), 7.96 (1H) , d, J = 2.1 Hz), 8.16-8.20 (1H, m).

(I-14-61);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.5Hz),2.45-2.63(5H,m),3.85(3H,s),7.02(1H,dd,J=8.4,2.4Hz),7.12(1H,d,J=2.4Hz),7.19(1H,d,J=8.4Hz),7.29-7.32(3H,m),7.98(1H,d,J=2.0Hz),8.26-8.29(1H,m). (I-14-61); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.5 Hz), 2.45-2.63 (5H, m), 3.85 (3H, s), 7.02 (1H, Dd, J = 8.4, 2.4 Hz), 7.12 (1H, d, J = 2.4 Hz), 7.19 (1H, d, J = 8.4 Hz), 7.29-7.32 (3H, m), 7.98 (1H, d, J) =2.0Hz), 8.26-8.29 (1H, m).

(I-14-62);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.29(3H,s),2.43-2.67(2H,m),3.87(3H,s),6.94(1H,dd,J=8.3,2.4Hz),7.08(1H,d,J=2.4Hz),7.12(1H,d,J=8.3Hz),7.52(1H,d,J=8.5Hz),7.70(1H,dd,J=8.5,2.2Hz),7.94(1H,d,J=2.2Hz),7.96(1H,d,J=1.8Hz),8.13-8.16(1H,m). (I-14-62); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.43-2.67 (2H, m), 3.87 (3H, s), 6.94 (1H, dd, J = 8.3, 2.4 Hz), 7.08 (1H, d, J = 2.4 Hz), 7.12 (1H, d, J = 8.3 Hz), 7.52 (1H, d, J = 8.5) Hz), 7.70 (1H, dd, J = 8.5, 2.2 Hz), 7.94 (1H, d, J = 2.2 Hz), 7.96 (1H, d, J = 1.8 Hz), 8.13-8.16 (1H, m).

(I-14-63);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.29(3H,s),2.43-2.68(2H,m),3.87(3H,s),6.96(1H,dd,J=8.5,2.4Hz),7.10(1H,d,J=2.4Hz),7.12(1H,d,J=8.5Hz),7.60(1H,t,J=2.0Hz),7.75(2H,d,J=2.0Hz),7.95(1H,d,J=2.3Hz),8.15-8.19(1H,m). (I-14-63); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.29 (3H, s), 2.43-2.68 (2H, m), 3.87 (3H, s), 6.96 (1H, dd, J = 8.5, 2.4 Hz), 7.10 (1H, d, J = 2.4 Hz), 7.12 (1H, d, J = 8.5 Hz), 7.60 (1H, t, J = 2.0) Hz), 7.75 (2H, d, J = 2.0 Hz), 7.95 (1H, d, J = 2.3 Hz), 8.15-8.19 (1H, m).

(I-14-64);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.08(6H,s),2.40(3H,s),2.44-2.65(2H,m),3.85(3H,s),6.98-7.04(3H,m),7.13(1H,d,J=2.5Hz),7.18(1H,d,J=8.4Hz),7.23(1H,t,J=7.6Hz),7.98(1H,d,J=2.3Hz),8.21-8.24(1H,m). (I-14-64); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.08 (6H, s), 2.40 (3H, s), 2.44-2.65 (2H, m), 3.85 (3H, s), 6.98-7.04 (3H, m), 7.13 (1H, d, J = 2.5 Hz), 7.18 (1H, d, J = 8.4 Hz), 7.23 (1H, t, J =7.6 Hz), 7.98 (1H, d, J = 2.3 Hz), 8.21-8.24 (1H, m).

(I-14-65);1H NMR(CDCl3)δ ppm:1.15(3H,t,J=7.6Hz),2.44(3H,s),2.45-2.65(2H,m),3.69(6H,s),3.84(3H,s),6.50(2H,d,J=8.4Hz),7.02(1H,dd,J=8.4,2.4Hz),7.15(1H,d,J=2.4Hz),7.18(1H,d,J=8.4Hz),7.30(1H,t,J=8.4Hz),7.98(1H,d,J=2.0Hz),8.22-8.25(1H,m). (I-14-65); 1 H NMR (CDCl 3 ) δ ppm: 1.15 (3H, t, J = 7.6 Hz), 2.44 (3H, s), 2.45-2.65 (2H, m), 3.69 (6H, s), 3.84 (3H, s), 6.50 (2H, d, J = 8.4 Hz), 7.02 (1H, dd, J = 8.4, 2.4 Hz), 7.15 (1H, d, J = 2.4 Hz), 7.18 ( 1H, d, J = 8.4 Hz), 7.30 (1H, t, J = 8.4 Hz), 7.98 (1H, d, J = 2.0 Hz), 8.22 - 8.25 (1H, m).

(I-14-66);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.37(3H,s),2.44-2.66(2H,m),3.29(3H,s),3.77(3H,s),4.61(1H,d,J=5.9Hz),4.64(1H,d,J=5.9Hz),7.05(1H,dd,J=8.5,2.4Hz),7.15(1H,d,J=2.4Hz),7.23(1H,d,J=8.5Hz),7.98(1H,d,J=2.1Hz),8.25-8.28(1H,m). (I-14-66); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.37 (3H, s), 2.44-2.66 (2H, m), 3.29 (3H, s), 3.77 (3H, s), 4.61 (1H, d, J = 5.9 Hz), 4.64 (1H, d, J = 5.9 Hz), 7.05 (1H, dd, J = 8.5, 2.4 Hz), 7.15 ( 1H, d, J = 2.4 Hz), 7.23 (1H, d, J = 8.5 Hz), 7.98 (1H, d, J = 2.1 Hz), 8.25-8.28 (1H, m).

(I-14-67);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.37-2.65(5H,m),3.85(3H,s),6.93(2H,d,J=7.8Hz),7.09(1H,dd,J=8.4,2.3Hz),7.18-7.28(3H,m),7.33(2H,t,J=7.8Hz),8.00(1H,d,J=2.3Hz),8.17-8.21(1H,m). (I-14-67); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.37-2.65 (5H, m), 3.85 (3H, s), 6.93 (2H, d, J = 7.8 Hz), 7.09 (1H, dd, J = 8.4, 2.3 Hz), 7.18-7.28 (3H, m), 7.33 (2H, t, J = 7.8 Hz), 8.00 (1H, d, J) =2.3Hz), 8.17-8.21 (1H, m).

(I-14-68);1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.37(3H,s),2.44-2.66(2H,m),3.29(3H,s),3.77(3H,s),4.61(1H,d,J=5.9Hz),4.64(1H,d,J=5.9Hz),7.05(1H,dd,J=8.5,2.4Hz),7.15(1H,d,J=2.4Hz),7.23(1H,d,J=8.5Hz),7.98(1H,d,J=2.1Hz),8.24-8.27(1H,m). (I-14-68); 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.37 (3H, s), 2.44-2.66 (2H, m), 3.29 (3H, s), 3.77 (3H, s), 4.61 (1H, d, J = 5.9 Hz), 4.64 (1H, d, J = 5.9 Hz), 7.05 (1H, dd, J = 8.5, 2.4 Hz), 7.15 ( 1H, d, J = 2.4 Hz), 7.23 (1H, d, J = 8.5 Hz), 7.98 (1H, d, J = 2.1 Hz), 8.24 - 8.27 (1H, m).

(I-14-69);1H NMR(CDCl3)δ ppm:1.21(3H,t,J=7.6Hz),2.43-2.67(8H,m),3.84(3H,s),7.10(1H,dd,J=8.4,2.4Hz),7.19(1H,d,J=2.4Hz),7.28(1H,d,J=8.4Hz),7.99(1H,d,J=2.0Hz),8.15-8.18(1H,m). (I-14-69); 1 H NMR (CDCl 3 ) δ ppm: 1.21 (3H, t, J = 7.6 Hz), 2.43-2.67 (8H, m), 3.84 (3H, s), 7.10 (1H, Dd, J = 8.4, 2.4 Hz), 7.19 (1H, d, J = 2.4 Hz), 7.28 (1H, d, J = 8.4 Hz), 7.99 (1H, d, J = 2.0 Hz), 8.15-8.18 ( 1H, m).

(I-14-70);1H NMR(CDCl3)δ ppm:1.08(3H,t,J=7.6Hz),2.25-2.52(2H,m),2.55(3H,s),3.82(3H,s),6.82(1H,dd,J=8.4,2.5Hz),6.92(1H,d,J=2.5Hz),7.02(1H,d,J=8.4Hz),7.40(4H,d,J=4.5Hz),7.56-7.62(1H,m),8.02(1H,d,J=2.0Hz),8.28-8.32(1H,m). (I-14-70); 1 H NMR (CDCl 3 ) δ ppm: 1.08 (3H, t, J = 7.6 Hz), 2.25-2.52 (2H, m), 2.55 (3H, s), 3.82 (3H, s), 6.82 (1H, dd, J = 8.4, 2.5 Hz), 6.92 (1H, d, J = 2.5 Hz), 7.02 (1H, d, J = 8.4 Hz), 7.40 (4H, d, J = 4.5) Hz), 7.56-7.62 (1H, m), 8.02 (1H, d, J = 2.0 Hz), 8.28-8.32 (1H, m).

(I-14-71);1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.10(3H,s),2.41-2.51(1H,m),2.53-2.64(1H,m),3.74(3H,s),3.91(3H,s),7.02(1H,dd,J=8.4,2.3Hz),7.09(1H,d,J=8.4Hz),7.15(1H,d,J=2.3Hz),7.99(1H,d,J=2.2Hz),8.27-8.29(1H,m). (I-14-71); 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.10 (3H, s), 2.41-2.51 (1H, m), 2.53-2.64 ( 1H, m), 3.74 (3H, s), 3.91 (3H, s), 7.02 (1H, dd, J = 8.4, 2.3 Hz), 7.09 (1H, d, J = 8.4 Hz), 7.15 (1H, d , J = 2.3 Hz), 7.99 (1H, d, J = 2.2 Hz), 8.27-8.29 (1H, m).

製造例15 Manufacturing Example 15

4-(2-乙基-4-(3-氯-5-三氟甲基吡啶-2-基氧基)苯基)-2,6-二甲基-5-苄氧基-3(2H)-嗒酮(化合物(I-15-1))的合成 4-(2-Ethyl-4-(3-chloro-5-trifluoromethylpyridin-2-yloxy)phenyl)-2,6-dimethyl-5-benzyloxy-3 (2H )-despair Synthesis of ketone (compound (I-15-1))

將化合物(I-7)300mg、苄基溴(benzyl bromide)128mg、碳酸銫267mg及丙酮10ml的混合溶液在加熱回流下攪拌3小時。將該反應液冷卻至室溫後以精製矽藻土過濾,將濾液減壓濃縮。將殘渣以氧化矽凝膠管柱層析法(己烷:乙酸乙酯=2:1)精製,獲得油狀的化合物(I-15-1)324mg。 A mixed solution of 300 mg of the compound (I-7), 128 mg of benzyl bromide, 267 mg of cesium carbonate and 10 ml of acetone was stirred under reflux with heating for 3 hours. After cooling the reaction mixture to room temperature, it was filtered with purified celite, and the filtrate was concentrated under reduced pressure. The residue was purified by yttrium gel column chromatography (hexane: ethyl acetate = 2:1) to afford 324 mg of Compound (I-15-1) as an oil.

1H NMR(CDCl3)δ ppm:1.18(3H,t,J=7.6Hz),2.31(3H,s),2.44-2.68(2H,m),3.77(3H,s),4.49(1H,d,J=11.2Hz),4.53(1H,d,J=11.2Hz),7.06-7.14(3H,m),7.18(1H,d,J=2.3Hz),7.27-7.34(4H,m),7.99(1H,d,J=2.3Hz),8.24-8.26(1H,m). 1 H NMR (CDCl 3 ) δ ppm: 1.18 (3H, t, J = 7.6 Hz), 2.31 (3H, s), 2.44-2.68 (2H, m), 3.77 (3H, s), 4.49 (1H, d , J = 11.2 Hz), 4.53 (1H, d, J = 11.2 Hz), 7.06 - 7.14 (3H, m), 7.18 (1H, d, J = 2.3 Hz), 7.27-7.34 (4H, m), 7.99 (1H, d, J = 2.3 Hz), 8.24 - 8.26 (1H, m).

使用2-硝基苄基氯取代苄基溴,依照製造例15而獲得4-(2-乙基-4-(3-氯-5-三氟甲基吡啶-2-基氧基)苯基)-2,6-二甲基-5-(2-硝基苄氧基)-3(2H)-嗒酮(化合物(I-15-2))。 4-(2-ethyl-4-(3-chloro-5-trifluoromethylpyridin-2-yloxy)phenyl was obtained according to Preparation 15 using 2-nitrobenzyl chloride in place of benzyl bromide. -2,6-Dimethyl-5-(2-nitrobenzyloxy)-3(2H)-oxime Ketone (compound (I-15-2)).

1H NMR(CDCl3)δ ppm:1.19(3H,t,J=7.6Hz),2.34(3H,s),2.45-2.69(2H,m),3.78(3H,s),4.98(2H,s),6.99(1H,dd,J=8.4,2.4Hz),7.14(1H,d,J=2.4Hz),7.19(1H,d,J=8.4Hz),7.48(1H,t,J=7.8Hz),7.52(1H,d,J=7.8Hz),7.60-7.66(1H,m),7.97(1H,d,J=1.8Hz),8.08(1H,dd,J=7.8,1.1Hz),8.24-8.26(1H,m). 1 H NMR (CDCl 3 ) δ ppm: 1.19 (3H, t, J = 7.6 Hz), 2.34 (3H, s), 2.45-2.69 (2H, m), 3.78 (3H, s), 4.98 (2H, s ), 6.99 (1H, dd, J = 8.4, 2.4 Hz), 7.14 (1H, d, J = 2.4 Hz), 7.19 (1H, d, J = 8.4 Hz), 7.48 (1H, t, J = 7.8 Hz) ), 7.52 (1H, d, J = 7.8 Hz), 7.60-7.66 (1H, m), 7.97 (1H, d, J = 1.8 Hz), 8.08 (1H, dd, J = 7.8, 1.1 Hz), 8.24 -8.26(1H,m).

其次將式(II)表示的化合物的製造例示於參考例1至參考例3。 Next, the production examples of the compound represented by the formula (II) are shown in Reference Example 1 to Reference Example 3.

參考例1 Reference example 1

化合物(II-1)的合成 Synthesis of Compound (II-1)

參考例1-1 Reference example 1-1

4-溴-3-乙基苯酚的合成 Synthesis of 4-bromo-3-ethylphenol

在將3-乙基苯酚25.2g溶解於三氯甲烷300ml中而成的溶液中,添加三溴化吡啶鎓(pyridinium bromide perbromide)69.27g,在室溫下攪拌30分鐘。將該反應液以水清洗(2次),以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將殘渣以氧化矽凝膠管柱層析法(己烷:乙酸乙酯=95:5)精製,得油狀的4-溴-3-乙基苯酚39.1g。 To a solution obtained by dissolving 25.2 g of 3-ethylphenol in 300 ml of chloroform, 69.27 g of pyridinium bromide perbromide was added, and the mixture was stirred at room temperature for 30 minutes. The reaction mixture was washed with water (2×), brine, evaporated The residue was purified by silica gel column chromatography (hexane: ethyl acetate=95:5) to yield 39.1 g of 4-bromo-3-ethylphenol as an oil.

1H NMR(CDCl3)δ ppm:1.21(3H,t,J=7.6Hz),2.69(2H,q,J=7.6Hz),4.80(1H,s),6.55(1H,dd,J=8.7,3.1Hz),6.73(1H,d,J=3.1Hz),7.35(1H,d,J=8.7Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.21 (3H, t, J = 7.6 Hz), 2.69 (2H, q, J = 7.6 Hz), 4.80 (1H, s), 6.55 (1H, dd, J = 8.7 , 3.1 Hz), 6.73 (1H, d, J = 3.1 Hz), 7.35 (1H, d, J = 8.7 Hz).

參考例1-2 Reference example 1-2

4-苄氧基-2-乙基溴苯的合成 Synthesis of 4-benzyloxy-2-ethylbromobenzene

將4-溴-3-乙基苯酚39.1g(194mmol)、苄基溴33.2g(194mmol)、碳酸鉀29.6g(214mmol)及乙腈120ml的混合溶液在加熱回流下攪拌4小時。將該反應液冷卻至室溫後過濾,將濾液在減壓下濃縮。 將殘渣以氧化矽凝膠管柱層析法(己烷:乙酸乙酯=95:5)精製,獲得油狀的4-苄氧基-2-乙基溴苯46.2g。 A mixed solution of 39.1 g (194 mmol) of 4-bromo-3-ethylphenol, 33.2 g (194 mmol) of benzyl bromide, 29.6 g (214 mmol) of potassium carbonate and 120 ml of acetonitrile was stirred under reflux for 4 hours. The reaction solution was cooled to room temperature and then filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 95:5) to afford 46.2 g of 4-benzyloxy-2-ethylbromobenzene as an oil.

1H NMR(CDCl3)δ ppm:1.21(3H,t,J=7.6Hz),2.71(2H,q,J=7.6Hz),5.03(2H,s),6.68(1H,dd,J=8.7,3.1Hz),6.87(1H,d,J=3.1Hz),7.30-7.45(6H,m). 1 H NMR (CDCl 3 ) δ ppm: 1.21 (3H, t, J = 7.6 Hz), 2.71 (2H, q, J = 7.6 Hz), 5.03 (2H, s), 6.68 (1H, dd, J = 8.7 , 3.1Hz), 6.87 (1H, d, J = 3.1Hz), 7.30-7.45 (6H, m).

參考例1-3 Reference example 1-3

4-苄氧基-2-乙基苯基硼酸的合成 Synthesis of 4-benzyloxy-2-ethylphenylboronic acid

將4-苄氧基-2-乙基溴苯46.2g溶解於無水THF 180ml中而成的溶液冷卻至-70℃,緩緩滴入正丁基鋰(1.64mol/L,己烷溶液)106ml。滴入結束後在-50至-60℃攪拌3小時後,緩緩滴入硼酸三甲酯35ml。將該反應液在-78℃下攪拌3小時後,在室溫下再攪拌一夜。在該反應液添加4N鹽酸136ml,攪拌2小時。將該反應液以MTBE萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將殘渣以氧化矽凝膠管柱層析法精製,獲得固體的4-苄氧基-2-乙基苯基硼酸3.83g。 A solution of 46.2 g of 4-benzyloxy-2-ethylbromobenzene dissolved in 180 ml of anhydrous THF was cooled to -70 ° C, and slowly dropped into n-butyllithium (1.64 mol/L, hexane solution) 106 ml. . After the completion of the dropwise addition, the mixture was stirred at -50 to -60 ° C for 3 hours, and then 35 ml of trimethyl borate was gradually added dropwise. After the reaction mixture was stirred at -78 ° C for 3 hours, it was stirred at room temperature overnight. To the reaction liquid, 136 ml of 4N hydrochloric acid was added, and the mixture was stirred for 2 hours. The reaction mixture was extracted twice with EtOAc (EtOAc)EtOAc. The residue was purified by cerium oxide gel column chromatography to give 3.83 g of 4-benzyloxy-2-ethylphenylboronic acid as a solid.

1H NMR(CDCl3)δ ppm:1.34(3H,t,J=7.5Hz),3.20(3H,q,J=7.5Hz),5.14(2H,s),6.89-6.96(2H,m),7.31-7.50(5H,m),8.18(1H,d,J=8.2Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.34 (3H, t, J = 7.5 Hz), 3.20 (3H, q, J = 7.5 Hz), 5.14 (2H, s), 6.89-6.96 (2H, m), 7.31-7.50 (5H, m), 8.18 (1H, d, J = 8.2 Hz).

參考例1-4 Reference example 1-4

4-(2-乙基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮的合成 4-(2-ethyl-4-benzyloxyphenyl)-2,6-dimethyl-5-methoxy-3(2H)-indole Ketone synthesis

將4-溴-5-甲氧基-2,6-二甲基-3(2H)-嗒酮4.81g、4-苄氧基-2-乙基苯基硼酸5.82g、四(三苯膦)鈀955mg、碳駿鈉4.81g、溴化四丁基銨1.66g、1,4-二烷170ml及水50ml的混合物,在氮環境下,加熱回流下攪拌5小時。將該反應物冷卻至室溫後,以MTBE萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將殘渣以氧化矽凝膠管柱層析法(己烷:乙酸乙酯=2:1)精製,獲得油狀的4-(2-乙基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮6.91g。 4-bromo-5-methoxy-2,6-dimethyl-3(2H)-oxime 4.81 g of ketone, 5.82 g of 4-benzyloxy-2-ethylphenylboronic acid, 955 mg of tetrakis(triphenylphosphine)palladium, 4.81 g of sodium carbonate, 1.66 g of tetrabutylammonium bromide, 1,4-two A mixture of 170 ml of alkane and 50 ml of water was stirred under a nitrogen atmosphere for 5 hours under reflux. The reaction mixture was cooled to room temperature. The residue was purified by yttrium gel column chromatography (hexane: ethyl acetate = 2:1) to afford 4-(2-ethyl-4-benzyloxyphenyl)-2. -Dimethyl-5-methoxy-3(2H)-oxime Ketone 6.91 g.

1H NMR(CDCl3)δ ppm:1.16(3H,t,J=7.6Hz),2.27(3H,s),2.37-2.59(2H,m),3.37(3H,s),3.73(3H,s),5.08(2H,s),6.85(1H,dd,J=8.5,2.6Hz),6.96(1H,d,J=2.6Hz),7.08(1H,d,J=8.5Hz),7.33(1H,t,J=7.3Hz),7.40(2H,t,J=7.3Hz),7.45(2H,d,J=7.3Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.16 (3H, t, J = 7.6 Hz), 2.27 (3H, s), 2.37-2.59 (2H, m), 3.37 (3H, s), 3.73 (3H, s ), 5.08 (2H, s), 6.85 (1H, dd, J = 8.5, 2.6 Hz), 6.96 (1H, d, J = 2.6 Hz), 7.08 (1H, d, J = 8.5 Hz), 7.33 (1H) , t, J = 7.3 Hz), 7.40 (2H, t, J = 7.3 Hz), 7.45 (2H, d, J = 7.3 Hz).

參考例1-5 Reference example 1-5

化合物(II-1)的合成 Synthesis of Compound (II-1)

在將4-(2-乙基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮7.45g溶解於乙酸40ml中而成的溶液中,添加47%溴化氫酸23ml,在100℃下攪拌3小時。將該反應液注入於冰水,以乙酸乙酯萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將所得的固體以己烷清洗,獲得化合物(II-1)5.03g。 In the 4-(2-ethyl-4-benzyloxyphenyl)-2,6-dimethyl-5-methoxy-3(2H)-oxime 7.45 g of a ketone was dissolved in 40 ml of acetic acid, and 23 ml of 47% hydrogen bromide was added thereto, followed by stirring at 100 ° C for 3 hours. The reaction mixture was poured into ice water, and the mixture was evaporated to ethylamine. The obtained solid was washed with hexane to obtain 5.03 g of Compound (II-1).

1H NMR(DMSO-d6)δ ppm:0.99(3H,t,J=7.6Hz),2.20(3H,s),2.26(2H,q,J=7.6Hz),3.55(3H,s),6.61(1H,dd,J=8.3,2.5Hz),6.70(1H,d,J=2.5Hz),6.79(1H,d,J=8.3Hz),9.36(1H,br s),9.82(1H,s). 1 H NMR (DMSO-d 6 ) δ ppm: 0.99 (3H, t, J = 7.6 Hz), 2.20 (3H, s), 2.26 (2H, q, J = 7.6 Hz), 3.55 (3H, s), 6.61 (1H, dd, J = 8.3, 2.5 Hz), 6.70 (1H, d, J = 2.5 Hz), 6.79 (1H, d, J = 8.3 Hz), 9.36 (1H, br s), 9.82 (1H, s).

參考例2 Reference example 2

化合物(II-2)的合成 Synthesis of Compound (II-2)

參考例2-1 Reference example 2-1

4-(2-甲基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮的合成 4-(2-Methyl-4-benzyloxyphenyl)-2,6-dimethyl-5-methoxy-3(2H)-indole Ketone synthesis

使用4-苄氧基-2-甲基苯基硼酸取代4-苄氧基-2-乙基苯基硼酸,依照參考例1-4而獲得4-(2-甲基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮。 Substituting 4-benzyloxy-2-methylphenylboronic acid for 4-benzyloxy-2-ethylphenylboronic acid gave 4-(2-methyl-4-benzyloxy) according to Reference Example 1-4. Phenyl)-2,6-dimethyl-5-methoxy-3(2H)-oxime ketone.

1H NMR(CDCl3)δ ppm:2.18(3H,s),2.27(3H,s),3.36(3H,s),3.73(3H,s),5.07(2H,s),6.85(1H,dd,J=8.5,2.7Hz),6.90(1H,d,J=2.7Hz),7.10(1H,d,J=8.5Hz),7.30-7.46(5H,m). 1 H NMR (CDCl 3 ) δ ppm: 2.18 (3H, s), 2.27 (3H, s), 3.36 (3H, s), 3.73 (3H, s), 5.07 (2H, s), 6.85 (1H, dd , J = 8.5, 2.7 Hz), 6.90 (1H, d, J = 2.7 Hz), 7.10 (1H, d, J = 8.5 Hz), 7.30-7.46 (5H, m).

參考例2-2 Reference example 2-2

化合物(II-2)的合成 Synthesis of Compound (II-2)

使用4-(2-甲基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮取代4-(2-乙基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮,依照參考例1-5而獲得化合物II-2。 4-(2-Methyl-4-benzyloxyphenyl)-2,6-dimethyl-5-methoxy-3(2H)-oxime Ketone-substituted 4-(2-ethyl-4-benzyloxyphenyl)-2,6-dimethyl-5-methoxy-3(2H)-oxime Ketone, Compound II-2 was obtained according to Reference Example 1-5.

1H NMR(DMSO-d6)δ ppm:1.96(3H,s),2.20(3H,s),3.55(3H,s),6.60(1H,dd,J=8.4,2.3Hz),6.67(1H,d,J=2.3Hz),6.84(1H,d,J=8.4Hz),9.35(1H,s),9.84(1H,s). 1 H NMR (DMSO-d 6 ) δ ppm: 1.96 (3H, s), 2.20 (3H, s), 3.55 (3H, s), 6.60 (1H, dd, J = 8.4, 2.3 Hz), 6.67 (1H) , d, J = 2.3 Hz), 6.84 (1H, d, J = 8.4 Hz), 9.35 (1H, s), 9.84 (1H, s).

參考例3 Reference example 3

化合物(II-3)的合成 Synthesis of Compound (II-3)

參考例3-1 Reference example 3-1

4,5-二氯-6-羥基-2-甲基-3(2H)-嗒酮的合成 4,5-Dichloro-6-hydroxy-2-methyl-3(2H)-嗒 Ketone synthesis

在將二氯丙二酸酐107g溶解於THF 200ml中而成的溶液中,在冰冷下緩緩滴入甲基聯胺29.5g。將該反應液在加熱回流下攪拌2小時後,在減壓下濃縮。將所得的固體以MTBE及丙酮清洗,獲得4,5-二氯-6-羥基-2-甲基-3(2H)-嗒酮100g。 In a solution obtained by dissolving 107 g of dichloromalonic anhydride in 200 ml of THF, 29.5 g of methylamine was slowly added dropwise under ice cooling. The reaction solution was stirred under heating and reflux for 2 hr. The obtained solid was washed with MTBE and acetone to obtain 4,5-dichloro-6-hydroxy-2-methyl-3(2H)-indole. Ketone 100g.

1H NMR(DMSO-d6)δ ppm:3.54(3H,s),12.37(1H,br s). 1 H NMR (DMSO-d 6 ) δ ppm: 3.54 (3H, s), 12.37 (1H, br s).

參考例3-2 Reference example 3-2

4,5-二氯-6-甲氧基-2-甲基-3(2H)-嗒酮的合成 4,5-Dichloro-6-methoxy-2-methyl-3(2H)-oxime Ketone synthesis

在硫酸二甲酯22.4g、碳酸銫36.8g及DMF 100ml的混合物 中,在70℃下緩緩添加4,5-二氯-6-羥基-2-甲基-3(2H)-嗒酮20g並攪拌30分鐘。將該反應液注入於冰水,將所得的固體過濾,將固體以水、MTBE依序清洗,乾燥而獲得4,5-二氯-6-甲氧基-2-甲基-3(2H)-嗒酮15.1g。 In a mixture of 22.4 g of dimethyl sulfate, 36.8 g of cesium carbonate and 100 ml of DMF, 4,5-dichloro-6-hydroxy-2-methyl-3(2H)-oxime was slowly added at 70 °C. The ketone was 20 g and stirred for 30 minutes. The reaction solution was poured into ice water, and the obtained solid was filtered, and the solid was washed successively with water and MTBE, and dried to obtain 4,5-dichloro-6-methoxy-2-methyl-3 (2H). -despair Ketone 15.1 g.

1H NMR(CDCl3)δ ppm:3.72(3H,s),3.92(3H,s). 1 H NMR (CDCl 3 ) δ ppm: 3.72 (3H, s), 3.92 (3H, s).

參考例3-3 Reference example 3-3

4-氯-5,6-二甲氧基-2-甲基-3(2H)-嗒酮的合成 4-chloro-5,6-dimethoxy-2-methyl-3(2H)-oxime Ketone synthesis

在4,5-二氯-6-甲氧基-2-甲基-3(2H)-嗒酮2.0g(9.56mmol)及甲醇20ml的混合物中,在室溫下添加28%甲氧化鈉甲醇溶液1.93g,攪拌3小時。將該反應液在減壓下濃縮。將所得的固體以水清洗,以己烷:MTBE=3:1的混合溶媒清洗,乾燥而獲得4-氯-5,6-二甲氧基-2-甲基-3(2H)-嗒酮1.22g。 In 4,5-dichloro-6-methoxy-2-methyl-3(2H)-oxime To a mixture of 2.0 g (9.56 mmol) of ketone and 20 ml of methanol, 1.93 g of a 28% sodium methoxide methanol solution was added at room temperature, followed by stirring for 3 hours. The reaction solution was concentrated under reduced pressure. The obtained solid was washed with water, washed with a mixed solvent of hexane:MTBE=3:1, and dried to give 4-chloro-5,6-dimethoxy-2-methyl-3(2H)-indole. Ketone 1.22 g.

1H NMR(CDCl3)δ ppm:3.68(3H,s),3.90(3H,s),4.06(3H,s). 1 H NMR (CDCl 3 ) δ ppm: 3.68 (3H, s), 3.90 (3H, s), 4.06 (3H, s).

參考例3-4 Reference example 3-4

4-(2-乙基-4-苄氧基苯基)-2-甲基-5,6-二甲氧基-3(2H)-嗒酮的合成 4-(2-ethyl-4-benzyloxyphenyl)-2-methyl-5,6-dimethoxy-3(2H)-indole Ketone synthesis

將4-氯-5,6-二甲氧基-2-甲基-3(2H)-嗒酮1.03g、4-苄氧基-2-乙基苯基硼酸1.42g、2-二環己基膦基-2',6'-二甲氧聯苯830mg、三 (二亞苄基丙酮)二鈀457mg、磷酸鉀4.31g及乙二醇二甲醚50ml的混合物,在氮環境下、加熱回流下攪拌11小時。將該反應物冷卻室溫後,在減壓下濃縮。在殘渣添加水,以乙酸乙酯萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將殘渣以氧化矽凝膠管柱層析法(己烷:乙酸乙酯=2:1)精製而獲得油狀的4-(2-乙基-4-苄氧基苯基)-2-甲基-5,6-二甲氧基-3(2H)-嗒酮1.75g。 4-Chloro-5,6-dimethoxy-2-methyl-3(2H)-oxime Ketone 1.03g, 4-benzyloxy-2-ethylphenylboronic acid 1.42g, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl 830mg, tris(dibenzylideneacetone) II A mixture of 457 mg of palladium, 4.31 g of potassium phosphate and 50 ml of ethylene glycol dimethyl ether was stirred under heating under reflux for 11 hours under a nitrogen atmosphere. After cooling the reaction mixture at room temperature, it was concentrated under reduced pressure. Water was added to the residue, and the mixture was evaporated. The residue was purified by cerium oxide gel column chromatography (hexane: ethyl acetate = 2:1) to give 4-(2-ethyl-4-benzyloxyphenyl)-2- Radyl-5,6-dimethoxy-3(2H)-oxime Ketone 1.75 g.

1H NMR(CDCl3)δ ppm:1.14(3H,t,J=7.5Hz),2.37-2.58(2H,m),3.56(3H,s),3.66(3H,s),3.92(3H,s),5.08(2H,s),6.85(1H,dd,J=8.5,2.7Hz),6.96(1H,d,J=2.7Hz),7.05(1H,d,J=8.5Hz),7.33(1H,t,J=7.2Hz),7.39(2H,t,J=7.2Hz),7.45(2H,d,J=7.0Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.14 (3H, t, J = 7.5 Hz), 2.37-2.58 (2H, m), 3.56 (3H, s), 3.66 (3H, s), 3.92 (3H, s ), 5.08 (2H, s), 6.85 (1H, dd, J = 8.5, 2.7 Hz), 6.96 (1H, d, J = 2.7 Hz), 7.05 (1H, d, J = 8.5 Hz), 7.33 (1H) , t, J = 7.2 Hz), 7.39 (2H, t, J = 7.2 Hz), 7.45 (2H, d, J = 7.0 Hz).

參考例3-5 Reference example 3-5

化合物(II-3)的合成 Synthesis of Compound (II-3)

使用4-(2-乙基-4-苄氧基苯基)-2-甲基-5,6-二甲氧基-3(2H)-嗒酮取代4-(2-乙基-4-苄氧基苯基)-2,6-二甲基-5-甲氧基-3(2H)-嗒酮,依照參考例1-5而獲得化合物(II-3)。 4-(2-Ethyl-4-benzyloxyphenyl)-2-methyl-5,6-dimethoxy-3(2H)-oxime Ketone-substituted 4-(2-ethyl-4-benzyloxyphenyl)-2,6-dimethyl-5-methoxy-3(2H)-oxime The ketone was obtained according to Reference Example 1-5 to give the compound (II-3).

1H NMR(CDCl3)δ ppm:1.08(3H,t,J=7.5Hz),2.32-2.49(2H,m),3.68(3H,s),3.95(3H,s),6.65(1H,dd,J=8.3,2.6Hz),6.74(1H,d,J=2.6Hz),6.90(1H,d,J=8.3Hz),8.31(1H,br s). 1 H NMR (CDCl 3 ) δ ppm: 1.08 (3H, t, J = 7.5 Hz), 2.32-2.49 (2H, m), 3.68 (3H, s), 3.95 (3H, s), 6.65 (1H, dd , J = 8.3, 2.6 Hz), 6.74 (1H, d, J = 2.6 Hz), 6.90 (1H, d, J = 8.3 Hz), 8.31 (1H, br s).

參考例4 Reference example 4

化合物(II-1)的合成 Synthesis of Compound (II-1)

參考例4-1 Reference example 4-1

2-乙基-4-甲氧基溴苯的合成 Synthesis of 2-ethyl-4-methoxybromobenzene

在將4-溴-3-乙基苯酚3.02g溶解於乙腈14ml中而成的溶液中,添加碘甲烷1.22ml及碳酸鉀3.12g,在60℃下攪拌4小時。將該反應液放冷至室溫,過濾,將濾液濃縮。將殘渣以氧化矽凝膠管柱層析法(己烷:乙酸乙酯=95:5)精製,獲得目的物2.79g。 To a solution obtained by dissolving 3.02 g of 4-bromo-3-ethylphenol in 14 ml of acetonitrile, 1.22 ml of methyl iodide and 3.12 g of potassium carbonate were added, and the mixture was stirred at 60 ° C for 4 hours. The reaction solution was cooled to room temperature, filtered, and the filtrate was concentrated. The residue was purified by yttrium gel column chromatography (hexane: ethyl acetate = 95:5) to yield 2.79 g of the object.

1H NMR(CDCl3)δ ppm:1.22(3H,t,J=7.6Hz),2.71(2H,q,J=7.6Hz),3.78(3H,s),6.62(1H,dd,J=8.7,3.0Hz),6.79(1H,d,J=3.0Hz),7.40(1H,d,J=8.7Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.22 (3H, t, J = 7.6 Hz), 2.71 (2H, q, J = 7.6 Hz), 3.78 (3H, s), 6.62 (1H, dd, J = 8.7 , 3.0Hz), 6.79 (1H, d, J = 3.0Hz), 7.40 (1H, d, J = 8.7Hz).

參考例4-2 Reference example 4-2

2-乙基-4-甲氧基苄醛的合成 Synthesis of 2-ethyl-4-methoxybenzylaldehyde

將2-乙基-4-甲氧基溴苯2.79g溶解於無水THF 13ml中而成的溶液冷卻至-70℃,緩緩滴入正丁基鋰(1.64mol/L,己烷溶液)9ml。滴入結束後在-50至-78℃攪拌1小時後,緩緩滴入DMF 2ml。將該反應液在-78℃下攪拌15分鐘後,在室溫下添加2N鹽酸20ml,再攪拌30分鐘。將該反應液以MTBE萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮而獲得目的物2.22g。 A solution of 2.79 g of 2-ethyl-4-methoxybromobenzene dissolved in 13 ml of anhydrous THF was cooled to -70 ° C, and slowly dropped into n-butyllithium (1.64 mol/L, hexane solution) 9 ml. . After stirring at -50 to -78 ° C for 1 hour after the completion of the dropwise addition, 2 ml of DMF was slowly added dropwise. After the reaction mixture was stirred at -78 ° C for 15 minutes, 20 ml of 2N hydrochloric acid was added at room temperature and stirred for 30 minutes. The reaction mixture was extracted twice with EtOAc (EtOAc) EtOAc.

1H NMR(CDCl3)δ ppm:1.27(3H,t,J=7.6Hz),3.05(2H,q,J=7.6Hz),3.88(3H,s),6.78(1H,d,J=2.6Hz),6.85(1H,dd,J=8.6,2.6Hz),7.80(1H,d,J=8.6Hz),10.13(1H,s). 1 H NMR (CDCl 3 ) δ ppm: 1.27 (3H, t, J = 7.6 Hz), 3.05 (2H, q, J = 7.6 Hz), 3.88 (3H, s), 6.78 (1H, d, J = 2.6 Hz), 6.85 (1H, dd, J = 8.6, 2.6 Hz), 7.80 (1H, d, J = 8.6 Hz), 10.13 (1H, s).

參考例4-3 Reference example 4-3

2-乙基-4-甲氧基苄醇的合成 Synthesis of 2-ethyl-4-methoxybenzyl alcohol

在將2-乙基-4-甲氧基苄醛40g溶解於乙醇200ml中而成的溶液中,將硼氫化鈉4.38g少量多次添加。將該反應液在室溫下攪拌1小時。反應結束後添加丙酮而驟冷(quench)後,在減壓下濃縮。在殘渣添加水,以乙酸乙酯萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮而獲得目的物37g。 In a solution obtained by dissolving 40 g of 2-ethyl-4-methoxybenzyl aldehyde in 200 ml of ethanol, 4.38 g of sodium borohydride was added in small portions several times. The reaction solution was stirred at room temperature for 1 hour. After completion of the reaction, acetone was added thereto, followed by quenching, followed by concentration under reduced pressure. Water was added to the residue, and the mixture was extracted twice with ethyl acetate.

1H NMR(CDCl3)δ ppm:1.25(3H,t,J=7.6Hz),2.72(2H,q,J=7.6Hz),3.81(3H,s),4.66(2H,s),6.73(1H,dd,J=8.2,2.7Hz),6.79(1H,d,J=2.7Hz),7.26(2H,d,J=8.2Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.25 (3H, t, J = 7.6 Hz), 2.72 (2H, q, J = 7.6 Hz), 3.81 (3H, s), 4.66 (2H, s), 6.73 ( 1H, dd, J = 8.2, 2.7 Hz), 6.79 (1H, d, J = 2.7 Hz), 7.26 (2H, d, J = 8.2 Hz).

參考例4-4 Reference example 4-4

2-乙基-4-甲氧基苄氯的合成 Synthesis of 2-ethyl-4-methoxybenzyl chloride

在將2-乙基-4-甲氧基苄醇37g溶解於甲苯100ml中而成的溶液中,在冰冷下滴入亞硫醯氯15.4ml。滴入結束後在室溫下攪拌2小時。將該反應液以水清洗,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮而獲得目的物38.5g。 In a solution obtained by dissolving 37 g of 2-ethyl-4-methoxybenzyl alcohol in 100 ml of toluene, 15.4 ml of sulfite chloride was added dropwise under ice cooling. After the completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours. The reaction mixture was washed with water, washed with brine, dried over anhydrous magnesium sulfate, and evaporated.

1H NMR(CDCl3)δ ppm:1.28(3H,t,J=7.6Hz),2.76(2H,q,J=7.6Hz),3.81(3H,s),4.62(2H,s),6.72(1H,dd,J=8.2,2.7Hz),6.78(1H,d,J=2.7Hz),7.25(1H,d,J=8.2Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.28 (3H, t, J = 7.6 Hz), 2.76 (2H, q, J = 7.6 Hz), 3.81 (3H, s), 4.62 (2H, s), 6.72 ( 1H, dd, J = 8.2, 2.7 Hz), 6.78 (1H, d, J = 2.7 Hz), 7.25 (1H, d, J = 8.2 Hz).

參考例4-5 Reference example 4-5

2-乙基-4-甲氧基苯乙腈的合成 Synthesis of 2-ethyl-4-methoxybenzeneacetonitrile

在將2-乙基-4-甲氧基苄氯2.12g溶解於無水DMF 5ml中而成 的溶液中添加氰化鈉0.62g,在室溫下攪拌一夜。在該反應液添加MTBE,再添加水,以MTBE萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮而獲得目的物1.99g。 2.2 g of 2-ethyl-4-methoxybenzyl chloride was dissolved in 5 ml of anhydrous DMF. To the solution was added 0.62 g of sodium cyanide, and the mixture was stirred at room temperature overnight. MTBE was added to the reaction mixture, and water was added thereto, and the mixture was extracted twice with EtOAc (EtOAc).

1H NMR(CDCl3)δ ppm:1.26(3H,t,J=7.6Hz),2.63(2H,q,J=7.6Hz),3.64(2H,s),3.81(3H,s),6.75(1H,dd,J=8.3,2.8Hz),6.79(1H,d,J=2.8Hz),7.27(3H,d,J=8.3Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.26 (3H, t, J = 7.6 Hz), 2.63 (2H, q, J = 7.6 Hz), 3.64 (2H, s), 3.81 (3H, s), 6.75 ( 1H, dd, J = 8.3, 2.8 Hz), 6.79 (1H, d, J = 2.8 Hz), 7.27 (3H, d, J = 8.3 Hz).

參考例4-6 Reference example 4-6

2-乙基-4-甲氧基苯基乙酸的合成 Synthesis of 2-ethyl-4-methoxyphenylacetic acid

在將2-乙基-4-甲氧基苯乙腈1.0g溶解於乙酸2ml中而成的溶液中添加50%硫酸水溶液4ml,在105℃下攪拌3小時。將該反應液注入於冰水,以MTBE萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮而獲得目的物1.01g。 To a solution obtained by dissolving 1.0 g of 2-ethyl-4-methoxyphenylacetonitrile in 2 ml of acetic acid, 4 ml of a 50% aqueous sulfuric acid solution was added, and the mixture was stirred at 105 ° C for 3 hours. The reaction mixture was poured into ice water, and the mixture was extracted twice with EtOAc.

1H NMR(CDCl3)δ ppm:1.21(3H,t,J=7.6Hz),2.62(2H,q,J=7.6Hz),3.62(2H,s),3.79(3H,s),6.71(1H,dd,J=8.4,2.8Hz),6.78(1H,d,J=2.8Hz),7.12(1H,d,J=8.4Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.21 (3H, t, J = 7.6 Hz), 2.62 (2H, q, J = 7.6 Hz), 3.62 (2H, s), 3.79 (3H, s), 6.71 ( 1H, dd, J = 8.4, 2.8 Hz), 6.78 (1H, d, J = 2.8 Hz), 7.12 (1H, d, J = 8.4 Hz).

參考例4-7 Reference example 4-7

4-(2-乙基-4-甲氧基苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮的合成 4-(2-ethyl-4-methoxyphenyl)-2,6-dimethyl-5-hydroxy-3(2H)-indole Ketone synthesis

將2-乙基-4-甲氧基苯基乙酸3.06g、亞硫醯氯2.3ml及甲苯15ml的混合溶液在100℃下攪拌1小時後,在減壓下濃縮。將該 混合溶液在冰冷下添加於2-(2-甲基亞聯胺基)丙烷酸乙酯2.1g、吡啶1.72ml及THF 20ml的混合溶液中。將該反應液在室溫下攪拌一夜後,添加水,以MTBE萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將使殘渣溶解於無水THF 15ml中而成的溶液,在35至40℃下添加於三級丁氧鉀5.83g及無水THF 20ml的溶液中。將該反應液在室溫下攪拌1小時後,添加2N鹽酸50ml,以MTBE萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮,將殘渣以氧化矽凝膠管柱層析法精製而獲得目的物1.41g。 A mixed solution of 3.06 g of 2-ethyl-4-methoxyphenylacetic acid, 2.3 ml of sulfinium chloride and 15 ml of toluene was stirred at 100 ° C for 1 hour, and then concentrated under reduced pressure. Will The mixed solution was added to a mixed solution of 2.1 g of ethyl 2-(2-methylimino)propanoate, 1.72 ml of pyridine and 20 ml of THF under ice cooling. After the reaction mixture was stirred at room temperature overnight, water was added, and the mixture was evaporated. A solution obtained by dissolving the residue in 15 ml of anhydrous THF was added to a solution of 5.83 g of potassium tributoxide and 20 ml of anhydrous THF at 35 to 40 °C. After the reaction mixture was stirred at room temperature for 1 hour, 50 ml of 2N hydrochloric acid was added, and the mixture was extracted twice with MTBE, washed with brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Purification by column chromatography gave 1.41 g of the object.

1H NMR(CDCl3)δ ppm:1.11(3H,t,J=7.6Hz),2.32(3H,s),2.35-2.55(2H,m),3.74(3H,s),3.84(3H,s),5.54(1H,s),6.84(1H,dd,J=8.5,2.6Hz),6.94(1H,d,J=2.6Hz),7.05(1H,d,J=8.5Hz). 1 H NMR (CDCl 3 ) δ ppm: 1.11 (3H, t, J = 7.6 Hz), 2.32 (3H, s), 2.35-2.55 (2H, m), 3.74 (3H, s), 3.84 (3H, s ), 5.54 (1H, s), 6.84 (1H, dd, J = 8.5, 2.6 Hz), 6.94 (1H, d, J = 2.6 Hz), 7.05 (1H, d, J = 8.5 Hz).

參考例4-8 Reference example 4-8

化合物(II-1)的合成 Synthesis of Compound (II-1)

在將4-(2-乙基-4-甲氧基苯基)-2,6-二甲基-5-羥基-3(2H)-嗒酮1.22g溶解於乙酸5ml中而成的溶液中,添加47%溴化氫酸5ml,在110℃下攪拌12小時。將該反應液注入於冰水,以乙酸乙酯萃取2次,以飽和食鹽水清洗,以無水硫酸鎂乾燥,在減壓下濃縮。將所得的固體以己烷清洗而獲得化合物(II-1)1.07g。 In the 4-(2-ethyl-4-methoxyphenyl)-2,6-dimethyl-5-hydroxy-3(2H)-oxime A solution of 1.22 g of ketone dissolved in 5 ml of acetic acid was added to 5 ml of 47% hydrogen bromide, and the mixture was stirred at 110 ° C for 12 hours. The reaction mixture was poured into ice water, and the mixture was evaporated to ethylamine. The obtained solid was washed with hexane to obtain 1.07 g of Compound (II-1).

其次表示製劑例。 Next, the formulation examples are shown.

製劑例1 Formulation Example 1

水合劑 Hydrating agent

將上述成分混合粉碎而得水合劑。 The above components are mixed and pulverized to obtain a hydrating agent.

代替化合物(I-1),以同樣的方式得到化合物(I-2)至化合物(I-13)、化合物(I-14-1)至化合物(I-14-71)、化合物(I-15-1)至化合物(I-15-2)的各自的水合劑。 Substituting the compound (I-1), the compound (I-2) to the compound (I-13), the compound (I-14-1) to the compound (I-14-71), and the compound (I-15) are obtained in the same manner. -1) to the respective hydrating agents of the compound (I-15-2).

製劑例2 Formulation Example 2

粒劑 Granule

將上述成分混合,加水並混合捏揉造粒/乾燥而得粒劑。 The above ingredients are mixed, water is added and kneaded and granulated/dried to obtain granules.

代替化合物(I-1),以同樣的方式獲得化合物(I-2)至化合物(I-13)、化合物(I-14-1)至化合物(I-14-71)、化合物(I-15-1)至化合物(I-15-2)的各自的粒劑。 Substituting the compound (I-1), the compound (I-2) to the compound (I-13), the compound (I-14-1) to the compound (I-14-71), and the compound (I-15) are obtained in the same manner. -1) to the respective granules of the compound (I-15-2).

製劑例3 Formulation Example 3

可流動性劑 Flowability agent

將上述成分混合,以濕式粉碎法加以微粉碎而得可流動性劑。 代替化合物(I-1),以同樣的方式得化合物(I-2)至化合物(I-13)、化合物(I-14-1)至化合物(I-14-71)、化合物(I-15-1)至化合物(I-15-2)的各自的可流動性劑。 The above components are mixed and finely pulverized by a wet pulverization method to obtain a flowable agent. Substituting the compound (I-1), the compound (I-2) to the compound (I-13), the compound (I-14-1) to the compound (I-14-71), and the compound (I-15) are obtained in the same manner. -1) to respective flowable agents of the compound (I-15-2).

試驗例1 旱田發芽後處理試驗 Test Example 1 Post-emergence treatment test in dry land

在直徑8cm、深度6.5cm的塑膠杯中,充填市售的育苗培土,在該杯中播種稗的種子,覆土約0.5cm後,在溫室內栽培一定的期間。植物生長到1至2葉期時,將含有本發明化合物的藥劑稀釋液以一定的處理藥量均勻撒布於植物全體。又,藥劑稀釋液是藉由將本發明化合物的一定量溶解於吐溫乳化劑20(tween 20,聚氧基乙烯去水山梨醇脂肪酸酯,MP Biomedicals公司製)的二甲基甲醯胺溶液(2%)中,以去離子水稀釋而調製。將藥劑處理後的植物在溫室內栽培,處理20日後觀察評估對稗的防治效力,以0至10的11個階段表示(0無作用、10完全枯死,將中間分成1至9的階段加以評估)。 In a plastic cup having a diameter of 8 cm and a depth of 6.5 cm, a commercially available seedling soil was filled, and the seed of the pot was seeded in the cup, and the soil was covered for about 0.5 cm, and then cultivated in a greenhouse for a certain period of time. When the plant is grown to the 1st to 2nd leaf stage, the drug diluent containing the compound of the present invention is evenly spread over the entire plant with a certain amount of treatment. Further, the drug diluent is a dimethylformamide which is dissolved in a Tween emulsifier 20 (tween 20, polyoxyethylene sorbitan fatty acid ester, MP Biomedicals) by a certain amount of the compound of the present invention. The solution (2%) was prepared by diluting with deionized water. The treated plants were cultivated in a greenhouse, and after 20 days of treatment, the efficacy of the control against cockroaches was evaluated and evaluated in 11 stages of 0 to 10 (0 no effect, 10 completely dead, and the middle was divided into 1 to 9 stages to be evaluated. ).

以同樣的方式,其他的本發明化合物也提供進行試驗。 In the same manner, other compounds of the invention are also provided for testing.

其結果,化合物(I-1)、(I-2)、(I-3)、(I-4)、(I-5)、(I-6)、(I-7)、(I-8)、(I-9)、(I-11)、(I-12)、(I-13)、(I-14-1)、(I-14-2)、(I-14-3)、(I-14-5)、(I-14-6)、(I-14-7)、(I-14-8)、(I-14-9)、(I-14-10)、(I-14-11)、(I-14-12)、(I-14-13)、(I-14-14)、(I-14-15)、(I-14-16)、(I-14-17)、(I-14-18)、(I-14-19)、(I-14-20)、(I-14-21)、(I-14-22)、(I-14-23)、(I-14-24)、(I-14-25)、(I-14-26)、(I-14-27)、(I-14-28)、(I-14-29)、(I-14-30)、(I-14-31)、(I-14-32)、(I-14-33)、(I-14-34)、(I-14-35)、(I-14-36)、(I-14-37)、(I-14-38)、(I-14-39)、(I-14-40)、(I-14-41)、(I-14-42)、(I-14-43)、(I-14-44)、(I-14-45)、(I-14-46)、(I-14-47)、 (I-14-48)、(I-14-49)、(I-14-50)、(I-14-51)、(I-14-52)、(I-14-53)、(I-14-55)、(I-14-56)、(I-14-57)、(I-14-58)、(I-14-59)、(I-14-60)、(I-14-62)、(I-14-63)、(I-14-65)、(I-14-66)、(I-14-67)、(I-14-68)、(I-14-69)、(I-14-70)、(I-14-71)、(I-15-1)及(I-15-2)以1,000g/10000m2的處理藥量表現9以上的效力。 As a result, the compounds (I-1), (I-2), (I-3), (I-4), (I-5), (I-6), (I-7), (I-8) ), (I-9), (I-11), (I-12), (I-13), (I-14-1), (I-14-2), (I-14-3), (I-14-5), (I-14-6), (I-14-7), (I-14-8), (I-14-9), (I-14-10), (I -14-11), (I-14-12), (I-14-13), (I-14-14), (I-14-15), (I-14-16), (I-14 -17), (I-14-18), (I-14-19), (I-14-20), (I-14-21), (I-14-22), (I-14-23 ), (I-14-24), (I-14-25), (I-14-26), (I-14-27), (I-14-28), (I-14-29), (I-14-30), (I-14-31), (I-14-32), (I-14-33), (I-14-34), (I-14-35), (I -14-36), (I-14-37), (I-14-38), (I-14-39), (I-14-40), (I-14-41), (I-14 -42), (I-14-43), (I-14-44), (I-14-45), (I-14-46), (I-14-47), (I-14-48 ), (I-14-49), (I-14-50), (I-14-51), (I-14-52), (I-14-53), (I-14-55), (I-14-56), (I-14-57), (I-14-58), (I-14-59), (I-14-60), (I-14-62), (I -14-63), (I-14-65), (I-14-66), (I-14-67), (I-14-68), (I-14-69), (I-14 -70), (I-14-71), (I-15-1), and (I-15-2) exhibit an efficacy of 9 or more at a treatment amount of 1,000 g/10000 m 2 .

試驗例2 旱田發芽前處理試驗 Test Example 2 Pre-emergence treatment test in dry land

在直徑8cm、深度6.5cm的塑膠杯中,充填蒸氣滅菌過的旱田土壤,在該杯中播種義大利黑麥草的種子,覆土約0.5cm。繼之,將含有本發明化合物的藥劑稀釋液以一定的處理藥量在土壤表面均勻撒布。又,藥劑稀釋液是以與試驗例1同様的方法調製。將藥劑處理後的植物在溫室內栽培,處理3週後觀察評估對義大利黑麥草防治的效力,與試驗例1同様分成0至10的11個階段表示。 In a plastic cup having a diameter of 8 cm and a depth of 6.5 cm, steam-sterilized dry soil was filled, and seeds of Italian ryegrass were planted in the cup, covering about 0.5 cm. Subsequently, the drug diluent containing the compound of the present invention is evenly spread on the surface of the soil with a certain amount of treatment. Further, the drug diluent was prepared in the same manner as in Test Example 1. The plants treated with the drug were cultivated in a greenhouse, and the efficacy of the control against Italian ryegrass was evaluated after 3 weeks of treatment, and was shown in 11 stages divided into 0 to 10 in the same manner as in Test Example 1.

同様,其他的本發明化合物也提供進行試驗。 In the same manner, other compounds of the invention are also provided for testing.

其結果,化合物(I-2)、(I-3)、(I-4)、(I-5)、(I-6)、(I-7)、(I-8)、(I-11)、(I-12)、(I-13)、(I-14-1)、(I-14-2)、(I-14-3)、(I-14-5)、(I-14-6)、(I-14-7)、(I-14-8)、(I-14-9)、(I-14-12)、(I-14-15)、(I-14-16)、(I-14-17)、(I-14-19)、(I-14-20)、(I-14-22)、(I-14-23)、(I-14-24)、(I-14-25)、(I-14-26)、(I-14-27)、(I-14-29)、(I-14-30)、(I-14-31)、(I-14-32)、(I-14-33)、(I-14-34)、(I-14-35)、(I-14-36)、(I-14-38)、(I-14-39)、(I-14-40)、(I-14-41)、(I-14-43)、(I-14-44)、(I-14-47)、(I-14-51)、(I-14-52)、(I-14-53)、(I-14-55)、(I-14-56)、(I-14-58)、(I-14-59)、(I-14-62)、(I-14-63)、(I-14-66)、(I-14-67)、(I-14-68)、(I-14-70)、(I-14-71)、及(I-15-2)以1,000g/10000m2的處理藥量表現9以上的效 力。 As a result, the compounds (I-2), (I-3), (I-4), (I-5), (I-6), (I-7), (I-8), (I-11) ), (I-12), (I-13), (I-14-1), (I-14-2), (I-14-3), (I-14-5), (I-14 -6), (I-14-7), (I-14-8), (I-14-9), (I-14-12), (I-14-15), (I-14-16 ), (I-14-17), (I-14-19), (I-14-20), (I-14-22), (I-14-23), (I-14-24), (I-14-25), (I-14-26), (I-14-27), (I-14-29), (I-14-30), (I-14-31), (I -14-32), (I-14-33), (I-14-34), (I-14-35), (I-14-36), (I-14-38), (I-14 -39), (I-14-40), (I-14-41), (I-14-43), (I-14-44), (I-14-47), (I-14-51 ), (I-14-52), (I-14-53), (I-14-55), (I-14-56), (I-14-58), (I-14-59), (I-14-62), (I-14-63), (I-14-66), (I-14-67), (I-14-68), (I-14-70), (I -14-71) and (I-15-2) exhibit an efficacy of 9 or more at a treatment amount of 1,000 g/10000 m 2 .

試驗例3 對水田雜草的除草效果試驗 Test Example 3 Test for weeding effect on weeds in paddy fields

將蒸氣滅菌土壤充填於直徑9cm、深度10cm的塑膠杯,播種稻稗,在溫室內栽培至一定生長階段(1葉期)。調整蓄水深為3cm後,將含有本發明化合物的藥劑稀釋液以一定的處理藥量處理蓄水土壤。又,藥劑稀釋液是藉由將本發明化合物的一定量分別溶解於吐溫乳化劑20(聚氧基乙烯去水山梨醇脂肪酸酯,MP Biomedicals公司製)的丙酮溶液(2%),以去離子水稀釋而調製。將藥劑處理後的植物在溫室內栽培,在處理20日後觀察評估雜草防治的效力,以0至10的11個階段表示(0無作用、10完全枯死,其中間以等間隔分成1至9的階段評估)。 The steam-sterilized soil was filled in a plastic cup having a diameter of 9 cm and a depth of 10 cm, and the rice bran was sown and cultivated in a greenhouse to a certain growth stage (1 leaf stage). After adjusting the water storage depth to 3 cm, the drug dilution containing the compound of the present invention was treated with a certain treatment amount to treat the water storage soil. Further, the drug diluent is obtained by dissolving a predetermined amount of the compound of the present invention in an acetone solution (2%) of Tween emulsifier 20 (polyoxyethylene sorbitan fatty acid ester, MP Biomedicals). Dilute with deionized water to prepare. The plants treated with the medicament were cultivated in a greenhouse, and the efficacy of weed control was evaluated after 20 days of treatment, and was represented by 11 stages of 0 to 10 (0 no effect, 10 complete death, and 1 to 9 at equal intervals therebetween) Stage evaluation).

其結果,化合物(I-3)、(I-4)、(I-5)、(I-9)、(I-11)及(I-14-66)以1,000g/10000m2的處理藥量表現9以上的效力。化合物(I-2)、(I-6)、(I-7)、(I-8)、(I-12)、(I-13)、(I-14-1)、(I-14-2)、(I-14-3)、(I-14-29)、(I-14-32)、(I-14-33)、(I-14-66)、(I-14-68)、(I-14-71)、(I-15-1)及(I-15-2)以250g/10000m2的處理藥量表現9以上的效力。 As a result, the compounds (I-3), (I-4), (I-5), (I-9), (I-11), and (I-14-66) are treated with 1,000 g/10000 m 2 of the drug. The amount shows an effect of 9 or more. Compounds (I-2), (I-6), (I-7), (I-8), (I-12), (I-13), (I-14-1), (I-14- 2), (I-14-3), (I-14-29), (I-14-32), (I-14-33), (I-14-66), (I-14-68) (I-14-71), (I-15-1), and (I-15-2) exhibited an efficacy of 9 or more at a treatment amount of 250 g/10000 m 2 .

試驗例4 對水田雜草的除草效果試驗 Test Example 4 Test for weeding effect on weeds in paddy fields

將蒸氣滅菌土壤充填於直徑9cm、深度10cm的塑膠杯,播種稻稗,在溫室內栽培至一定生長階段(1葉期)。調整蓄水深為0cm後,將含有本發明化合物的藥劑稀釋液以一定的處理藥量進行莖葉處理。又,藥劑稀釋液是藉由將本發明化合物的一定量分別溶解於吐溫乳化劑20(聚氧基乙烯去水山梨醇脂肪酸酯,MP Biomedicals公司製)的二甲基甲醯胺溶液(2%),以去離子水稀釋而調製。處理24小時後,再灌水以使蓄水深成為3cm。將藥劑處理 後的植物在溫室內栽培,在處理20日後觀察評估雜草防治的效力,以0至10的11個階段表示(0無作用、10完全枯死,其中間以等間隔分成1至9的階段評估)。 The steam-sterilized soil was filled in a plastic cup having a diameter of 9 cm and a depth of 10 cm, and the rice bran was sown and cultivated in a greenhouse to a certain growth stage (1 leaf stage). After adjusting the water storage depth to 0 cm, the drug dilution containing the compound of the present invention was subjected to stem and leaf treatment at a predetermined treatment amount. Further, the drug diluent is obtained by dissolving a predetermined amount of the compound of the present invention in a dimethylformamide solution of Tween emulsifier 20 (polyoxyethylene sorbitan fatty acid ester, MP Biomedicals). 2%), prepared by dilution with deionized water. After 24 hours of treatment, water was refilled to make the water storage depth 3 cm. Dispensing the agent The plants were cultivated in a greenhouse, and the efficacy of weed control was evaluated after 20 days of treatment, and was expressed in 11 stages of 0 to 10 (0 no effect, 10 complete death, and a stage evaluation of 1 to 9 at equal intervals) ).

其結果,(I-14-5)、(I-14-6)、(I-14-7)、(I-14-8)、(I-14-12)、(I-14-13)、(I-14-15)、(I-14-16)、(I-14-17)、(I-14-18)、(I-14-19)、(I-14-20)、(I-14-21)、(I-14-22)、(I-14-23)、(I-14-24)、(I-14-25)、(I-14-26)、(I-14-27)、(I-14-28)、(I-14-30)、(I-14-31)、(I-14-34)、(I-14-35)、(I-14-36)、(I-14-37)、(I-14-38)、(I-14-39)、(I-14-40)、(I-14-41)、(I-14-43)、(I-14-44)、(I-14-46)、(I-14-47)、(I-14-48)、(I-14-51)、(I-14-52)、(I-14-53)、(I-14-55)、(I-14-56)、(I-14-58)、(I-14-59)、(I-14-60)、(I-14-62)、(I-14-63)、(I-14-67)、(I-14-69)及(I-14-70)化合物以1,000g/10000m2的處理藥量表現9以上的效力。 As a result, (I-14-5), (I-14-6), (I-14-7), (I-14-8), (I-14-12), (I-14-13) , (I-14-15), (I-14-16), (I-14-17), (I-14-18), (I-14-19), (I-14-20), ( I-14-21), (I-14-22), (I-14-23), (I-14-24), (I-14-25), (I-14-26), (I- 14-27), (I-14-28), (I-14-30), (I-14-31), (I-14-34), (I-14-35), (I-14- 36), (I-14-37), (I-14-38), (I-14-39), (I-14-40), (I-14-41), (I-14-43) , (I-14-44), (I-14-46), (I-14-47), (I-14-48), (I-14-51), (I-14-52), ( I-14-53), (I-14-55), (I-14-56), (I-14-58), (I-14-59), (I-14-60), (I- 14-62), (I-14-63), (I-14-67), (I-14-69), and (I-14-70) compounds exhibit 9 or more at a treatment dose of 1,000 g/10000 m 2 Effectiveness.

比較試驗例1 對水田雜草的除草效果試驗 Comparative test example 1 herbicidal effect test on weeds in paddy fields

依照試驗例3所述的方法,使用化合物(I-2)及比較化合物1進行對水田雜草的除草效果試驗。其結果表示於第2表。 The herbicidal effect test on the weeds in the paddy field was carried out according to the method described in Test Example 3 using the compound (I-2) and the comparative compound 1. The result is shown in the second table.

比較化合物1是在WO2009086041A1的Table 5CA(67至68頁)中記載為有除草活性的化合物。 Comparative Compound 1 is a compound which is described as herbicidal activity in Table 5CA (pp. 67 to 68) of WO2009086041A1.

本發明化合物具有雜草防治效力。 The compounds of the invention have weed control efficacy.

Claims (11)

式(I)表示的嗒酮化合物: [式中,R1表示氫、C1-6烷基、C3-8環烷基、(C3-8環烷基)C1-6烷基、C3-4烯基或C3-4炔基,R2表示氫、鹵素、氰基、硝基、C1-6烷基、C1-6鹵烷基、C1-6烷氧基、C1-6鹵烷氧基、C1-6烷硫基、C1-6烷基亞磺醯基、C1-6烷基磺醯基、C1-6鹵烷硫基、C1-6鹵烷基亞磺醯基、C1-6鹵烷基磺醯基、C3-8環烷基、(C3-8環烷基)C1-6烷基、C3-8環烷氧基、(C3-8環烷基)C1-6烷氧基、(C1-6烷硫基)C1-6烷氧基、(C1-6烷氧基)C1-6烷氧基、C3-6烯氧基、C3-6炔氧基、氰基C1-6烷氧基、(C1-6烷氧基)羰基C1-6烷氧基、胺甲醯基C1-6烷氧基、{(C1-6烷基)胺基羰基}C1-6烷氧基、{二(C1-6烷基)胺基羰基}C1-6烷氧基、胺基、C1-6烷胺基、二(C1-6烷基)胺基、甲醯基胺基、(C1-6烷基)羰基胺基、羥基C1-6烷基、(C1-6烷氧基)C1-6烷基、(C1-6鹵烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、{(C3-8環烷基)C1-6烷氧基}C1-6烷基、(C1-6烷硫基)C1-6烷基、(C1-6鹵烷硫基)C1-6烷基、氰基C1-6烷基、羥基亞胺基C1-6烷基、(C1-6烷氧基)亞胺基C1-6烷基、甲醯基或(C1-6烷基)羰基,R3表示鹵素、C1-3烷基、C1-3鹵烷基、C2-4烯基、C2-4炔基、 C1-3烷氧基、C1-3鹵烷氧基或C3-8環烷基,R4及R5可以相同或不相同,表示氫、鹵素、C1-3烷基、C1-3鹵烷基、C2-4烯基、C2-4炔基、C1-3烷氧基、C1-3鹵烷氧基或C3-8環烷基,A表示單環式或二環式縮合環的芳基、或者含由氮、氧及硫所成的群選出的1個以上的原子作為雜原子的單環式或二環式縮合環的雜芳基,該等基可以具有由B群選出的1個以上的原子或基,G表示氫或下述式表示的任一種基: [式中,L表示氧或硫,R6表示C1-12烷基、C3-8環烷基、C2-12烯基、C2-12炔基、可以具有由D群選出的1個以上的原子或基的C6-10芳基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-12烷基、C1-12烷氧基、C3-8環烷氧基、C3-12烯氧基、C3-12炔氧基、可以具有由D群選出的1個以上的原子或基的C6-10芳氧基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-12烷氧基、(C3-8環烷基)C1-6烷基、(C1-6烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、(C1-6烷硫基)C1-6烷基、(C1-6烷基亞磺醯基)C1-6烷基、(C1-6烷基磺醯基)C1-6烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳氧基)C1-12烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基硫基)C1-12烷基、{(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-6烷氧基}C1-6烷 基、(C3-8環烷基)C1-6烷氧基、二(C1-6烷基)胺基、二(C3-6烯基)胺基、(C1-6烷基)(C6-10芳基)胺基或5至6員的雜芳基,R7表示C1-6烷基、C1-3鹵烷基、可以具有由D群選出的1個以上的原子或基的C6-10芳基或二(C1-6烷基)胺基,R8及R9可以相同或不相同,表示C1-6烷基、C3-8環烷基、C6-10芳基、C1-6烷氧基、C3-8環烷氧基、C6-10芳氧基、(C6-10芳基)C1-6烷氧基、C1-6烷硫基或二(C1-6烷基)胺基,R10表示氫或C1-6烷基,W表示可以具有由D群選出的1個以上的原子或基的苯基、C1-6烷氧基、C1-6烷硫基、C1-6烷基亞磺醯基或C1-6烷基磺醯基;在這裏,R6、R7、R8、R9及W個別所表示的任意的基都可以具有鹵素,R6的C3-8環烷基,R6、R8及R9的C3-8環烷氧基,R8及R9的(C1-6烷基)(C6-10芳基)胺基的芳香部分及5至6員的雜芳基任何一個都可以具有C1-6烷基],B群:由鹵素、C1-3烷基、C1-3鹵烷基、C1-3烷氧基、C1-3鹵烷氧基、C3-8環烷基、C2-4烯基、C2-4鹵烯基、C2-4炔基、C1-3烷硫基、C1-3鹵烷硫基、C1-3烷基亞磺醯基、C1-3鹵烷基亞磺醯基、C1-3烷基磺醯基、C1-3鹵烷基磺醯基、硝基、氰基、(C1-6烷基)羰基、(C1-6烷氧基)羰基、胺甲醯基、(C1-3烷基)胺基羰基、二(C1-3烷基)胺基羰基、(C1-6烷基)羰基胺基、(C3-8環烷基)羰基胺基、(C3-8烷氧基)羰基胺基、及(C1-3烷氧基)C1-3烷基所成的群,D群:由鹵素、C1-6烷基、C1-3鹵烷基、C1-3烷氧基、C1-3鹵烷氧基、C1-3烷硫基、氰基及硝基所成的群]。 嗒 expressed by formula (I) Ketone compounds: Wherein R 1 represents hydrogen, C 1-6 alkyl, C 3-8 cycloalkyl, (C 3-8 cycloalkyl) C 1-6 alkyl, C 3-4 alkenyl or C 3- 4 alkynyl, R 2 represents hydrogen, halogen, cyano, nitro, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 1-6 alkylthio, C 1-6 alkylsulfinyl, C 1-6 alkylsulfonyl, C 1-6 haloalkylthio, C 1-6 haloalkylsulfinyl, C 1-6 haloalkylsulfonyl, C 3-8 cycloalkyl, (C 3-8 cycloalkyl) C 1-6 alkyl, C 3-8 cycloalkoxy, (C 3-8 naphthenic) yl) C 1-6 alkoxy, (C 1-6 alkylthio) C 1-6 alkoxy, (C 1-6 alkoxy) C 1-6 alkoxy, C 3-6 alkenyloxy a group, a C 3-6 alkynyloxy group, a cyano C 1-6 alkoxy group, a (C 1-6 alkoxy)carbonyl C 1-6 alkoxy group, an amine carbaryl C 1-6 alkoxy group, {(C 1-6 alkyl)aminocarbonyl}C 1-6 alkoxy, {di(C 1-6 alkyl)aminocarbonyl}C 1-6 alkoxy, amine, C 1-6 An alkylamino group, a di(C 1-6 alkyl)amino group, a decylamino group, a (C 1-6 alkyl)carbonylamino group, a hydroxy C 1-6 alkyl group, a (C 1-6 alkoxy group) C 1-6 alkyl, (C 1-6 haloalkoxy) C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, {(C 3-8 naphthenic) Base) C 1-6 alkoxy} C 1-6 alkane , (C 1-6 alkylthio) C 1-6 alkyl, (C 1-6 haloalkylthio) C 1-6 alkyl, cyano C 1-6 alkyl, hydroxyimino C 1 a -6 alkyl group, a (C 1-6 alkoxy) imido C 1-6 alkyl group, a decyl group or a (C 1-6 alkyl) carbonyl group, and R 3 represents a halogen, a C 1-3 alkyl group, C 1-3 haloalkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-3 alkoxy, C 1-3 haloalkoxy or C 3-8 cycloalkyl, R 4 and R 5 may be the same or different and represents hydrogen, halogen, C 1-3 alkyl, C 1-3 haloalkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-3 alkoxy, C 1-3 haloalkoxy or C 3-8 cycloalkyl, A represents an aryl group of a monocyclic or bicyclic condensed ring, or one or more selected from the group consisting of nitrogen, oxygen and sulfur. a heteroaryl group having a monocyclic or bicyclic condensed ring of a hetero atom, wherein the group may have one or more atoms or groups selected from the group B, and G represents hydrogen or any one of the following formulas: Wherein L represents oxygen or sulfur, and R 6 represents C 1-12 alkyl, C 3-8 cycloalkyl, C 2-12 alkenyl, C 2-12 alkynyl, and may have 1 selected from group D. one or more atoms or C 6-10 aryl group, (D may have selected a group of one or more atoms or groups C 6-10 aryl) C 1-12 alkyl, C 1-12 alkoxy a C 3-8 cycloalkoxy group, a C 3-12 alkenyloxy group, a C 3-12 alkynyloxy group, a C 6-10 aryloxy group which may have one or more atoms or groups selected from the D group, (C 6-10 aryl group having 1 or more atoms or groups selected from the D group) C 1-12 alkoxy group, (C 3-8 cycloalkyl) C 1-6 alkyl group, (C 1 -6 alkoxy) C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, (C 1-6 alkylthio) C 1-6 alkyl, (C 1- 6 alkylsulfinyl acyl) C 1-6 alkyl, (C C1-6 alkylsulfonyl group) C 1-6 alkyl, (C may have a group selected from D or more atoms or groups 6-10 aryloxy) C 1-12 alkyl, (D may have selected a group of one or more atom or group of C 6-10 arylthio) C 1-12 alkyl, {(may have One or more atoms selected from group D or a C 6-10 aryl)C 1-6 alkoxy}C 1-6 alkyl group, (C 3-8 cycloalkyl) C 1-6 alkoxy group base Di (C 1-6 alkyl) amino, di (C 3-6 alkenyl) amino, (C 1-6 alkyl) (C 6-10 aryl) amino group or 5-6 heteroaryl And R 7 represents a C 1-6 alkyl group, a C 1-3 haloalkyl group, a C 6-10 aryl group or a di(C 1-6 alkyl group) which may have one or more atoms or groups selected from the D group. Amino, R 8 and R 9 may be the same or different and represent C 1-6 alkyl, C 3-8 cycloalkyl, C 6-10 aryl, C 1-6 alkoxy, C 3-8 Cycloalkoxy, C 6-10 aryloxy, (C 6-10 aryl) C 1-6 alkoxy, C 1-6 alkylthio or di(C 1-6 alkyl)amine, R 10 represents hydrogen or C 1-6 alkyl, W represents a one or more atom or group selected from the group D is phenyl, C 1-6 alkoxy, C 1-6 alkylthio, C 1- a 6 -alkylsulfinyl group or a C 1-6 alkylsulfonyl group; here, any of R 6 , R 7 , R 8 , R 9 and W each independently may have a halogen, R 6 C 3-8 cycloalkyl, R 6 , R 8 and R 9 C 3-8 cycloalkoxy, R 8 and R 9 (C 1-6 alkyl)(C 6-10 aryl)amino Any of the aromatic moiety and the heteroaryl group of 5 to 6 members may have a C 1-6 alkyl group, and the group B: halogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-3 alkane Oxyl, C 1- 3 -haloalkoxy, C 3-8 cycloalkyl, C 2-4 alkenyl, C 2-4 haloalkenyl, C 2-4 alkynyl, C 1-3 alkylthio, C 1-3 halo Sulfhydryl, C 1-3 alkylsulfinyl, C 1-3 haloalkylsulfinyl, C 1-3 alkylsulfonyl, C 1-3 haloalkylsulfonyl, nitro, Cyano, (C 1-6 alkyl)carbonyl, (C 1-6 alkoxy)carbonyl, aminecarbamyl, (C 1-3 alkyl)aminocarbonyl, di(C 1-3 alkyl) Aminocarbonyl, (C 1-6 alkyl)carbonylamino, (C 3-8 cycloalkyl)carbonylamino, (C 3-8 alkoxy)carbonylamino, and (C 1-3 alkoxy a group of C 1-3 alkyl groups, group D: from halogen, C 1-6 alkyl, C 1-3 haloalkyl, C 1-3 alkoxy, C 1-3 haloalkoxy a group of C 1-3 alkylthio, cyano and nitro groups]. 如申請專利範圍第1項所述的嗒酮化合物, 其中,A表示苯基、萘基、吡啶基、嗒基、嘧啶基、吡基、苯并噻唑基、苯并唑基、喹啉基、噌啉基、喹唑啉基、喹啉基或苯并三基,該等的基可以具有由B群選出的1個以上的原子或基,G表示氫或下述式表示的任一種基: [式中,R6a表示C1-12烷基、C1-12鹵烷基、C3-8環烷基、可以具有由D群選出的1個以上的原子或基的C6-10芳基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-12烷基、C1-12烷氧基、C3-12烯氧基、C3-12炔氧基、可以具有由D群選出的1個以上的原子或基的C6-10芳氧基、(C3-8環烷基)C1-6烷基、(C1-6烷氧基)C1-6烷基、(C3-8環烷氧基)C1-6烷基、(C1-6烷硫基)C1-6烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳氧基)C1-12烷基、(可以具有由D群選出的1個以上的原子或基的C6-10芳基硫基)C1-12烷基、{(可以具有由D群選出的1個以上的原子或基的C6-10芳基)C1-6烷氧基}C1-6烷基或(C3-8環烷基)C1-6烷氧基,R7a表示C1-6烷基或可以具有由D群選出的1個以上的原子或基的C6-10芳基,Wa表示C1-3烷氧基或可以具有由D群選出的1個以上的原子或基的苯基]B群是鹵素、C1-3烷基、C1-3鹵烷基、C1-3烷氧基、C1-3鹵烷氧基、硝基或氰基。 As described in the first paragraph of the patent application scope a ketone compound, wherein A represents a phenyl group, a naphthyl group, a pyridyl group, an anthracene Base, pyrimidinyl, pyridyl Benzothiazolyl, benzo Azyl, quinolyl, porphyrin, quinazolinyl, quin Porphyrin or benzotrien The group may have one or more atoms or groups selected from the group B, and G represents hydrogen or any of the groups represented by the following formula: Wherein R 6a represents a C 1-12 alkyl group, a C 1-12 haloalkyl group, a C 3-8 cycloalkyl group, or a C 6-10 aryl group which may have one or more atoms or groups selected from the D group. a group, a C 6-10 aryl group (which may have one or more atoms or groups selected from the D group), a C 1-12 alkyl group, a C 1-12 alkoxy group, a C 3-12 alkenyloxy group, a C 3 group a -12 alkynyloxy group, a C 6-10 aryloxy group having 1 or more atoms or groups selected from the D group, (C 3-8 cycloalkyl) C 1-6 alkyl group, (C 1-6 Alkoxy)C 1-6 alkyl, (C 3-8 cycloalkoxy) C 1-6 alkyl, (C 1-6 alkylthio) C 1-6 alkyl, (may have a group D C 6-10 aryl group selected one or more atom or group) C 1-12 alkyl, (which may have one or more atom or group selected from the group D C 6-10 arylthio) C 1-12 alkyl, {(C 6-10 aryl which may have 1 or more atoms selected from the D group) C 1-6 alkoxy} C 1-6 alkyl or (C 3- 8 -cycloalkyl)C 1-6 alkoxy, R 7a represents a C 1-6 alkyl group or a C 6-10 aryl group which may have one or more atoms or groups selected from the D group, and W a represents C 1 a -3 alkoxy group or a phenyl group B which may have one or more atoms or groups selected from the D group is a halogen, a C 1-3 alkyl group , C 1-3 haloalkyl, C 1-3 alkoxy, C 1-3 haloalkoxy, nitro or cyano. 如申請專利範圍第2項所述的嗒酮化合物,其中,R2是氫、C1-3烷基、C1-3鹵烷基、C1-6烷氧基、C1-6鹵烷氧基、C3-8環烷基、C3-8環烷氧基或(C3-8環烷基)C1-6烷氧基。 As described in the second paragraph of the patent application scope a ketone compound, wherein R 2 is hydrogen, C 1-3 alkyl, C 1-3 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 3-8 cycloalkyl, C 3-8 cycloalkoxy or (C 3-8 cycloalkyl) C 1-6 alkoxy. 如申請專利範圍第3項所述的嗒酮化合物,其中,R1是甲基。 As described in item 3 of the patent application scope A ketone compound wherein R 1 is a methyl group. 如申請專利範圍第3項所述的嗒酮化合物,其中,R2是氫、甲基或甲氧基。 As described in item 3 of the patent application scope A ketone compound wherein R 2 is hydrogen, methyl or methoxy. 如申請專利範圍第2項所述的嗒酮化合物,其中,R1是甲基,R2是氫、甲基或甲氧基,R3是甲基、乙基、丙基、環丙基、鹵素或鹵甲基。 As described in the second paragraph of the patent application scope A ketone compound wherein R 1 is methyl, R 2 is hydrogen, methyl or methoxy, and R 3 is methyl, ethyl, propyl, cyclopropyl, halogen or halomethyl. 如申請專利範圍第1項所述的嗒酮化合物,其中,A是吡啶基、苯并噻唑基、苯并唑基或喹啉基,該等的基可以具有由B群選出的1個以上的原子或基。 As described in the first paragraph of the patent application scope a ketone compound wherein A is pyridyl, benzothiazolyl, benzo The azole group or the quinolyl group may have one or more atoms or groups selected from the group B. 如申請專利範圍第6項所述的嗒酮化合物,其中,R3是甲基、乙基、丙基、環丙基,R4及R5是氫,A是吡啶基、苯并噻唑基、苯并唑基或喹啉基,該等的基可以具有由B群選出的1個以上的原子或基。 As described in item 6 of the patent application scope a ketone compound wherein R 3 is methyl, ethyl, propyl or cyclopropyl, R 4 and R 5 are hydrogen, and A is pyridyl, benzothiazolyl, benzo The azole group or the quinolyl group may have one or more atoms or groups selected from the group B. 一種除草劑,係含有如申請專利範圍第1項至第8項中任一項所述的嗒酮化合物作為有效成分。 A herbicide containing the hydrazine as described in any one of claims 1 to 8. A ketone compound is used as an active ingredient. 一種雜草的防治方法,是將如申請專利範圍第1項至第8項中任一項所述的嗒酮化合物的有效量施用於雜草或雜草生長的土壤的雜草的防治方法。 A method for controlling weeds according to any one of claims 1 to 8 An effective amount of a ketone compound is applied to the control of weeds in weeds or weed-growing soils. 一種申請專利範圍第1項至第8項任一項所述的嗒酮化合物 之用途,係用於雜草的防治。 A patent application according to any one of claims 1 to 8 The use of ketone compounds is used for the control of weeds.
TW103103102A 2013-01-30 2014-01-28 Pyridazinone compound and herbicide containing the same TW201443026A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013015195 2013-01-30

Publications (1)

Publication Number Publication Date
TW201443026A true TW201443026A (en) 2014-11-16

Family

ID=51262467

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103103102A TW201443026A (en) 2013-01-30 2014-01-28 Pyridazinone compound and herbicide containing the same

Country Status (2)

Country Link
TW (1) TW201443026A (en)
WO (1) WO2014119770A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI508957B (en) * 2013-06-27 2015-11-21 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201412735D0 (en) * 2014-07-17 2014-09-03 Syngenta Participations Ag Herbicidal compounds
GB201507464D0 (en) 2015-04-30 2015-06-17 Syngenta Participations Ag Herbicidal compounds
PL3438095T3 (en) * 2016-03-30 2021-11-29 Ishihara Sangyo Kaisha, Ltd. Pyridazinone compound or its salt, and herbicide containing it
JP2021008405A (en) * 2017-09-27 2021-01-28 石原産業株式会社 Pyridazinone-based compound or salt thereof, and herbicide containing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008002703A1 (en) * 2007-09-14 2009-11-20 Sumitomo Chemical Co Compounds derived from 1,4-dihydro-2h-pyridazin-3-one; herbicidal composition comprising said compounds; weed control method; use of said compounds for weed control; and intermediate compounds.
CL2008003785A1 (en) * 2007-12-21 2009-10-09 Du Pont Pyridazine derived compounds; herbicidal compositions comprising said compounds; and method of controlling the growth of unwanted vegetation.
EP2204366A1 (en) * 2008-12-19 2010-07-07 Bayer CropScience AG Herbicidal and insecticidal phenyl-substituted pyridazinones
JP2010235603A (en) * 2009-03-13 2010-10-21 Sumitomo Chemical Co Ltd Pyridazinone compound and use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI508957B (en) * 2013-06-27 2015-11-21 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands

Also Published As

Publication number Publication date
WO2014119770A1 (en) 2014-08-07

Similar Documents

Publication Publication Date Title
JP2010235603A (en) Pyridazinone compound and use thereof
US20100216642A1 (en) Pyridazinone compound and herbicide containing the same
CN102428082A (en) Pyrimidine compound and its use in pest control
TW201443026A (en) Pyridazinone compound and herbicide containing the same
JP2011098956A (en) Iso-oxazoline compound and application thereof
US20110319266A1 (en) Herbicidal composition
EP2906557B1 (en) Pyrone compounds and herbicides comprising the same
JP2012056903A (en) Pyridazinone compound, and herbicide and noxious arthropod controlling agent containing the same
JP6205427B2 (en) Dihydropyrone compound and herbicide containing the same
JP2014210806A (en) Pyridazinone compound and herbicide comprising the same
WO2014084410A1 (en) Cyclohexanone compounds and herbicides comprising the same